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SUMMARY 
The cortex is a contractile cross-linked network of actin filaments and myosin motors lining the plasma 
membrane. It defines the shape of animal cells, and regulated changes in cortex mechanics drive many 
cellular processes, including cell migration and division. The molecular mechanisms controlling cortical 
contractility in space and time are therefore essential for cell physiology, but are still not well 
understood.  
During cell division, in cytokinesis, tightly controlled changes to cortical contractility separate the two 
daughter cells. When very large cells undergo cell divisions, they exhibit highly stereotypical patterns 
of cortical contractility, termed surface contraction waves (SCWs). These waves occur in cells of a wide 
variety of species and move across the cells immediately prior to the division. The molecular 
mechanisms underlying this striking phenomenon are not known. 
I set out to investigate SCWs in starfish oocytes, which display a prominent contraction wave during 
the meiotic division which can be imaged live using fluorescence microscopy. Combined with 
quantitative image analysis, this allowed me to correlate cell shape changes with the localization of 
key cortical and cell cycle proteins in untreated oocytes and following biochemical and physical 
manipulations.  
I find that morphologically the contraction wave is a band of flattening that forms at the vegetal pole 
and moves across the cell to the animal pole. The flattening is driven by increased cortical contractility 
induced by localisation of myosin II to the cortex. Myosin II recruitment is controlled by RhoA kinase 
and RhoA, which in turn is activated by release of its inhibition by the cell cycle kinase, cdk1-cyclin B. 
Importantly, I could show that cdk1-cyclin B activity forms a gradient along the animal-vegetal axis 
generated by the accumulation of cdk1-cyclin B in the nucleus which is located at the animal pole. 
Therefore, as cyclin B is degraded, the bottom threshold of cdk1 activity will be reached first opposite 
of the animal pole, marking the starting point of the contraction wave. The gradient of cdk1-cyclin B 
activity furthermore controls the progression of the contraction wave across the cell. Additionally, I 
show that feedback internal to the downstream signalling network contributes to defining the speed 
of the wave and determines the width of the band of activity. 
Overall, this data for the first time establishes the molecular mechanisms underlying SCWs, a 
phenomenon observed in oocytes of many species. I show that the contraction wave is driven by the 
highly conserved RhoA-Rok-Myosin II pathway, and is patterned in space and time by an activity 
gradient of cdk1 as well as feedbacks internal to the signalling pathway. My work thereby reveals how 
this biochemical signalling network can define a spatially and temporally complex cellular behaviour.   
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ZUSAMMENFASSUNG 
Unterhalb der Zellmembran liegt in allen tierischen Zellen der Zellkortex. Dieser ist ein dicht 
verknüpftes kontraktiles Netz aus Aktinfilamenten und Myosin- Motorproteinen. Der Kortex definiert 
die Form aller Zellen. Kontrollierte Veränderungen in der Kortexmechanik steuern viele zelluläre 
Vorgänge wie Zellmigration und Zellteilung. Auch wenn die molekularen Mechanismen, die die 
Kontraktilität des Kortexes lokal und temporal kontrollieren, für die Zellphysiologie essentiell sind, 
wissen wir noch wenig über sie. 
Während der Zellteilung führen straff kontrollierte Veränderungen in kortikalen Kontraktilität zur 
Spaltung der Zelle. Wenn sich sehr große Zellen teilen, zeigen sie in diesem Prozess stereotype Formen 
kortikaler Kontraktilität, die Oberflächenkontraktionswellen genannt werden. Diese 
Kontraktionswellen kommen in vielen verschiedenen Spezies vor und laufen kurz vor der Zellteilung 
über die gesamte Zelloberfläche. Die molekularen Mechanismen, die zu diesen eindrucksvollen 
Bewegungen führen, waren bisher nicht bekannt. 
Ich habe die Oberflächenkontraktionswellen in Seesterneizellen erforscht, da diese eine deutliche 
Kontraktionswelle während ihrer meiotischen Zellteilung zeigen, die mit Fluoreszenzmikroskopie live 
gut beobachtet werden kann. In Kombination mit quantitativer Bildanalyse konnte ich die 
Veränderungen der Zellform mit der Verteilung bedeutender Proteine des Zellkortex und des 
Zellzyklus jeweils in unbehandelten und biochemisch und physikalisch manipulierten Eizellen in 
Verbindung bringen.  
Ich fand heraus, dass die Kontraktionswelle entsteht, indem sich ein Band des abgeflachten Kortexes 
am vegetativen Pol der Zelle bildet und sich über die gesamte Zelle zum animalen Pol hin bewegt. 
Diese Abflachung wird durch die lokal steigende kortikale Kontraktilität ausgelöst, die durch eine 
Lokalisation von Myosin II Molekülen zum Kortex entsteht. Diese Ansammlung von Myosin II wird von 
der RhoA Kinase und RhoA gesteuert, welche wiederum selbst aktiviert werden, indem ihre Hemmung 
durch die wichtige Zellzykluskinase Cdk1-cyclin B aufgehoben wird. Ich konnte zeigen, dass die 
Aktivität von Cdk1-cyclin B einen Gradienten quer durch die Zelle entlang der animalen-vegetativen 
Achse bildet. Dieser entsteht durch die Ansammlung von Cdk1-cyclin B im am animalen Pol gelegenen 
Zellkern. Daher wird, während Cyclin B im Laufe des Zellzyklus abgebaut wird, der untere Grenzwert 
der Cdk1 Aktivität zuerst gegenüber des animalen Pols erreicht, wo sich der Startpunkt der 
Kontraktionswelle befindet. Des Weiteren kontrolliert der Gradient der Cdk1-cyclin B Aktivität die 
Ausbreitung der Welle über die gesamte Zelle hinweg. Außerdem konnte ich zeigen, dass ein Feedback 
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auf dem Signalweg dazu beiträgt, die Geschwindigkeit mit der sich die Welle ausbreitet und die Breite 
des Aktivitätsbandes zu definieren. 
Die von mir hier vorgestellten Daten beschreiben zum ersten Mal die molekularen Mechanismen die 
den Oberflächenkontraktionswellen, einem weit verbreiteten Phänomen, welches in den Eizellen 
vieler Spezies vorkommt, zu Grunde liegen. Ich kann zeigen, dass die Kontraktionswellen von der hoch 
konservierten Signalkaskade RhoA-Rok-Myosin II kontrolliert werden und dass sie in ihrem räumlichen 
und zeitlichen Auftreten sowohl durch einen Gradienten von Cdk1 Aktivität als auch durch internes 
Feedback auf dem Signalweg bestimmt werden. Meine Arbeit zeigt daher, wie ein biochemisches 
Signalsystem solch ein räumlich und zeitlich komplexes Zellverhalten hervorrufen kann.  
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1.1 CORTICAL CONTRACTILITY 
1.1.1 Cortical contractility controls key cellular functions 
The cortex is a thin meshwork of actin filaments and many associated proteins which lies directly 
underneath the cell membrane in all animal cells. The plasticity and contractility of the cortex are key 
for most cellular processes. 
In the steady state the cortex protects cells against outside mechanical disruption (Bray & White 1988) 
and serves as a counterforce to the internal osmotic pressure (Stewart et al. 2011). In non-animal cells 
this function is fulfilled by the cell wall. As the cortex determines the cell shape, cortical contractility 
is key in shaping tissues during development (Figure 1a and b)(Levayer & Lecuit 2012). The ability to 
the cortex to contract is furthermore important during cell migration, both in normal cells (Cramer 
2010) as well as in metastasis of cancer cells (Figure 1d and e)(Sedzinski et al. 2011; Charras & Paluch 
2008). Cortical contractility is also the key driving force behind cell division, the process by which a 
single cell gives rise to two daughter cells (Figure 1c) (Stewart et al. 2011; Kunda et al. 2008).   
Figure 1: Cortical contractility drives diverse cellular functions. 
These range from changes in cell shape (a,b), to cytokinesis (c) and cell migration (d,e). The green area shows the parts of the 
cell cortex that is contracting. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews (Murrell et al. 2015), 
copyright 2015. 
Even though it is a key feature of cells and their behaviour, a lot of things remain unknown about the 
cortex and cortical contractility, such as cortical organisation on the filament level or how the cortex’s 
mechanical properties and responses are regulated. 
1.1.2 The cortex has a complex molecular architecture 
1.1.2.1 The cortex is an actin meshwork with many associated proteins 
As the cortex serves such varied and important functions its structure is understandably complex. The 
key component of the cortex is actin, organised in a highly crosslinked meshwork of filaments. In 
addition to the actin filaments, the cortex contains a large number of other proteins required for 
cortical integrity and function. Even though it is a complex assembly of many proteins, the cortex as a 
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whole is a relatively thin structure with a thickness of around 100 nm (Clark et al. 2013). This thickness 
seems to be well conserved between different cells, from Dictyostelium (Ogihara et al. 1988) to 
mammalian cells (Charras et al. 2006; Clark et al. 2013). The whole actin cortex turns over rapidly, in 
the range of 30 sec (Fritzsche et al. 2013). This allows for stress dissipation and quick responses to the 
changing environment. 
 
Figure 2: Actin forms a variety of structures in the cell. 
While all cells have an actin cortex (i), cells under certain conditions also form other complex actin structures, such as 
lamellipodia (a,b) and filopodia (v). As shown, the actin cortex consists of actin filaments along with myosin and ERM proteins. 
Figure form (Blanchoin et al. 2014), copyright Physiological Reviews, 2014. 
The cortex is one of many actin structures in the cell (Figure 2), in which actin filaments interact with 
a wide variety of proteins, allowing the cortex to fulfil its various functions. The proteins of the cortex 
fall into 4 categories: (1) actin nucleators, (2) actin crosslinkers, (3) cortex-membrane crosslinkers, and 
(4) motor proteins. 
(1) The key actin nucleators in the cortex are Arp2/3 and formins, which, at least in human cells, 
produce roughly half of the actin filaments each (Bovellan et al. 2014). These two actin nucleators give 
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rise to two different populations of actin filaments. Formins form long, straight actin filaments (Higgs 
2005) while Arp2/3 nucleated actin is highly branched (Mullins et al. 1998). These actin nucleators are 
in turn regulated by a variety of activators. In the cortex Arp2/3, for example, is regulated by the WASP 
and WAVE protein family (Takenawa & Miki 2001). This allows for the specific regulation of actin 
polymerisation in the cortex. 
(2) The actin filaments in the cortex are highly crosslinked to form a coherent strong network. The 
actin crosslinkers are a very diverse group, and most actin binding and crosslinking proteins have been 
shown to localise to the cortex. The key crosslinkers appear to be α-actinin, fimbrin and filamin 
(Falzone et al. 2012; Stossel et al. 2001). Crosslinkers are key for producing a coherent meshwork, and 
for allowing force generation between actin filaments. This is achieved by crosslinkers forming points 
against which forces can be applied, as a non-crosslinked network only undergoes translation of 
filaments relative to each other (Figure 3) (Schaller et al. 2013).  
Figure 3: Contraction of motors on actin filaments with and without crosslinkers.  
A) Motor action on actin filaments without crosslinkers leads to sliding of the filaments against each other. B) When motors 
work on crosslinked actin filaments internal stress is generated, which can lead to buckling of the actin filaments. Reprinted 
by permission from Macmillan Publishers Ltd: Nature Reviews (Murrell et al. 2015), copyright 2015. 
(3) The cortex is linked to the membrane via a well-conserved protein family called ERMs – Ezrin, 
Radixin, Moesin (Figure 4) (Fehon et al. 2010). Other anchor-proteins, such as ankyrin B, are also 
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involved (Charras et al. 2006). The ERMs are multi-domain proteins which can in their active 
conformation bind to both the plasma membrane and actin filaments and thereby tether the cortex 
to the membrane. They also play important roles in forming specific membrane domains, by locally 
increasing the concentration of certain anchored proteins, i.e. during signalling.   
Figure 4: ERM proteins link the cortex to the membrane. 
Ezrin, a member of the ERM family of proteins, links actin filaments of the cortex to the membrane via interaction with 
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Reprinted by permission from Macmillan Publishers Ltd: Nature 
Reviews (Fehon et al. 2010), copyright 2010. 
(4) To generate cortical tension and contractility, motor proteins which generate force on the actin 
filaments are required. Even though a variety of motor proteins have been shown to localise to the 
cortex, such as myosin I, it is clear that the main driver of cortical contractility, as well as cortical 
tension, is a single protein complex called non-muscle myosin II (Salbreux et al. 2012).    
1.1.2.2 Myosin II is the key motor generating cortical contractility 
There are 20 known classes of myosins (Krendel & Mooseker 2005), of which myosin II is the most 
studied and best understood. Non-muscle myosin II, the myosin II isoform found in all cells except 
striated muscle cells, is a hexamer made up of 2 heavy chains (230 kDa each), 2 essential light chains 
(17 kDa each) and 2 regulatory light chains (20 kDa each) (Vicente-Manzanares et al. 2009). These six 
proteins form a structurally highly conserved protein complex, which is characterised by a head, neck, 
long coiled-coil rod and a short tail (Figure 5a). Myosin binds to its substrate F-actin through the head 
domain and translocates along the filament.  
The movement is achieved through the transfer of chemical energy into mechanical work via a 
conformational change in the neck region induced by ATP hydrolysis. This moves the myosin head 
along the actin filament. To achieve efficient contractility, non-muscle myosin II proteins assemble 
into bipolar filaments through their rod domains (Figure 5b)(Ricketson et al. 2010).  
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Figure 5: Non-muscle myosin II. 
(a) Myosin structure of the individual molecular complex in the active and inactive state, (b) as well as the formation of bipolar 
filaments and subsequent binding to actin. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews (Vicente-
Manzanares et al. 2009), copyright 2009. 
Myosin II driven contraction has mainly be studied in striated muscle cells, where myosin II and the 
actin filaments on which it contracts are organised in a very ordered manner. We owe a lot of our 
understanding of the workings of myosin II to this highly organised system. But in most other contexts, 
such as in the cortex, contractility arises on unorganised actin filaments in a process we understand 
much less about (Murrell et al. 2015).  
1.1.3 Cortical contractility is regulated on multiple levels 
1.1.3.1 Rho GTPases regulate cortical contractility via different pathways 
The cortical architecture is clearly highly complex with myosin II being one of the main components in 
addition to the actin filaments. Myosin II in this context drives cortical contractility. This contractility 
is important for cortical functions and is therefore highly regulated. One of the key regulatory 
mechanisms is mediated by the Rho family of GTPases.  
GTPases are molecular switches, which have an active GTP-bound and an inactive GDP-bound form 
(Figure 6)(Jaffe & Hall 2005). The GTP-bound active form of these lipid-modified proteins binds to the 
membrane. This membrane binding is obligatory for the interaction with its downstream effectors 
while the inactive form of the GTPase is localised in the cytoplasm. While the name suggests that 
GTPases are able to hydrolyse GTP, on its own this reaction is very slow (Haeusler et al. 2003) and in 
vivo only works with the assistance of a GTPase activating protein (GAPs) (Bernards 2003). GAPs are 
specific to the individual GTPase and promote the transition from the active to the inactive state 
(Figure 6). On the activatory side of the cycle, guanine nucleotide exchange factors (GEFs) serve to 
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activate the GTPases by exchanging GDP for GTP (Schmidt & Hall 2002). An additional layer of control 
is achieved through the function of guanine nucleotide dissociation inhibitors (GDIs). These proteins 
bind to the inactive cytoplasmic form and prevent spontaneous activation by inhibiting nucleotide 
disassociation as well as capping the membrane interacting domain (Figure 6)(Olofsson 1999).  
 
Figure 6: The regulatory cycle of Rho GTPases. 
Active GTP-bound Rho is localised to the membrane where it activates its effectors. The active Rho is converted into an inactive 
GDP-bound Rho by the activity of GAPs while the reverse reaction is driven by GEFs. GDIs maintain Rho in its inactive state 
while GDFs lift this inhibition. Reprinted with permission from John Wiley and Sons: BioEssays (Bement et al. 2006), copyright 
2006. 
Of the many classes of GTPases, the Rho family is the most important in regulating cortical 
contractility. It has 22 members in mammals, the most common of which are RhoA, Cdc42 and Rac 
(Jaffe & Hall 2005; Hall 1998). These 3 proteins alone have many downstream target proteins, affecting 
varied cellular processes (Figure 7) (Bishop & Hall 2000). 
9 
 
Figure 7: Downstream effectors of the key Rho GTPases family members. 
The three Rho GTPase family members RhoA, Cdc42 and Rac have many downstream effectors which regulate a wide variety 
of cellular process. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews (Iden & Collard 2008), copyright 
2008. 
The Rho GTPases regulate cortical contractility via multiple effectors. One is via a change in the actin 
polymerisation, either directly by activating actin nucleators like the formin mDia (Otomo et al. 2005), 
or by activating actin nucleation regulators, such as WASP and WAVE (Takenawa & Miki 2001). These 
factors, in turn, activate the actin nucleator Arp2/3. At the same time, both RhoA and Cdc42 can 
activate myosin II contractility via the kinases ROCK or MRCK (Leung et al. 1996), thereby controlling 
cortical contractility.  
1.1.3.2 Myosin-driven contractility is regulated via phosphorylation 
Myosin II activity is in the short term regulated by the phosphorylation by such kinases. The target of 
this phosphorylation is the regulatory light chain (MRLC). The main phosphorylation sites of MRLC are 
the amino acids Thr18 and Ser19 (Hirata et al. 2009; Ikebe et al. 1986). The phosphorylation of these 
sites does not result in an increase in actin binding affinity (Sellers et al. 1982), but rather in an increase 
in the ATPase activity (Somlyo & Somlyo 2003). This increases myosin movement speed and 
processivity, and it also increases myosin filament assembly (Scholey et al. 1980).  
The main kinases phosphorylating this site are myosin light chain kinase (MLCK), citron kinase and Rho 
kinase (Rok) (Somlyo & Somlyo 2003; Matsumura 2005; Tan et al. 2008). With multiple kinases 
phosphorylating the same site, the specificity of myosin activation in response to upstream signals is 
clearly controlled at the kinase level. This means that different kinases are dominant in different 
cellular contexts.  
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It is interesting to note that for MLCK the myosin light chain is the only target while both citron kinase 
and Rok have other phosphorylation targets. Rok can also activate myosin light chain through an 
interesting round-about way - by inhibiting myosin phosphatase. Myosin phosphatase would 
otherwise inhibit myosin activity by dephosphorylating MRLC (Matsumura & Hartshorne 2008). This 
inhibition is lifted by phosphorylation of myosin phosphatase by Rok.  
There is also an alternative phosphorylation site in MRLC, targeted by cyclin B related to cell cycle 
control of myosin activity  at Ser1 and Ser2 (Satterwhite et al. 1992). This site is also shared by PKC 
(Nishikawa et al. 1984). The significance of these phosphorylation sites has been less explored. 
From this, it is clear that cortical contractility is regulated on the molecular level by Rho GTPases and 
specifically myosin II activity is regulated via phosphorylation. 
1.1.3.3 Microtubules suppress cortical contractility 
In addition to these specific molecular regulations of cortical contractility, interesting evidence exists 
that cortical contractility in cells is broadly inhibited via microtubules. This was first concluded from 
observations of periodic contractility induced in spreading fibroblasts whose microtubules were 
removed via nocodazole treatment (Pletjushkina et al. 2001; Lyass 1988). In these experiments, the 
authors could show that these periodic contractions were driven by myosin II and were calcium-
dependent, and persisted for several hours until the cells attached firmly to their substrate.  
A similar phenomenon of periodic contraction based on myosin II activation was observed when cells 
whose microtubules were removed were prevented from attaching to any surface (Paluch et al. 2005). 
Interestingly, under these conditions the extent of contractility depended on the cell-cycle stage of 
the cells, suggesting cell cycle regulation further upstream of the contractility regulation. These 
periodic contractions could also be observed in cell fragments, indicating that this process can emerge 
from very simple components. The authors show that the cortical contraction arises from symmetry 
breaking in the spherical cells or cell fragments which results in the formation of blebs which travel 
across the cell (Figure 8).  
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Figure 8: Model for oscillations in cells without microtubules. 
A) Small inhomogeneity in the distribution of myosin II in the cortex lead to breakage and bleb formation (b,c). In a self-
enhancing process, more myosin accumulates at the break points, increasing the bleb size (d). The contractile myosin moves 
across the cell and new cortex forms in the bleb (e,f). Myosin in the mainly redistributed across the cell (g,h), until a small 
inhomogeneity lead to a repeat of the process (i). Reprinted from (Paluch et al. 2006) with permission from Elsevier. 
Although these observations have only been made in cultured cells under abnormal conditions, i.e. 
nocodazole treatment, the data suggests a negative regulation of contractility by microtubules which 
is consistent with data from cardiomyocytes. In these cells increase in microtubules density leads to a 
reduction in contractility which occurs in hypertrophied myocardia (Zile et al. 1999; Ishibashi & Tsutsui 
1996).  
While these datasets seem to converge to illustrate the importance of microtubules in regulating 
contractility, no data is yet available indicating the specific pathway by which this regulation is 
achieved.  
As the control of cortical contractility is a very varied process, including a large number of disparate 
signalling pathways, it is easiest to understand this regulation when looking at a specific example of 
this regulation. In the next section, I will therefore focus on cytokinesis, which is a process driven by 
strong differentiation of cortical contractility across the cell.   
12 
 
1.2 CYTOKINESIS IS A FORM OF HIGHLY REGULATED CORTICAL CONTRACTILITY 
1.2.1 Cytokinesis is spatially regulated by signals originating from the spindle 
Cytokinesis is the process by which a single cell is divided into two daughter cells at the end of mitosis. 
Cytokinesis happens after the chromosomes have been separated and it is a process that involves the 
whole cell, mainly focussed on and driven by the cell cortex.  
During cytokinesis, the cortex differentiates and forms a specialised structure, the contractile ring, in 
the middle of the cell. The contraction of this ring leads to the formation of the cytokinetic furrow 
which progressively constricts to separate the cytoplasm of the two cells.  
A key part of our mechanistic understanding of the process of cytokinesis was laid by Ray Rappaport, 
who from 1960 onwards used physical manipulations and simple, low-tech observations of the sand 
dollar egg to establish the cell cortex’ response to the division signal. What became clear from these 
experiments is that the main factor determining the formation of the cytokinetic furrow is the mitotic 
apparatus or spindle. In normal cases, the cytokinetic furrow forms directly over the middle of the 
spindle. Repositioning the spindle led to the formation of a furrow in the new place and disappears in 
the old (Rappaport 1985). The signal inducing this response responds therefore dynamically to the 
position of the spindle, due to a positive signal delivered by the microtubules to the cortex (Rappaport 
1964). 
The most famous of Rappaport’s experiment was to investigate which type of microtubule structure 
is required for the furrow signal (Rappaport 1961). In this experiments, he compressed sand dollar 
eggs into doughnut shapes (Figure 9A), which led at the first division to the formation of a single 
horseshoe shaped cells (Figure 9B). This configuration leads to the formation of a binucleated cell, 
where, in the next division, the asters of the spindle overlapped with no chromosomes between them 
(Figure 9C). Surprisingly, this overlap was sufficient to induce a furrow and subsequent division (Figure 
9D). This type of furrow, caused by the overlap of microtubules with no chromosomes between them, 
has been termed a Rappaport furrow. They have subsequently also been generated in other systems 
(Savoian et al. 1999). This indicates that an overlap of antiparallel microtubules is all that is required 
for furrow formation and chromosomes are not required. 
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Figure 9: Formation of a Rappaport furrow. 
A) An embryo is compressed with a glass bead (grey sphere), pushing the spindle to one side. B) This cell divides only on the 
side of the sphere where the spindle was located, forming a binucleated cell. C) This cell then in the next round of divisions 
forms 2 normal furrows as well as a so-called Rappaport furrow. D) This furrow fully constricts to form 4 individual cell, same 
as in the control embryo. Reprinted with permission from John Wiley and Sons: Journal of Experimental Zoology (Rappaport 
1961), copyright 1961, with additional labels for clarity.  
The molecular understanding of the contractile ring which forms the furrow lagged behind the physical 
understanding of the process provided by Rappaport for many years. But in recent years the molecular 
side has caught up and now a fairly complete view of the molecular components of cytokinesis has 
been established (Green et al. 2012; Eggert et al. 2006).  
As the contractile ring is essentially a differentiation of the cortex, it is not surprising that the two key 
components of the contractile ring are actin (Schroeder 1973) and myosin II (Mabuchi & Okuno 1977). 
This molecular composition suggests an intuitive mechanism for contractility, with actin acting as a 
scaffold on which myosin exerts its contraction force to progressively reduce the ring diameter 
(Murthy & Wadsworth 2005). But intriguingly it appears that myosin, at least under some 
circumstances, serves in the contractile ring only as a stabiliser or scaffold (Carvalho et al. 2009) and 
its force generation is not required for contractile ring closure (Beach & Egelhoff 2009). How 
widespread this function of myosin as a pure scaffold is, remains unclear, as in most circumstances 
myosin II contractility is in fact required for contractile ring closure (Murthy & Wadsworth 2005).  
Assembly and activity of actin and myosin II in the contractile ring are controlled by the GTPase RhoA 
via two key downstream effectors (Figure 10). Firstly RhoA activates formins, which are actin 
nucleators producing the straight unbranched actin filaments of the contractile ring (Severson et al. 
2002; Otomo et al. 2005; Rose et al. 2005). Secondly, RhoA activates RhoA kinase (Rok) which activates 
myosin II in the contractile ring, leading to the contraction (Amano et al. 1996; Kimura et al. 1993; 
Piekny & Mains 2002).  
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Figure 10: Function of RhoA in controlling the components of the contractile ring. 
RhoA is localised and activated at the furrow via centralspindlin and Ect2. RhoA then activates formin to nucleate actin 
filaments and activates Rok which in turn activates myosin II. The combination of these two processes leads to the formation 
of the contractile ring and its contraction. Reprinted from (Miller 2011) with permission from Elsevier. 
In accordance with the regulation of contractile ring formation by RhoA, recent work by Wagner and 
Glotzer showed that active RhoA alone is sufficient to induce contractile ring formation, independent 
of any signal from the spindle (Wagner & Glotzer 2016). They showed this by locally activating RhoA 
at various membrane sites via an optogenetic construct, leading to accumulation of actin and myosin II 
at these sites and the so formed contractile rings were functional as seen through partial ingression. 
This induction of ring formation was surprisingly independent of the cell cycle stage, allowing the 
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formation of contractile rings even in interphase cells (Figure 11). This shows that the formation of 
the contractile ring solely requires active RhoA at the cortex. 
 
Figure 11: RhoA signal alone is sufficient to drive contractile ring formation. 
Contractile ring formation in interphase cells was induced by optogenetic activation of RhoA at the cortex. Figure reprinted 
from (Wagner & Glotzer 2016) under creative commons CC-BY-NC-ND 4.0 international license. 
Due to RhoAs function as a master regulator of contractile ring formation, its activation and 
localisation obviously have to be finely controlled to allow for successful cytokinesis. This control is 
achieved through RhoA activating factors, termed GEFs.  
The main GEF which activates RhoA in the formation of the contractile ring is Ect2 (Yüce et al. 2005), 
although GEF-H1 is also involved in parallel to Ect2, at least in certain cells (Birkenfeld et al. 2007; 
Krendel et al. 2002). Ect2 is localised to the prospective contractile furrow overlying the spindle 
midzone where it activates RhoA (Figure 10). Ect2 is transported to the cortex along microtubules and 
comes from the central spindle region (Figure 12)(Bement et al. 2005; Bement & von Dassow 2014; 
Somers & Saint 2003).  
At the central spindle region, Ect2 colocalises and is activated by the heterotrimeric centralspindlin 
complex (Nishimura & Yonemura 2006). This complex is made up of MgcRacGAP and MKLP1 (Mishima 
et al. 2002; Pavicic-Kaltenbrunner 2007) and localises to the antiparallel microtubule overlap in the 
spindle midzone and midbody (Lekomtsev et al. 2012). The activation signal is then transmitted from 
the central spindle region to the cortex through the action of the MKLP1 subunit, which is a kinesin 
and can travel along the microtubules to the cortex. As this transport is microtubule-based, Ect2 is 
concentrated in regions with a lot of microtubules touching the cortex, i.e. the region where the 
microtubules of each aster meet at the cortex (Figure 12) (Lekomtsev et al. 2012; Miller 2011; Su et 
al. 2014). There it then activates RhoA, which leads to the formation of the contractile ring. 
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Figure 12: Ect2 is localised to the contractile furrow via microtubules. 
Sea urchin embryos showing Ect2 (gold) located to the tips of microtubules (blue), leading to its localisation at the furrow. 
Zooms in A’ and A’’ show overlaps of Ect2 and microtubules at different stages of furrow ingression. Republished with 
permission of American Society of Cell Biology, from (Su et al. 2014),  permission conveyed through Copyright Clearance 
Center, Inc. 
The GAPs, which in turn inactivate RhoA, are key for driving the flux of RhoA into the inactive form 
during cytokinesis. This flux through the active (GTP-bound) and inactive (GDP-bound) form is required 
for the success of cytokinesis (Miller & Bement 2009).  There are two RhoA GAPs which have been 
implicated in cytokinesis – p190RhoGAP and the centralspindlin component MgcRacGAP. 
p190RhoGAP localises to the cytokinetic furrow and overexpression causes division failure (Su et al. 
2009; Mikawa et al. 2008), and its role in cytokinesis in limiting RhoA activity is unambiguous. On the 
other hand, MgcRacGAP has been much more controversially discussed in the literature. This is 
partially due to the fact that, as the name suggests, MgcRacGAP functions (at least in vitro) specifically 
as a GAP against the GTPases Rac and Cdc42 and is inefficient as a GAP for RhoA (Touré et al. 1998). 
At the same time, MgcRacGAP is clearly a necessary component of the centralspindlin complex and 
artificial localisation to the cortex is sufficient to induce furrowing (D’Avino & Savoian 2006; Jantsch-
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Plunger & Gönczy 2000), while knock-out leads to a much broader RhoA zone and cytokinesis failure  
(Yoshizaki & Ohba 2004; Miller & Bement 2009). While these in vivo experiments suggest that 
MgcRacGAP inactivates RhoA in the required manner, it is possible that this function is indirect, either 
through Ect2 localisation or through the other GTPase family members.  
With this, the molecular toolbox which locally regulates the cortex to form the contractile ring during 
cytokinesis is fairly well established. 
1.2.2 Redundancy in the spatial regulation of cytokinesis ensures cytokinesis success 
In addition to the contraction of the contractile ring, it has long been proposed that to allow for 
cytokinesis, a relaxation of the polar regions of the cell is also necessary (Swann & Mitchison 1958). 
The original theory suggested that furrowing is achieved or at least allowed by a lessening of the 
membrane tension at the poles of the cells away from the cytokinetic furrow (Figure 13) (Gudejko et 
al. 2012) . 
Figure 13: Different populations of microtubules in cytokinesis.  
a) Cell in anaphase with chromatin mass in blue and microtubules in green. Astral microtubules (light green) and midzone 
microtubules (dark green) from two separate populations and contact the cortex at different points. b) Potential polar 
relaxation signal in red is delivered by astral microtubules, while equatorial stimulation signal in blue is delivered by midzone 
microtubules. Reprinted from (Eggert et al. 2006), copyright Annual Review of Biochemistry, 2006. 
A number of works indicates that microtubule density, the connected differential cortical contractility 
and the resulting polar relaxation are important for cytokinesis (Glotzer 2004; Foe & von Dassow 
2008), even though no molecular mechanism for this has been proposed. This is due to the fact that 
the molecular work has been focussed on the understanding of the cytokinetic ring and the cortical 
stimulation that induces furrowing.  
These two potentially different signals are most likely born out of two populations of microtubules. 
The astral microtubules and the central spindle microtubules are these two signalling centres, whose 
differential importance remains not fully understood. It is very likely that the cortex, once it has been 
put in its receptive state by the cell cycle incorporates signals from both of these. In normal cells, the 
cytokinetic furrow may be positioned by a number of parallel signals, and this redundancy is important 
as the correct localisation of the division furrow is key for forming functional and equal sized daughter 
cells after division. The cortex seems to respond first to signals from the astral microtubules to initial 
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furrowing while the signal from the spindle midzone microtubules is required for sustaining the furrow 
and allowing completion of cytokinesis (Bringmann & Hyman 2005; von Dassow 2009).  
To allow the cortex to flexibly react to these varied signals from the spindle, it as a whole has to be 
adapted to cytokinesis. 
1.2.3 The cortex behaves as an excitable medium during cytokinesis 
Therefore, the cortex of the whole cell undergoes drastic changes during C-phase, above and beyond 
those directly related to the formation of the cytokinetic ring. C-phase is the phase of the cell cycle in 
which cytokinesis takes place, and although it normally overlaps with late anaphase and telophase, it 
is designated as a separate phase of the cell cycle (Canman et al. 2000). This phase is defined by the 
cortex being in a division ready state in which it can respond to signals which induce furrowing. And 
while C-phase is normally a relatively short, it can be extended to last up to 1 hour by preventing 
completion of cell division using inhibitors (Straight et al. 2003; Martineau et al. 1995). 
During this time the altered cortex state gives rise to interesting phenomena. One of these are rapid 
fluctuations of RhoA activity and actin polymerisation in an activator-inhibitor coupling, inducing 
fascinating motile patterns (Bement et al. 2015). These RhoA and actin waves are cell-cycle dependent 
and move across the whole cell cortex in very large cells, such as the Xenopus and starfish eggs (Figure 
14). This indicated that the cell cortex in C-phase behaves as an excitable medium which shows local 
amplifications and fast reactivity (Newman 2009; Bement et al. 2015). This is likely beneficial for the 
cell by allowing quick adaptation to changing environmental circumstances and ensuring cytokinesis 
success.  
Figure 14: RhoA waves at the cortex during C-phase. 
Active RhoA forms spiral patterns in the cortex during the time of C-phase – the temporal development of the patterns and 
change in signal intensity can be seen at the different time points. These patterns of RhoA activity move across the cell (as 
seen in the zoom-ins 1 and 2). The patterns are strengthened to these striking levels using Ect2 overexpression. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Cell Biology (Bement et al. 2015), copyright 2015. 
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1.2.4 Cytokinesis is temporally regulated by Cdk1-cyclin B 
Of course, cytokinesis has to be specifically regulated not only in a spatial dimension, with the 
determination of the position of the contractile ring, but it also has to be regulated in time. The 
temporal regulation of the cell division process is part of the cell cycle. 
After the cell duplicates its DNA in S-phase the actual cell division process happens in M-phase. During 
this, the cell organises and then divides both its DNA and cytoplasm into two daughter cells.  
M-phase consists of a number of well-defined subphases, termed prophase, metaphase, anaphase 
and telophase. During prophase, the chromosomes condense and cytoplasmic events prepare the cell 
for the cell cycle, by, among others, separating centrosomes. As prophase progresses into metaphase, 
the nuclear envelope breaks down, allowing access of the microtubules of the forming spindle to the 
chromosomes. Once all the chromosomes have assembled into the metaphase plate of the spindle, 
the cell passes into anaphase where the sister chromatids are separated towards the poles of the 
spindle. The two groups of chromosomes are enclosed in the forming daughter nuclei during 
telophase and the cells separate via cytokinesis. Cytokinesis normally overlaps with late anaphase and 
telophase (Cooper 2000).  
The key regulator of M-phase is a protein complex originally termed MPF (mitosis promoting factor)  
made up of a kinase Cdk1 (cyclin-dependent kinase 1) and a regulatory protein cyclin B (Smith & Ecker 
1971; Masui & Markert 1971). Cdk1-cyclin B controls all the changes that go along with mitosis and is, 
therefore, subject to a complex system of feedback loops to control its activation and inactivation 
(Lindqvist et al. 2009). 
Cdk1 is regulated by phosphorylation and is present at constant levels throughout the cell cycle while 
cyclin B levels vary periodically. Cyclin B protein levels are controlled transcriptionally (Katula et al. 
1997; Fung & Poon 2005) but once cyclin B is produced, it immediately binds to the Cdk1 protein. The 
complex is then held in an inactive state through two inhibitory phosphorylations at sites T14 and Y15. 
The activity state of the Cdk1-cyclin B complex is controlled through the balance between the kinase 
pair Wee1/Myt1, which inhibits the complex, and the phosphatase Cdc25, which lifts the inhibition 
(Figure 15)(Morgan 2007). Once Cdk1-cyclin B is activated to a sufficient level, it can, in turn, 
phosphorylate Wee1/Myt1, leading to their inactivation, resulting in the auto-amplification of Cdk1 
activity. The regulators themselves are controlled by a wide variety of inputs, such as the Plk1 and 
MAPK pathway (Lindqvist et al. 2009). But while the wider regulation is, of course, important for the 
precise timing of the cell cycle, for our purposes it is sufficient to focus on the inner feedback loop 
regulating Cdk1-cyclin B activity (Figure 15).  
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Figure 15: Regulation of Cdk1-cyclin B activity. 
The Cdk1-cyclin B activity state is controlled by the balance of activation by Cdc25 and inhibition by Wee1/Myt1. Once 
activated above a threshold, Cdk1-cyclin B activates its mitotic targets via phosphorylation. At anaphase Cdk1-cyclin B is 
inactivates by APC/C which is regulated in its activity by Cdk1-cyclin B. 
The activation of Cdk1/cyclin B is closely linked to its nuclear import in prophase which is important 
for the auto-amplification process (Hagting et al. 1999). Once levels of active Cdk1/cyclin B have 
reached a certain threshold, their many downstream effects become first visible with nuclear 
envelope breakdown (NEBD) mediated by phosphorylation of NE components (Macaulay et al. 1995; 
Peter et al. 1991). This is also commonly used as a marker for the start of metaphase.  
Cdk1-cyclin B also drives other hallmarks of metaphase – such as cell rounding (Ramanathan et al. 
2015), completion of chromosome condensation (Gavet & Pines 2010), spindle assembly (Wu et al. 
2013) and ER/Golgi fragmentation (Yeong 2013). 
The main cellular process in metaphase though is the formation of the spindle and alignment of the 
chromosomes at the metaphase plate. Once this process is completed and the spindle checkpoint is 
satisfied, the cell switches to anaphase. In this switch cyclin B levels again play the key role, although 
regulated in a different manner than during metaphase entry.  
While phosphorylation is a widely used form of activation that is key to cell cycle control, it is by nature 
a very transient and reversible modification. To commit to the next stage in the cell cycle then, the 
cell requires a more drastic regulation, in the form of protein degradation. Cyclin B is degraded at 
anaphase exit by the APC/C (anaphase-promoting complex or cyclosome), which is an E3 ubiquitin 
ligase, binding ubiquitin chains to its target protein. These proteins are then targeted for destruction 
by the proteasome. APC/C activity itself is controlled via phosphorylation by Cdk1/cyclin B and by the 
spindle assembly checkpoint and the APC/C itself has a number of different substrates (Figure 
15)(Pines 2006). The key substrates for the synchronicity of the events of anaphase are cyclin B and 
securin (Clute & Pines 1999; Hagting et al. 2002).  
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The degradation of securin allows the separation of the chromosomes while the degradation of 
cyclin B leads to the lifting of the cdk1-cyclin B imposed phosphorylations. The loss of these 
phosphorylations is responsible for the activation of the molecular cascade leading to cytokinesis and 
the changes in cortical contractility that go along with it. 
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1.3 SURFACE CONTRACTION WAVES  
1.3.1 Surface Contraction Waves are division-associated cortical contractility events 
In 1971, Koki Hara observed a curious phenomenon while studying dividing axolotl embryos, which 
continues to puzzle us to this day. Hara called what he observed surface contraction waves or SCWs 
(Hara 1971). These waves are observable as shifts in the pigmentation pattern of the embryo and 
changes in the cell shape. They precede each cell division in the early embryo and move across the 
whole cell in a circular pattern. Similar SCWs were observed in the embryos and eggs of a variety of 
other species, the most famous and well-studied example being in the Xenopus laevis embryo (Hara 
et al. 1980).  
It may seem surprising that such an obvious movement of the cell had not been discovered earlier and 
that so little remains understood of its molecular nature. Especially as the large and abundant eggs of 
amphibians and echinoderms where SCWs are common, were the workhorses of early cell biology 
since the 19th century.  The explanation lies within the duration of the waves, which last 5 to 10 
minutes. This is just slow enough to make the SCWs very hard to notice by observation with the naked 
eye. Therefore, a true exploration of SCWs only began with the advent of time-lapse imaging or 
cinematography, as Hara called it in 1971. 
1.3.2 Surface Contraction Waves are found in many species  
If one looks at the literature, there are very few papers reporting surface contraction waves in eggs or 
embryos in species other than the ones mentioned above as major findings. But when one careful 
reads old papers describing the behaviour of eggs and early embryos in a variety of species, mentions 
of shape changes, waves of surface stiffening and surface movements keep cropping up. These are 
indications for the presence of SCWs. 
This has allowed me to infer that contraction waves are found in a wide variety of species (Figure 16). 
Interestingly, these species are spread throughout the animal kingdom. SCWs are for example found 
in very simple multicellular organisms, in the phyla of ctenophore and cnidaria, that is comb jellies and 
jellyfish respectively (Houliston et al. 1993).  
In deuterostomes, SCWs are found in many species belonging to different phyla. SCWs are found in 
vertebrate species, many of the class of amphibia, including various species of frogs (Kubota 1967; 
Hara & Tydeman 1979), newts (Harvey & Fankhauser 1933; Selman & Waddington 1955; Sawai & 
Yoneda 1974) and axolotls (Hara 1971). A sister subphylum of the vertebrates, in the phylum of 
chordates, are the tunicates, were SCWs have been reported in a variety of species of sea squirts 
(Satoh & Deno 1984; Bell 1962; Sardet et al. 1989). The sister phylum of the chordates are the 
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echinoderms, were contraction waves are found in both sea urchins (Kojima 1962) and starfish 
(Hamaguchi & Hiramoto 1978).  
There is, of course, the large superphylum of protostomes, in which there is very little evidence for 
SCWs. The two examples I found come from the Lophotrochozoan phylum, in the annelid Tubifex 
(Shimizu 1983), and in the C. elegans nematode (Fabritius et al. 2012).   
Although evidence can be found for SCWs in these species, SCWs are surely not limited to these 
species. Given the wide evolutionary spread of SCWs exemplified above, it seems likely that upon 
investigation such waves could be found in many more species.  
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 Figure 16: Phylogenetic tree of SCWs.  
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A) General tree of animal phyla, highlighting those in which SCWs are found. Figure modified from (Telford et al. 2015), 
reprinted with permission from Elsevier. B) Detailed phylogenetic tree of all species with reported SCWs. Tree generated at 
http://phylot.biobyte.de/ (Letunic et al. 2012; Letunic & Bork 2007).  
1.3.3 Surface Contraction Waves share a number of common characteristics  
There are a few common characteristics that connect the SCWs in all these different species.  
(1) They are found exclusively in large cells, namely oocytes and early embryos. All these cells are 
significantly larger than normal somatic cells. The sizes of cells with reported contraction waves range 
from the sea urchin with a diameter of 90 µm (Kojima 1962) to newt eggs with a diameter of 2 mm 
(Selman & Waddington 1955).  
(2) Furthermore, SCWs always occur in the context of cell divisions. They have been reported to occur 
shortly before the cell division during both mitosis in the embryo and meiosis in the oocytes.  
(3) As the SCWs are clearly cortical events, it is not surprising that they go along with a rise in surface 
tension or stiffness (Hara et al. 1980). How this cortical contractility in the SCWs is regulated and what 
cytoskeletal components are involved remains unclear. Some evidence suggests an involvement of 
microtubules (Quaas & Wylie 2002; Houliston et al. 1993) while others show an independence from 
microtubules (Hara et al. 1980) and implicate actomyosin contractility (Pérez-Mongiovi et al. 1998; 
Prodon et al. 2008; Christensen & Merriam 1982). 
These factors make SCWs an interesting system to understand the regulation of cortical contractility 
by the cell cycle in large cells.  
1.3.4 A number of functions have been proposed for Surface Contraction Waves 
While SCWs have been described phenomenologically, their function remains unclear in most 
systems. Potential functions can arise from two characteristics of the waves. The first is the potential 
generation of force or pressure implied by the contractility and change in cell shape.  
This force generation hypothesis has been suggested to assist the cell division process in both meiosis 
in the starfish (Hamaguchi & Hiramoto 1978) and mitosis (Yoneda & Dan 1972; Sawai 1982), although 
this has never been conclusively shown in either system.  
Secondly, apart from the shape changes the SCWs go along with movements of the cytoplasm 
(Hamaguchi & Hiramoto 1978), although a causal link between the two processes is not clear. This 
cytoplasmic flow in the developmental context in which the SCWs occur, led to the hypothesis that 
SCWs serve to localise some developmental determinants. This has been indicated in the Xenopus 
embryo for the localisation of germplasm (Quaas & Wylie 2002) and for cER-mRNA domains in 
Ascidians (Figure 17) (Prodon et al. 2008; Prodon et al. 2005). As a specific inhibition of the 
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contractions has not been described, a proof of a link between the SCWs and the observed localisation 
defects has not been reported and their developmental consequences remain to be explored.  
Figure 17: The potential function of the SCWs in controlling embryonic polarisation.  
A) Mitochondria (green) are localised in a polarised manner across the ascidian eggs. B) Treatment with microtubule inhibitor 
Nocodazole did not affect the localisation, while manipulations of both actin (C) and myosin (D)  lead to a loss of polarisation, 
indicating a role of actomyosin contractility in the localisation. Republished from (Prodon et al. 2008), with permission from 
Elsevier. 
1.3.5 Surface Contraction Waves in the Xenopus embryo are driven by trigger waves 
The best-researched example of SCWs are the ones observed during the early embryonic division of 
the Xenopus laevis embryo. In this system two contraction waves, termed SCWa and SCWb, pass 
across the cell surface visible through a shift in the pigment pattern (Hara et al. 1980). Both of these 
waves start at the animal pole of the egg and spreads in a circular pattern across the cell, with a fixed 
time delay between the two and progress across the cell at a speed of 60 µm/min (Figure 18) (Hara et 
al. 1980; Chang & Ferrell 2013).  
Figure 18: SCWs in the Xenopus embryo. 
Kymograph of the surface pigmentation pattern of an artificially activated Xenopus egg. It shows three pairs of SCWs (1a&1b 
etc.), going along with 3 rounds of the cell cycle. Reprinted by permission from Macmillan Publishers Ltd: Nature (Chang & 
Ferrell 2013), copyright 2013. 
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These SCW reflect switching of the cytoplasm between different cell cycle states going along with each 
round of cell division (Hara et al. 1980; Pérez-Mongiovi et al. 1998). Specifically, the SCWa correlates 
with entry into mitosis, while SCWb is associated with mitotic exit (Rankin & Kirschner 1997). This 
explains why even though both waves were originally termed surface contraction waves, the SCWa is, 
in fact, a wave of relaxation with the cortex softening while the SCWb is a true contraction wave with 
an increase in surface tension (Yoneda et al. 1982). 
While SCWs were first observed right before the first embryonic division, they are independent of 
fertilisation and even the nuclear content of the egg, as they also occur in artificially activated (i.e. 
non-fertilised eggs) and de-nucleated eggs (Hara et al. 1980). This underscores the link between the 
cell cycle and the contraction waves, as the cell cycle oscillation run independently of these factors as 
well.  
The mechanism by which the cell cycle activation is spread across the very large Xenopus cell was long 
a mystery but recent reports  have provided a mechanistic explanation (Chang & Ferrell 2013; Ishihara 
et al. 2014). They showed that the signal transmission in Xenopus is driven by a phenomenon called a 
trigger wave. Diffusion, the classical mechanism for signal spreading, is distinctly too slow in such a 
large cell to allow efficient synchronisation of the cell cycle processes across the whole cell. The 
proposed trigger wave or chemical reaction waves can spread the activity across the cytoplasm much 
faster. This is achieved by local mixing of the cytoplasm by diffusion, which pushes the activity above 
a certain threshold leading to full activation of one area of cytoplasm. This activity then mixes into the 
closely neighbouring area, which in turn switches to an activated state. And thus, the activity is 
transmitted fast across large distances. To allow for such behaviour, the system in which it takes place 
has to be an excitable medium and locally amplify the active state of the system. The cell cycle 
regulation of Cdk1-cyclin B activity is exactly such as system. To visualise the trigger wave spreading 
over large distances Chang and Ferrell placed nuclei in Xenopus egg extract that goes through a 
number of cell cycles and observed the behaviour of the nuclei during these cycles. The nuclei break 
down at the start of mitosis and reform at its end, and both breakdown and reformation happen in a 
wave over large distances (Figure 19). 
The mechanism by which a trigger wave of cell cycle activity causes the cortical contractile behaviour 
remains an open question. 
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Figure 19: Trigger waves of the cell cycle. 
The cell cycle state is measured by the proxy of nuclear envelope breakdown and reformation in cycling Xenopus egg extract. 
b) The signal for nuclear envelope breakdown (red) and reformation (blue) spreads across long distance with constant speed, 
indicating trigger wave behaviour. Reprinted by permission from Macmillan Publishers Ltd: Nature (Chang & Ferrell 2013), 
copyright 2013. 
1.4 STARFISH OOCYTES SERVE AS A MODEL FOR THE STUDY OF SURFACE CONTRACTION WAVES 
1.4.1 Starfish oocytes in meiosis exhibit contraction waves 
Starfish oocytes are another system which exhibits striking contraction wave alongside their meiotic 
divisions. These were first described by Hamaguchi and Hiramoto in 1978 in the starfish Patiria 
pectinifera (Hamaguchi & Hiramoto 1978), where both the cell shape changes as well as the 
concomitant protoplasmic movements were observed (Figure 20). This resulted in the first detailed 
description of the SCW phenomenon for any organism. 
Figure 20: The SCW in the starfish oocyte 
An early description of the shape change and cytoplasmic movements occurring during the contraction wave in the starfish 
oocyte. Reprinted from (Hamaguchi & Hiramoto 1978), with permission from Elsevier. 
The contraction waves in the starfish oocyte occur immediately before each of the two meiotic 
divisions that the oocyte undergoes during the course of maturation. At the same time, the work by 
Hamaguchi and Hiramoto also proposed a function for the contraction wave, suggesting that they are 
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functionally linked to polar body formation, the specific form of asymmetric cell division occurring in 
meiosis. This link was proposed due to the close temporal link between the two events and intuitive 
appeal but has not been investigated.  
1.4.2 Starfish oocytes are highly specialised cells ideal for molecular imaging studies 
A number of the characteristics of the starfish oocyte make it ideal to use in investigating SCWs on a 
molecular level.  
The surface contraction wave at the first meiotic division is very pronounced. The system is 
experimentally easy to handle as meiosis is relatively quick in these cells, lasting only around 90 min 
in total and it can be induced by the experimenter via the addition of a hormone. 
Furthermore, its size and transparency make the oocyte ideal for fluorescence microscopy, which is a 
key methodology for identifying molecular players. The oocytes are also relatively non-sensitive to 
light exposure, allowing continuous imaging throughout the whole division process. Given their 
natural habitat in the open sea, the oocytes are additionally very sturdy which allows a variety of 
physical manipulations, such as centrifugation (Yoshikawa 1996; Nemoto et al. 1980) and mechanical 
constriction (Shoji et al. 1978), adding to the toolbox of biochemical manipulations.  
The starfish oocytes of the species Patiria miniata are the model system used for this study and I will 
in the following introduce these cells in a bit more detail.  
The oocytes are large cells, around 180 µm in diameter, with the nucleus localised at one point of the 
cortex (Figure 21) (Terasaki et al. 2001). This gives the oocytes an intrinsic polarity and the point where 
the nucleus is anchored is called the animal pole while the opposite point is called the vegetal pole. 
The nucleus is held at this position by microtubules nucleated from the centrosomes which are 
positioned at the animal pole (Miyazaki et al. 2000). 
The oocyte reaches its extraordinarily large size due to its large storage of both nutrients and pre-
synthesised proteins which are required for the development of the embryo. The nutrients are stored 
in the form of yolk platelets, roughly 1-2 µm in diameter (Terasaki 2006). The yolk is produced during 
the growth phase of the oocyte that precedes oocyte maturation (Takahashi & Kanatani 1981).  
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Figure 21: An immature starfish oocyte with important cellular structures labelled. 
The oocytes are arrested, tightly packed in the ovaries of the starfish, in prophase of meiosis I and can 
be easily isolated from there in large numbers. The oocytes begin their maturation upon stimulation 
by the hormone 1-Methyladenin (Kanatani et al. 1969). In the natural process where maturation is 
induced in the ovary, the oocytes exhibit the classical metaphase I arrest (Oita et al. 2004; Harada et 
al. 2003), that oocytes of many other animals share (Yamashita 1998). While in most other animals 
this arrest is lifted via fertilisation, in starfish it is lifted through spawning of the oocytes into seawater 
and the resulting pH change (Oita et al. 2004; Harada et al. 2003). When oocytes are artificially induced 
to undergo meiosis in sea water, there is no metaphase I arrest as the conditions are already fulfilled 
for the completion of meiosis (Kishimoto 1998). 
While starfish oocytes are naturally fertilised around metaphase I of meiosis (Nomura et al. 1991), 
they can complete the whole division process without fertilisation (Matsuura & Chiba 2004), so 
meiosis can be studied while disregarding the fertilisation process.  
1.4.3 Meiosis is a specialised form of cell division 
Meiosis is a very specific type of cell division that occurs only during the generation of the gametes for 
sexual reproduction. It is a reductive division, which produces both haploid sperm and oocytes. But 
the division process in these two cases is very different, given that a 4n spermatocyte gives rise to four 
1n sperm while the 4n oocyte gives rise to only one 1n mature egg. The rest of the genomic content 
of the oocyte is discarded into the polar bodies (see Figure 22). The main difference between mitosis 
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and meiosis is the lack of S-phase between meiosis I and meiosis II and extensive recombination with 
the connected suppression of sister chromatid separation during meiosis I. 
I will in the following focus on oocytes and their cell cycle adaptations while disregarding the 
mechanism of DNA recombination in meiosis and spermatogenesis. 
 
Figure 22: Meiotic cell cycle in the oocyte. 
A mature 4n oocytes forms a spindle and cell division takes place, giving rise to a 2n oocyte and a 2n polar body. The oocyte 
divides again, extruding a 1n polar body. This division cycle results in a mature haploid egg. Figure modified from (Borrego 
Pinto 2015).  
Oocytes are commonly arrested for long periods in prophase of meiosis I so the start of the cell division 
process is named meiotic resumption. Meiotic resumption is in the starfish oocyte very well 
understood on a molecular level (Figure 23) (Kishimoto 2011). It happens in response to an external 
hormone signal given by the tissue surrounding the oocytes. In the same manner as in mitosis, entry 
into meiosis requires activation of Cdk1-cyclin B. This is achieved following hormone stimulation 
through the Akt/PKB pathway, which inhibits the Cdk1 inhibitor Myt1 and activates the activator 
Cdc25 (Figure 23) (Okumura et al. 2002).   
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Figure 23: Meiotic resumption in the starfish oocyte. 
The 1-Methyladenin hormone signals through a G-protein receptor, leading to the activation of Akt/PKB. This, in turn, leads 
to the activation of Cdk1-cyclin B (here Cdc2-cyclin B) via inhibition of Myt1 and activation of Cdc25. The activation of Cdk1-
cyclin B leads to the start of meiosis and activates downstream targets, including Plk1, Aurora and Mos. Reprinted with 
permission from John Wiley and Sons: Molecular Reproduction & Development (Kishimoto 2011), copyright 2011.  
In comparison to meiosis I, meiosis II is a much quicker process which starts immediately after the 
completion of meiosis I without an intermediated S-phase, but the underlying molecular network is 
identical. The quick transition between meiosis I and meiosis two is controlled by Mos which 
prematurely upregulates Cdk1/cyclin B levels after metaphase I to prevent S-phase (Figure 24)  
(Furuno et al. 1994). In starfish, it was shown that Mos is the master regulator of meiosis and that 
expression of Mos in mitotic cells induces meiotic-style divisions (Tachibana et al. 2000). Furthermore, 
overexpression of Mos in oocytes leads to many rounds of meiosis (Figure 24)(Dumollard et al. 2011). 
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Figure 24: Mos is the master regulator of meiosis. 
Mos activity controls meiosis via the MAPK signalling pathway, which induces upregulation of Cdk1-cyclin B activity (here 
MPF – green) after meiosis I. When Mos is overexpressed (bottom panel) MAPK activity remains high and MPF activity cycles 
multiple times, resulting in multiple meiosis. Reprinted from (Dumollard et al. 2011), with permission from Company of 
Biologists: Development. 
1.4.4 Polar body formation is a specialised form of cytokinesis 
Oocyte meiosis goes along with a specialised form of cell division leading to the formation of the polar 
bodies. It is a hugely asymmetric form of division, even compared to other forms of asymmetric 
divisions, and has been a focus of research interest since it was first described by Carus in 1824 
(Schmerler & Wessel 2011). 
This highly asymmetric division is required to allow the oocyte to reduce its genomic content without 
losing too much of the cytoplasmic content containing precious nutrient. This is achieved by 
minimising the cytoplasm in one of the daughter cells. The size difference between oocyte and polar 
body is therefore especially pronounced in animals that undergo ex utero development, where the 
embryo relies solely on its maternal energy stores for early development (Liu 2012).  
In animals with in utreo development, the size difference is not a requirement. This was shown in the 
mouse system, where an oocyte with half its normal cytoplasmic volume, as would arise after a 
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symmetric division, can still develop normally (Wakayama & Yanagimachi 1998). At the same time, it 
has been suggested that the polar body’s small size is important to prevent the formation of an 
additional competing zygote as would result from fertilisation of a larger polar body (Otsuki et al. 
2011). This process has been known to happen in humans and result in unviable twins (Bieber et al. 
1981). It has also been suggested that asymmetry can assist in ensuring proper chromosome division 
and preventing aneuploidy (Cortes et al. 2015). 
The polar bodies that form during meiosis are usually not destined for much after their formation and 
in most organisms quickly apoptose. Although in some special cases, they have additional functions 
during development. They play an important role in parthenogenesis in insect species (Strand & Grbic 
1996), and form important nourishing and protective tissues in scale insects (Normark 2004; Ross et 
al. 2010) and parasitic wasps (Strand & Grbic 1996). On the other hand, modern screening technology 
often employs polar bodies for diagnosis in IVF treatments (Verlinsky & Rechitsky 1999).  
1.4.4.1 Polar body formation is distinct from standard asymmetric divisions 
Although polar body formation is commonly classified as a form of asymmetric cell divisions, I would 
argue that this categorisation is in fact neither strictly correct nor helpful for our understanding of 
either process.  
Standard asymmetric divisions are rare compared to symmetric divisions but play crucial roles during 
development (Betschinger & Knoblich 2004). The asymmetry in these cases is a size inequality but, 
more importantly, an inequality of their cytoplasmic content and developmental potential. The 
classical systems in which asymmetric cell divisions are studied are the Drosophila neuroblasts and the 
first embryonic division of the C. elegans embryo (Betschinger & Knoblich 2004). Surprisingly in these 
systems the spindle originally forms in the centre of the cell and only at the end of anaphase the 
posterior spindle pole is pulled off-centre (Albertson 1984; McCarthy Campbell et al. 2009). 
Alternatively, the asymmetric placement of the spindle can be achieved by forces generated by 
asymmetric cortical contractility which pushes the cell around the spindle (Ou et al. 2010). In 
Drosophila neuroblasts, the mechanism for driving asymmetry appears to be unequal microtubules 
elongation (Kaltschmidt et al. 2000; Yu 2003).   
In comparison to these standard asymmetric divisions, polar body formation is of course not less 
asymmetric – rather the opposite. In standard asymmetric divisions the daughter cells have only 
slightly different volumes, in C. elegans embryos, for example, a ratio of roughly 1/3 to 2/3 between 
the daughter cells is observed. In polar body formation, on the other hand, the daughter cells can be 
orders of magnitude different in volume. For example in the Xenopus oocyte, the polar body is roughly 
10 µm in diameter while the oocyte is 1 mm in size. In standard asymmetric divisions, the asymmetry 
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is much more on a functional level than on the size level, with the distribution of determinants being 
key. 
There is also a big mechanistic difference between the actual division processes in the two cases 
(Figure 25). In the normal asymmetric division, the spindle is positioned in the middle of the cell and 
is only at a late stage shifted slightly to one side. In the case of the polar body formation, the spindle 
is either formed already off-centre (in starfish, Xenopus etc.) (Lenart et al. 2005) or is transported 
there early in the division process (in mouse) (Chaigne et al. 2013).  
Furthermore, in standard asymmetric divisions, the contractile ring is still formed above the middle of 
the spindle without the cell undergoing any shape changes prior to constriction. In polar body 
formation, on the other hand, the cells first form the polar body by protruding a bulge into which the 
spindle subsequently moves, before the contractile ring forms above the spindle midzone at the base 
of the protrusion (Figure 25).  
 
Figure 25: Geometry of the cell division in symmetric and asymmetric divisions. 
A) In a symmetric cell division the contractile ring (red) forms in the middle of the cell above the spindle midzone. B) In the 
standard asymmetric division the spindle is positioned slightly off-centre and the contractile ring forms above the spindle 
midzone. C) In polar body formation, the spindle is located strongly off-centre and the cell protrudes the polar body before 
cytokinesis can take place. Cell sizes not to scale. 
1.4.4.2 Multiple mechanisms have been proposed for polar body protrusion 
Polar body formation is, therefore, a 2-step process, consisting of the formation of the protrusion and 
the cutting off of that protrusion.  
All data present is consistent with the hypothesis that the actual contractile ring in polar body is very 
similar, if not identical, to that formed in symmetric cell division (Maddox et al. 2012; Liu 2012). 
Therefore, the main mechanistic question concerns the formation of the protrusion.  
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The by far most widespread hypothesis concerning the mechanism of protrusion formation is the 
pressure model, which has a large intuitive appeal. It dates back almost all the way in polar body 
research, with the oldest proposal of this mechanism made by Conklin in his 1902 investigation of egg 
maturation in the sea snail Crepidula (Conklin 1902). He proposed that the polar body is pushed out 
by cytoplasmic pressure or flow at the site where the cortex is weakest.  
This idea has remained popular to this day (Satoh et al. 2013) and in the case of the starfish oocyte 
has been mechanistically linked to the surface contraction waves. When Hiramoto and Hamaguchi 
described the SCWs in starfish oocytes as preceding the polar body formation, they suggested that 
the waves built up the force necessary to push out the polar body (Hamaguchi & Hiramoto 1978).  
This pressure model was strongly argued against by a series of detailed experiments performed by Ray 
and Barbara Rappaport in the starfish oocyte (Rappaport & Rappaport 1985). They came to the 
conclusion that rather than the polar body forming at the weakest site of the cortex in a global 
pressure mechanism, the protrusion formed in a very local mechanism at a strong cortex site. This 
local stimulation hypothesis was based on a large number of physical perturbations of the oocyte. 
They showed that moving the spindle to a new cortical site lead to the formation of the polar body at 
the new site, showing that there was no predetermined weak site of the cortex. Furthermore neither 
flattening of the oocyte, osmotic swelling nor sucking on the forming polar body lead to increases in 
polar body size as would have been expected by the pressure hypothesis. And a release of potential 
pressure by injuring the oocyte close to the polar body did not block protrusion formation.  
Which of these two models – global pressure with local weakness or local stimulation – correctly 
described the mechanism behind polar body protrusion has remained unresolved to this day.  
The molecular mechanism that drives protrusion formation too remains a little-explored area, but 
recent work has strongly implicated the GTPase Cdc42 in this process, at least in Xenopus oocytes. 
Cdc42 is closely related to RhoA, which is the key GTPase in cytokinesis. Cdc42 is thought to bring 
about polar body protrusion by the activation of the Arp2/3 complex which nucleates branched actin 
(Ma et al. 2006). When Cdc42 is inhibited, the protrusion no longer forms and while the contractile 
ring still forms normally at the cortex, it contracts over nothing and polar body formation fails (Leblanc 
et al. 2011). So Cdc42 and RhoA in polar body formation form two concentric zones of activity around 
each other, leading to the assembly of different actin structures which result in protrusion and 
cytokinesis respectively (Figure 26) (Zhang et al. 2008).  
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Figure 26: Polar body protrusion. 
Protrusion formation is driven by Cdc42, activating Arp2/3-driven actin polymerisation, in the Xenopus oocyte. RhoA activity 
results in the formation of the contractile ring and activation of myosin II. Reprinted from (Leblanc et al. 2011) by permission 
of Oxford University Press. 
Evidence from a number of other systems also indicates an actin-rich protrusion overlying the future 
polar body, strengthening this hypothesis (Pielak et al. 2004; Dorn et al. 2010; Deng et al. 2007). This 
suggests that the cortex is not likely to be weaker at the site of polar body formation, but it is 
interesting to speculate that the cortex in this area might be less contractile. If actin here is indeed 
nucleated by Arp2/3, it is highly branched and highly dynamic, and thereby potentially a less efficient 
substrate for myosin II contractility, compared to the straight formin-nucleated actin of the contractile 
ring. This could give rise to potential mechanical differentiation of this small cortex regions leading to 
polar body protrusion. 
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Cell division is key for all life and it is a complex process in which spatially and temporally tightly 
coordinated changes to the actomyosin contractility of the cortex physically separate the two 
daughter cells. The regulation of the behaviour of the cortex during division is important for successful 
divisions as the cortex undergoes a series of complex changes to accommodate the changing cell 
shape and produce the required force. Apart from cytokinesis, the regulation of cortical contractility 
is a general feature of many cellular processes, including cell migration and shape changes.  
To explore the regulation of cortical contractility during cell division, I specifically studied a 
phenomenon termed surface contraction waves. These waves are striking changes in cortical 
contractility, which occur in very large cells, in close correlation with the cell division process. Surface 
contraction waves have been observed in diverse animal phyla, from one the most basic metazoan 
life forms of cnidarian to vertebrates, but their underlying mechanism is not known. They offer a 
chance to study the regulation of cortical contractility in general and the link between the cell cycle 
and contractility in particular. 
The general aim of my PhD project was to reveal the molecular regulatory pathways underlying 
surface contraction waves and understand how these signalling networks can spatially and 
temporally pattern this complex cellular behaviour. 
The model system I used to study the surface contraction waves were starfish oocytes, which exhibit 
dramatic contraction waves that can be imaged at high spatial and temporal resolution in the 
transparent oocytes. Indeed, surface contraction waves were first described in the starfish oocyte 
almost 40 years ago (Hamaguchi & Hiramoto 1978), and with the molecular tool and imaging 
technology now available they provide an exceptional opportunity to analyse this fundamental yet 
poorly understood phenomenon.   
Specifically, I focused on the following two main questions: 
1) What are the molecular mechanisms of contraction and its regulation underlying surface 
contraction waves? 
Although surface contraction waves have been described in several species, no molecular details had 
previously been identified. But of course, a detailed knowledge of the molecules that drive 
contractility and the upstream regulatory pathway is required for a broader understanding of the 
process. Therefore, as a necessary first step, I set out to characterise the molecular regulatory pathway 
driving the contraction wave. I took a candidate approach and used the literature to identify proteins 
involved in cortical contractility in other physiological contexts and tested their role in the regulation 
of the contraction wave. To this end, I used live-cell imaging of the starfish homologs of these 
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regulatory and contractile proteins to follow their localization to the contraction wave, and, where 
available, I used small molecule inhibitors against some of the candidate proteins. 
Additionally, the size of the cell and the dynamic motion of the contraction across the cell allowed me 
to explore the regulatory pathway that drives contractility from a different perspective compared to 
that commonly used in the literature and elucidates feedback mechanisms within the regulatory 
pathway. 
2) What is the link between the cell cycle processes and the contraction wave? 
Data from previous studies indicates a link between cell cycle progression and the contraction wave 
(Rankin & Kirschner 1997; Chang & Ferrell 2013; Hara et al. 1980). However, how these two processes 
are coupled in space and time and at the molecular level was not known. As a first step to answering 
this question, I visualised the spatial and temporal pattern of key cell cycle components in relation to 
the contraction wave. Additionally, I locally manipulated the activity of cell cycle kinases, and used 
other chemical and physical manipulations to observe the effects on the direction and speed of the 
contraction wave, to understand how the dynamic nature of the contraction wave arises from cell 
cycle regulation.  
 
In summary, I present here a comprehensive model for the molecular mechanism controlling surface 
contraction waves in space and time. My data provides an explanation for the widespread 
phenomenon of surface contraction waves in oocytes, and at the same time reveals novel internal 
feedback mechanisms within the conserved molecular network regulating cortical contractility. 
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3 MATERIALS AND METHODS 
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3.1 STARFISH HANDLING  
3.1.1 Animals 
All the work presented herein was performed using the oocytes of the bat star Patiria miniata. These 
animals originate from the North American coastline of the Pacific Ocean. We receive shipments of 
Patiria miniata from Southern California Sea Urchin Co. (Corona del Mar, CA), Marinus Scientific LLC 
(Newport Beach, CA) and Monterey Abalone Company (Monterey, CA) who collect the animals directly 
from the ocean. In the lab, the animals are maintained in seawater tanks at 15 °C, salinity of 4 %, 
pH 7.8. The animals are fed with shrimp every 2-3 days. 
3.1.2 Oocyte and sperm collection and maintenance 
To collect the oocytes from the starfish a small hole is made laterally on the dorsal side of an arm of 
the animal using a surgical biopsy puncher (Miltex). Through this hole, a segment of the ovary can be 
extracted. The ovary is placed in calcium-free seawater with 50 mM L-Phenylalanine (Sigma) (pH 8) 
for 15 – 20 min. The treatment with calcium-free seawater leads to the shedding of the follicle cells, 
which surround the oocyte, while the L-Phenylalanine acts as a hormone homolog, blocking 
spontaneous maturation which can occur during collection. The ovary is subsequently transferred into 
filtered sea water (FSW) containing 100 µM Acetylcholine (Sigma-Aldrich). This leads to the 
contraction of the ovary and the subsequent extrusion of the oocytes into the sea water. The thus 
retrieved oocytes are transferred into pure FSW and maintained at 14 °C in plastic petri dishes.  
The oocytes were always used within at most 3 days after collection.  
Oocyte maturation was induced by adding the hormone 1-Methyladenin (1-MA) to the FSW at a 
concentration of 10 µM. 
Sperm is collected from the animal by similarly making a small hole and extracting some testis tissue 
using forceps and placing the tissue in an Eppendorf tube which is kept on ice or at 4 °C. The tissue is 
kept as dry as possible to avoid premature activation of the sperm. Before fertilisation, sperm is 
activated by mixing a small piece of testis with FSW at 1:8000. Sperm quality is visually accessed and 
sperm is added to mature oocytes at low concentration to avoid polyspermy. 
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Ca-free seawater 
437  mM  NaCl 
9  mM KCl 
22.9 mM MgCl2 x 6 H2O 
25.5 mM MgSO4 x 6 H2O 
2.1 mM NaHCO3 
3.2 CLONING AND MOLECULAR WORK 
3.2.1 Cloning and construct preparation 
To generate the constructs use for the experiments described here I used the following general 
strategy. Firstly, I identified the amino acid sequence of the human protein of interest from the NCBI 
database, which I then used to perform a BLAST search in the starfish transcriptome database 
(http://starblast.embl.de/). This transcriptome was generated by the EMBL Sequencing facility using 
Patiria miniata oocytes. If the proteins could not be directly found in the starfish transcriptome I used 
the sea urchin genome as an intermediate step (http://Echinobase.org)(Cameron et al. 2009) to find 
the homolog there and using the sea urchin sequence probe the starfish transcriptome again. Using 
the thus obtained sequence I either designed primers for PCR amplification in the 5’ and 3’ UTR of the 
respective gene or designed a construct for synthesis by Genewiz (GENEWIZ, South Plainfield).  
Using the primers I set up PCR reactions to amplify the protein sequence using cDNA as template. The 
cDNA was generated from all the mRNAs of mature eggs and embryos, isolated using the Invitrogen 
Dynabead® Oligo(dT)25 kit and reverse transcribed using the Invitrogen GeneRacer® kit. After PCR 
clean-up using the Qiagen kit (PCR purification #28104), I ligated the resulting DNA fragment into the 
pJet1.2 vector system using the corresponding kit (ThermoScientific #K1232). For a list of primers used 
in this project see Table 2.  
The so clones constructs as well as those synthesised were tagged using genetically encoded 
fluorescent proteins linked either N- or C-terminally to the protein sequence (see Table 1). The tags 
used were either EGFP or mCherry, either as single proteins or in triplicate. To achieve the tagging a 
conventional “copy-and-paste” approach was employed, wherein both the receiving vector as well as 
the construct and the fluorescent proteins were cut using restriction enzymes and then ligated 
together (see Figure 27). The restriction enzymes used were purchased from either NEB or 
ThermoScientific. The ligation was performed using the T4 ligase (NEB #M0202).   
The vector system into which the sequences were inserted is the pGEMHE vector, with an Ampicillin 
resistance and a T7 promoter for the RNA production. The constructs were validated using sequencing 
by GATC (GATC Biotech AG, Constance) and amplified using either Mini- or Midi-preps (Qiagen kit 
#27106). 
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Figure 27: Copy-and-paste cloning strategy employed to generate constructs.  
The receiving vector pGEMHE with a T7 promoter was cut with two restriction enzymes (RE I and RE III) while the pJet1.2 
vector containing the sequence of the protein of interest (POI) was cut with RE I and RE II. The fluorescent protein sequence 
was cut from its donor vector using RE II and RE III. All 3 fragments were ligated to generate the pGEMHE-POI-FP construct 
containing the protein of interest fused to the fluorescent tag. 
Table 1: List of constructs used in the project. 
Protein 
name 
Vector C-/N-
terminal 
tag 
Fluorescent 
protein 
Species of 
origin 
Generated by 
Utrophin pGEMHE N EGFP3, 
mCherry3 
 Originally (Burkel et al. 2007), 
subcloned by Lenart lab 
Lifeact pGEMHE N EGFP Mus 
musculus 
Originally (Riedl et al. 2008), 
subcloned by Lenart lab 
EB3 pGEMHE N EGFP3, 
mCherry3 
 Originally (Stepanova et al. 2003), 
subcloned by Lenart lab 
MRLC pGEMHE N EGFP, 
mCherry 
Patiria 
miniata 
Originally by Masashi Mori, 
Subcloned by me 
Myo-II HC pGEMHE C EGFP, 
mCherry 
Patiria 
miniata 
Originally by Sarah Thome and 
Kalman Somogyi, subcloned by me 
rGBD pCS2 C EGFP Mus 
musculus 
(Benink & Bement 2005) 
Ect2 pCS2 C EGFP, 
mCherry 
Xenopus 
laevis 
(Bement et al. 2015) 
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Cyclin B pGEMHE N EGFP3, 
mCherry3 
Patiria 
miniata 
Johanna Bischof 
MBS/ 
MYPT1 
pGEMHE N EGFP Patiria 
miniata 
Johanna Bischof 
MyoGEF pGEMHE C EGFP Patiria 
miniata 
Johanna Bischof 
GEF-H1 pGEMHE C EGFP Patiria 
miniata 
Johanna Bischof 
 
Table 2: List of primers used for cloning from cDNA or mutagenesis. 
Name Sequence Length 
cycB-f4 CCATGGCAGTACAAGCATTGCTAT 24 
cyclinB-r3 TCGAGATTTATCGAAGAAGAAGCTTG 26 
MLC-S1.2A_fwd ATCACAATGGCTGCTAGAAAGACG 24 
MLC-S1.2A_rev CGTCTTTCTAGCAGCCATTGTGAT 24 
MLC-S1.2E_fwd ATCACAATGGAAGAAAGAAAGACG 24 
MLC-S1.2E_rev CGTCTTTCTTTCTTCCATTGTGAT 24 
MRLC-TS17.18AA(2)_fwd GCTCAGCGTGCGGCTGCTAACGTGTTTGCG 30 
MRLC-TS17.18AA(2)_rev CGCAAACACGTTAGCAGCCGCACGCTGAGC 30 
MRLC-TS17.18EE-rev AAACACGTTTTCTTCCGCACGCTG 24 
MRLC-TS17.18EE_fwd     CAGCGTGCGGAAGAAAACGTGTTT 24 
MYPT1_I_fwd GCACTGCATCATGGGTAGGTGA 22 
MYPT1_II_rev2 ACACTACAGGACGCTAAGCGAG 22 
 
3.2.2 Mutagenesis 
I generated mutations of both MRLC (see results) as well as cyclin B on the basis of the existing 
constructs using the Clontech In-Fusion® HD Cloning Plus Mutagenesis kit. This was done by producing 
a primer (see Table 2) covering the intended mutation site facing outwards to generate via PCR an 
open vector containing at each end the desired mutation. These linear vectors were re-circularised 
using the In-Fusion HD Enzyme (Clontech), generating a full vector containing the mutation (see Figure 
28). The mutations were validated by sequencing.  
Figure 28: Mutagenesis strategy. 
Mutagenesis was performed by introducing the mutation via PCR with primers containing the mutation and ligation of the 
resulting PCR copies of the vector containing overlap sufficient for ligation. This was done using the Clontech In-Fusion 
Mutagenesis kit. 
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3.2.3 RNA preparation 
To visualise the localisation of the proteins in the oocyte I injected RNA of the respective constructs 
into the oocyte. The RNA was produced in vitro from the above constructs using CellScript AmpliCap-
Max™ T7 High Yield Message Maker Kit for the pGEMHE constructs and AmpliCap™ SP6 High Yield 
Message Maker Kit for the pCS2 constructs and the A-Plus™ Poly(A) Polymerase Tailing Kit for both. 
Briefly, the constructs are first linearized, in vitro transcription and subsequent addition of a polyA-
tail.  
Linearization is performed by digestion with a set of restriction enzymes, always a combination of 
SgrAI, AscI, and AflIII, depending on the specific construct sequence. The linearized DNA was purified 
using a phenol/chloroform extraction and subsequently dissolved in RNase-free water to a 
concentration of around 1 µg/µl. The linearization success, as well as DNA quality, was tested by 
running a sample on a gel.  
This linear DNA construct served as a starting point for the in vitro transcriptions and polyA-tailing 
using the CellScript kits. The instructions in the kits were followed with no modifications. The final RNA 
was purified via an isopropanol extraction, diluted in RNase-free water to a final concentration of 
5 µg/µl and the quality checked on a gel.  
3.3 INJECTION  
The microinjection system was pioneered in its current form and application to starfish oocytes by 
Mark Terasaki and Rindy Jaffe and is described in detail at http://mterasaki.us/panda/injection/. It 
was originally applied to the starfish by (Hiramoto 1962) and is based on the idea of allowing picolitre 
precise injections using a syringe system. The high precision of the injected volumes is achieved by 
using microneedles containing small amounts of mercury, which allows the conversion of millilitre 
changes in syringe volume to picolitre changes in the tip of the needle.  
The starfish oocytes are sensitive to contaminations of the glass coverslips, which therefore have to 
be specifically washed before use. To wash coverslips, they (Menzel Gläser #1) are heated and 
incubated in a detergent-water solution before overnight incubation in 1 M HCl. The coverslips were 
then washed stringently in ddH2O and kept in Ethanol until being dried before use.  
To allow for injection and subsequent imaging, the starfish oocytes are kept in a specially designed U-
shaped injection chamber (Figure 29B), in which the oocytes are positioned on a shelf-like structure 
atop a coverslip to hold in the correct position for injection (Figure 29A). The shelf is constructed using 
specifically washed coverslips, a combination of single-sided and double-sided tape and a small piece 
of glass (Figure 29A). A standard coverslip, as well as the shelf coverslip, are attached to the injection 
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chambers using silicon grease (GE Bayer Silicones) which seals the sides of the chamber. It is then filled 
with FSW and the oocytes can be incubated in this chamber with regular washes for a number of days.  
Figure 29: Chamber setup for injection. 
A) Shelf coverslip holding the oocytes in position for injection. B) Complete microinjection chamber with oocytes in position. 
Figure from (Borrego Pinto 2015)  
To inject the oocytes, the following procedure is used: 
The solution that is to be injected is loaded into a loading capillary (Drummond) between portions of 
dimethylpolysiloxane silicone oil (20 cts viscosity, Sigma). The oocytes can be injected with a wide 
variety of liquids – e.g. RNA, proteins, drugs, marker molecules. The loading capillary is placed in the 
holding ridges of the injection chamber. 
Figure 30: Injection of the oocyte. 
The needle is filled with oil, mRNA and another layer of oil, as well as mercury and at the open end connected to the injection 
system. It is then positioned next to the oocyte which is to be injected (not to scale), held on the injection shelf. From (Borrego 
Pinto 2015).  
The microneedles are fabricated by pulling a capillary (Drummond) on the needle puller (Narishige 
PN-3 Glass Microelectrode Horizontal Needle Pipette Puller settings Heater 9, Magnet 8, Main Magnet 
8). The needle is filled from the back with a small volume of mercury (Sigma). The needle is then placed 
into the syringe injection system CellTram Oil manual injector, which is attached to a wide-field Nikon 
Eclipse Ti. The syringe system is filled with mineral oil (Sigma). The tip of the needle is broken via gentle 
tapping against the loading capillary and the mercury is pushed to the very tip of the needle and the 
needle is then filled with a buffer of oil from the loading capillary before sucking in the desired amount 
of liquid from the loading capillary. The needle filling is capped with a small amount of silicon oil to 
prevent mixing of RNA and sea water during the passage of the needle through the chamber (Figure 
30). The needle is then gently pushed into the oocyte and the liquid extruded together with a small 
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droplet of oil before the needle is removed.  The procedure is then repeated for all the oocytes in the 
chamber which have the correct orientation towards the cover slip, amenable for imaging. 
In the case of RNA injection, the cells are incubated overnight at 14 °C to allow for translation of the 
RNA, while for other injections imaging can proceed immediately.  
To calibrate the injected volume, I measured the diameter of oil droplets of units of injection volume 
(determined by scale in the microscope eyepiece) extruded into the water and calculated the 
conversion between arbitrary units of injection volume (IU) and volume as 𝑉[𝑝𝑙] = 3.033 ∗ 𝐼𝑈. 
3.4 IMAGING 
3.4.1 Confocal fluorescence microscopy 
The vast majority of the imaging for this project was performed on a Leica SP5 confocal microscope 
using the Leica LAS software, with a SuperZ Galvo stage, a 1.1 NA HC PL APO 40x water immersion 
objective (Leica), and two Hybrid detectors (Leica HyD).  
The oocytes were imaged directly in the injection chambers by placing these upside-down on the 
microscope stage in which case the oocytes rest directly on the cover slip above the objective. The 
standard imaging settings I used were 400-700 Hz scan speed, zoom 1.5-1.7, line average 2-3x, 
bidirectional scan on a single z-slice over time (xyt mode) on multiple positions. I selected oocytes for 
imaging which had a specific orientation with the AP-VP axis orthogonal to the objective and selected 
a single z-plane as close as possible to the AP-VP equator. This meant imaging relatively deep into the 
oocyte, which necessitated high fluorescence levels of my markers and the use of relative high laser 
power. I always attempted to minimise the used laser power to avoid photo-damage while achieving 
good signal levels. To allow for parallel imaging of a number of oocytes in a single chamber I selected 
a time resolution of 10 sec. Occasionally 15 sec frame intervals were also used. This time resolution 
allowed on average 5 to 7 oocytes to be imaged in parallel. 
In the case of acquiring z-stacks, I limited the number of z-slices to 5 per oocyte to minimise exposure 
and chose a z-spacing between 1.5 and 2 µm.  
3.4.2 Wide-field microscopy 
Some experiments were performed on the Zeiss Cellobserver at the EMBL Advance Light Microscopy 
Facility as this is a wide-field system, allowing for the observation of a larger number of cells 
simultaneously with very high time resolution. This system also contains a SuperZ Galvo stage and a 
high-power LED light source (Colibri LED illumination system), a CCD camera and a Zeiss 10x/ 0.30 Ph1 
air objective. Cells were imaged with 100 ms exposure and a time interval of at most 10 sec. 
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3.5 INHIBITOR TREATMENTS 
A list of all the chemicals used in this project can be found below with their specific solvents, 
concentrations, and delivery methods. All chemical stocks were kept at -20 °C in small aliquots and 
defrosted immediately prior to use. The chemical inhibitors which were applied to the cells were 
dissolved in FSW which was exchanged for the water covering the cells and incubated for the given 
times prior to hormone addition. Inhibitors which were injected were loaded into a loading capillary 
and injected as described above. Inhibitors were injected around 10 min after NEBD, roughly 20 min 
before the contraction wave as the direct delivery makes long incubation times unnecessary. Controls 
were performed using the respective solvent as the only treatment.  
For the local inhibitor treatments, cells were imaged in an adapted set-up to allow application of the 
drug on the microscope. To do this, the shelf coverslips containing the injected oocytes were sealed 
to the bottom of µ-Dish (Ibidi) which had their plastic bottom removed. The local inhibitor treatments 
were performed by adding the inhibitor directly on the open front of the shelf containing the oocytes 
using a small pipet. 
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Table 3: Used chemicals with function, concentration, solvent and incubation time. 
Name Supplier Function Stock 
conc. 
Final conc. Solvent Delivery 
method 
Incubation 
time/time 
to action 
Other comments 
Actinase E Sigma-
Aldrich 
Removal of jelly 
coat 
10 
mg/ml 
Dilution 
1:100 
Water Added to 
medium 
30 min Wash 3x with FSW after 
incubation 
EGTA Sigma-
Aldrich 
Chelate Ca2+ ions 0.2 M 5 mM – 100 
mM 
Water Added to 
medium 
20 min Added in Ca-free SW 
Roscovitine Merck 
Millipore 
Cdk1 inhibitor 50 mM n/a DMSO Local 
treatment 
5 min Added 2 µl of stock locally 
Flavopiridol Santa Cruz Cdk1 inhibitor 10 mM n/a DMSO Local 
treatment 
5 min Added 2 µl of stock locally 
RO-3306 Santa Cruz Cdk1 inhibitor 10 mM n/a DMSO Local 
treatment 
5 min Added 2 µl of stock locally 
Cytochalasin D Sigma Actin depolym. via 
filament capping 
10 mM 20 µM DMSO Added to 
medium 
40 min  
Latrunculin B Cayman 
Chemical 
Actin depolym. via 
monomer 
sequestering 
50 mM 5 µM DMSO Added to 
medium 
5 min  
Nocodazole Sigma MT 
depolymerisation 
20 mM 3.3 µM DMSO Added to 
medium 
5 min  
ML-7 Enzo MLCK inhibitor 20 mM 100 µM DMSO Added to 
medium 
40 min  
Peptide 18 Tocris MLCK inhibitor 1 mg/ml 30 µM in 
medium 
286 pg 
injected 
Water Added or 
injected 
20 min  
Y27632 Enzo Rok inhibitor 100 mM 3 mM – 12 
mM 
Water injected 20 min Effect from 3 mM , full 
inhibition >7 mM 
Phalloidin Invitrogen F-actin stabilising 
drug 
10 
mg/ml 
250 pg MeOH Inject 5 min 10 mg redissolved in 1 µl 
PBS before injection 
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C3 transferase Enzo RhoA inhibitor 1 µg/µl 35.5 pg – 
143 pg  
Water Inject 20 min  
Blebbistatin Abcam Myosin II inhibitor 100 mM 300 µM DMSO Added to 
medium 
1 h  At this concentration 
aggregates form in FSW 
Para-
Nitroblebbistatin 
Drugmotif Myosin II inhibitor 50 mM 300 µM DMSO Added to 
medium 
1 h  
10kDa-Dextran 
tagged with 
Alexa647 
Invitrogen Passive 
fluorescently 
labelled marker 
20 
mg/ml 
2 ng Water injected n/a 30 units were injected 
Ampicillin Sigma Antibiotic 100 
mg/ml 
1:1000 Water n/a n/a Added to LB for bacteria 
culture 
Kanamycin Sigma Antibiotic 50 
mg/ml 
1:1000 Water n/a n/a Added to LB for bacteria 
culture 
500kDa-Dextran 
tagged with Cy5 
Invitrogen Passive 
fluorescently 
labelled marker 
20 
mg/ml 
2 ng Water injected n/a Mixed 1:1 with Cdk1 
Paraformaldehyde EMS Fixative 16 % 1 % Fix 
buffer 
n/a n/a  
Glutaraldehyde  Fixative 25 % 0.1 % Fix 
buffer 
n/a n/a  
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3.6 PROTEIN INJECTION 
The method to purify active Cdk1/cyclin B complex from starfish oocytes was pioneered by the 
Kishimoto lab (Okumura 1996). I was kindly gifted some of the active protein by Eiichi Okumura, so 
did not perform the purification myself. In short it is done by generating high-speed extracts of 
maturing starfish oocytes, before incubating on a p13suc1-Sepharose column before elution by buffer 
A (80 mM Na-β-glycerophosphate, 20 mM EGTA, 15 mM MgCl2, 1 mM DTT, 10 % sucrose, 01 % Nonidet 
P-40). The procedure is described in detail in (Okumura 1996).  
I prepared aliquots of the active protein and froze in liquid nitrogen and kept the aliquots at -80 °C. To 
inject the protein was defrosted and loaded in a loading capillary and used immediately to maintain 
functionality. The capillary was kept on ice between the injections and refrozen in liquid nitrogen 
between experiments. As the protein is unlabelled, I co-injected it with large fluorescently-labelled 
Dextran to mark the site of injection.  
I also injected other fluorescently labelled proteins as an alternative to expression from mRNA. The 
proteins I used were H1 from calf thymus (Merck), Alexa647 labelled and tubulin from pig brain 
labelled with Cy3. The labelled tubulin was prepared by Kasia Tarnawska (Nedelec group, EMBL). 
These proteins were injected immediately prior to live imaging.  
When required for normalisation, I injected the oocytes with 10 kDa Dextran tagged with Alexa647, 
which serves as a passive marker to normalise optical effect brought on by imaging. This normalisation 
was performed for the quantifications of cyclin B and CalciumGreen. 
3.7 FIXATION AND IMMUNOHISTOCHEMISTRY 
To test for the presence of a gradient of Cdk1 activity in the oocytes, I fixed starfish oocytes and tested 
different antibodies on them. The antibodies tested were two versions of a rabbit antibody against 
starfish cyclin B – one generated by the Kishimoto lab and one generated by the Chiba lab – and an 
antibody against the active form of Cdk1, specifically the Tyr 15 phosphorylation site (Cell Signalling 
Phospho-cdc2 (Tyr15) Antibody #9111). This antibody has been reported to respond to a wide range 
of species from S. cerevisiae to Xenopus and human (Cell Signalling). I also fixed oocytes expressing 
injected cyclin B-EGFP RNA and staining using a GFP antibody (Rabbit anti-GFP #598 MBL Life Science).  
I tested both fixation protocols using aldehyde fixes as well as cold Methanol fixes. For the aldehyde 
fix I used a variation of the recipe developed by George von Dassow for echinoderm oocytes and 
embryos (Strickland et al. 2004), where a mixture of formaldehyde and glutaraldehyde in a specialised 
buffer (100 mM HEPES, 50 mM EGTA, 10 mM MgSO4, 0.5 % Triton, 1 % formaldehyde, 0.1 % 
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glutaraldehyde) is used to fix the oocytes for 1 h at room temperature. For the methanol fix I followed 
the protocol outlined in (Terasaki et al. 2003), where oocytes are incubated in -80 °C cold methanol 
for 1 h for fixation before rewarming to room temperature and washing in PBS. 
To perform both the fixation as well as the subsequent antibody staining I used both standard 
protocols with long incubation times at room temperature - primary AB overnight at 4 °C and 
secondary AB for 2 h, as well as 3x 5 min washes in PBS-T – as well as the specialised PELCO Biowave 
Pro microwave (Ted Pella, Inc.) which allows a much quicker procedure by increasing chemical 
penetration without heating the samples (see Table 4). 
Table 4: Microwave protocol for fixation. 
Originally developed by Joana Pinto and Natalia Wesolowska. 
 
All oocytes were stained using either an antibody against nuclear pore protein complexes (MAb414 
from Biolegend) or against tubulin (DM1A Sigma-Aldrich) and Draq5 (Biostatus) in addition to the 
antibody being tested, to ensure that the staining itself was successful. The secondary antibodies used 
were goat-anti-mouse IgG Alexa488 and goat-anti-rabbit IgG Alexa 546 from Invitrogen. Once the 
staining was complete oocytes were placed in a drop of ProLong® Gold Antifade (Life Technologies) 
between an objective slide with a spacer of double sided tape and a coverslip and imaged on the 
confocal as described above.  
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3.8 PHYSICAL MANIPULATIONS 
3.8.1 Surface tension measurements 
The technique to use pipet suction to measure surface tension has been well-established and has 
historically been applied to measure these in a number of marine animals including starfish. I 
performed surface tension measurements with the help of Jean-Leon Maitre from the Hiiragi lab at 
EMBL, using the set-up he established and which has previously been described for use in mouse 
embryos (Maître et al. 2015). Briefly, I forged the micropipettes for the measurements from capillaries 
(World Precision Instruments TW100-3) in a needle puller (Flaming Brown Sutter Instrument) and then 
cut them so that an opening of a diameter of ≈30 µm for measurements on mature oocytes and 
≈70 µm for measurements in immature oocytes was generated. The needles were then bent to an 
angle of roughly 45°. 
The thus produced micropipette was mounted in a Narishige micromanipulator connected to a liquid 
reservoir. The pressure in the system is controlled by a microfluidic pump which has a pressure 
resolution of 7 Pa, using the Labview software (National Instruments) (Maître et al. 2012).  
The jelly coat of the oocyte was removed previous to the measurements using Actinase E treatment 
for 30 min and subsequent washes. The cells were first measured either in the immature state as well 
as in the mature state after meiosis was completed. Secondly, two oocytes were measured during 
meiosis at roughly 5 min time intervals. 
To perform the actual measurements, the pipette is placed next to oocyte and the pressure is slowly 
increased until the protrusion into the pipette forms a half-sphere, i.e. it has the same radius as the 
pipette opening (Figure 31). In the immature oocyte, care was taken to measure not at the animal 
pole but laterally in the oocyte. The surface tension Tc was calculated from the size of the cell (RC), the 
size of the bulge (RP) and the required negative pressure (ΔP) using the following formula based on 
Young-Laplace’s law. 
∆𝑃 = 2𝑇𝑐 (
1
𝑅𝑝
−
1
𝑅𝑐
) 
𝑇𝑐 =  
∆𝑃
2 (
1
𝑅𝑝
−
1
𝑅𝑐
)
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Figure 31: Surface tension measurements.  
Picture of an immature oocyte on which the measurement is being performed with a hemisphere sucked into the pipette and 
showing the relevant measurements for calculating the tension. 
3.8.2 Centrifugation 
In the starfish oocyte, the nucleus can be moved from its original position at the animal pole to another 
site of the cortex by centrifugation (Miyazaki et al. 2000). To perform centrifugation oocytes are placed 
in the shelf chambers used for injection and these chambers are positioned in 50 ml Falcon tubes using 
custom-designed holders (Figure 32). The tubes are filled with FSW and centrifuged at 420 g (2400 
rpm Heraeus Multifuge) for 45 min at 4 °C.  
To determine the effect of the centrifugation I measured the relative angles between the axis of 
contraction and the old and new animal-vegetal axis respectively. I determined the old animal-vegetal 
axis using a marker for the centrosomes, EB3 or POC1, which sit at the animal pole and are not moved 
by centrifugation. While the new animal-vegetal axis is set by the point at which the nucleus connects 
to the cortex. The angle between the contraction wave and the two animal-vegetal axes was measured 
using the ImageJ Angle tool.  
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Figure 32: Set-up for centrifugation of starfish oocytes.  
Oocytes are placed on the coverslip shelves in random orientation and centrifuged in 50 ml Falcon tubes, resulting in all nuclei 
facing the top after centrifugation. Figure adapted from (Borrego Pinto 2015). 
3.8.3 Shape change wells 
To modify the geometry of the oocytes I used microfabricated chambers, which were originally 
developed by Nicolas Minc for application in sea urchin embryos (Minc et al. 2011). He helped me in 
the design and fabrication of the chambers which was performed by me in his lab at Institute Monod, 
Paris. 
To generate the chambers, I first designed the mask with a variety of shapes (Figure 33). To ensure 
that the cells move into the shapes, the shapes are designed for a height of 140 µm and the surface 
area of the desired shapes calculated accordingly. The mask was designed using the free Software 
QCAD and printed by Selba S.A.   
The chambers are produced using a photolithographic process. In this the wavers which form the 
substrate were first stringently cleaned using Acetone, Isopropanol, and ddH2O, and subsequently 
dehydrated by baking. The wavers were then pre-coated using the MicroChem OmniCoat. As the 
desired film thickness was at the highest limit possible with the used resin, the wavers were spin-
coated with SP8-50 at 750 rpm. Next, the wavers with the resin on them are soft baked to evaporate 
the solvent for 20 min at 65 °C and for 60 min at 98 °C. The mask with the designed shapes was placed 
on top of the thus prepared wavers and exposed to UV light for 22 sec, and then baked again to 
crosslink the just irradiated portions of the waver for 1 min at 65 °C and 12 min at 98°C. The wavers 
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were then placed in the SU-8 Developer for 18 min or until the run-off after isopropanol wash was 
clear. The finished chips were washed thoroughly with isopropanol and then cured at 130 °C, before 
slowly cooling down over 30 min to avoid cracking.   
 
Figure 33: Shape change wells.  
A) Mask design of the chosen shapes including control shapes in the last row. The final chip includes many repetitions of these 
blocks. B) Mechanism of introducing the cell into the shapes, republished from  (Minc et al. 2011), with permission by Elsevier.    
The PDMS chips were cast by pouring a mixture of PDMS and curing agent (10:1, Sigma) onto the 
positive and baking for at least 4 h at 65 °C. The hardened PDMS was then carefully cut with a scalpel 
and peeled away from the master. Immediately before each experiment, the PDMS chip was cleaned 
sequentially in acetone, isopropanol, and ddH2O. It was then attached to an objective slide with feet 
via double-sided tape and surface-activated by plasma cleaning (Zepto Plasma Cleaner from Diener). 
A drop of FSW was placed in the middle of the chip immediately after plasma treatment. 
As the immature oocytes are too stiff to enter into the shapes, I matured the cells in a dish before 
placing them onto the prepared and activated chip 40 min after hormone addition. At this stage, the 
cells are in the middle of metaphase and 10-15 minutes remain until the start of the contraction wave. 
A coverslip was then gently lowered onto the chip and the cells were pushed into the shapes by 
sucking out some of the water between chip and coverslip.  
The chip was then inverted and imaged on the confocal microscope as described above. After 
treatment, the chip was cleaned to remove the oocytes left in the moulds. The chips were reused 
multiple times.  
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3.9 IMAGE ANALYSIS AND PROCESSING 
3.9.1 General image processing 
I used ImageJ/Fiji for general viewing and processing of the imaging data (Schneider et al. 2012; 
Schindelin et al. 2012). For the images presented here, I adjusted the brightness and contrast settings 
to allow the important aspects to be seen as well as reversing the LUT for better visualisation in print. 
For multi-channel images, I overlaid the channels using the Image->Colour->Channel Tools and 
adjusting the relative intensities of each channel. In the cases of z-stacks, I applied the 
Image->Stacks->Z Project with maximum intensity projection. 
3.9.2 Curvature measurement 
To quantify the contraction wave I used an algorithm originally written for this specific problem by 
Imre Majer as an undergrad student in the Lenart lab. I used his code as the basis for my work with 
only a few modifications to improve functionality and usability.  
This analysis uses Matlab (MathWorks® Inc.) and Miji – a java package allowing interchange of image 
data between Matlab and ImageJ (Sage et al. 2012).  
The goal of the analysis is to automatically segment each image in a time series, calculate the curvature 
of the thus segmented cortex and for fluorescent images measure the fluorescence intensity along 
the cortex during the contraction process. To do this the workflow shown in Figure 34 was used. This 
analysis pipeline is designed to work with both brightfield and fluorescence images with varied 
fluorescence distributions. 
Firstly I want to allow ImageJ to automatically pick a rough outline of the cell. To do this I run a 
Laplacian filter and an averaging filter on the images which causes a sharpening of the edges and a 
reduction of any potential gaps in the signal respectively. Then a threshold is picked manually and the 
resulting mask (with any holes filled if necessary) is used as the starting point for the proper 
segmentation. This first mask already matched the rough shape of the cell but is not sufficient for 
detailed analysis. To perform a detailed segmentation a sparse-field Level Set algorithm is used with 
a lambda value of 2, which determines the sensitivity of the segmentation to small signal changes. The 
mask serves as a starting point for the algorithm which moves iteratively inwards. For the first image 
the algorithm running with 300,000 iterations, normally gives a good segmentation result, but this 
value can be adjusted based on the particular image quality. After the first image of the time series is 
segmented the user is consulted to check the quality of segmentation and potentially change the 
segmentation parameters. The following images in the time series are then automatically segmented 
using Level Set with the outline of the previous image serving as a starting point. 
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Figure 34: Image Analysis pipeline. 
This details the individual steps for a single example image as well as the different output types of the calculated data.   
Once the whole time series has been segmented, the curvature of the cortex is to be calculated. Before 
this can be done, the segmented outline needs to be smoothed as the Level Set algorithm gives a pixel-
fine outline and in this local curvature changes give high background noise level compared to the cell-
level curvature changes in which I am interested. To perform this smoothing the segmented outline is 
transposed into polar coordinates and smoothed by fitting a piecewise polynomial. The standard 
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settings I used for the smoothing were a 5th order polynomial with the cortex segmented into 200 
points. 
Furthermore, the axis of the cell is determined at this step, by detecting the movement of the centroid 
of the segmented object and plotting this point over time. The movement of the centroid has 
commonly two components – firstly the drift of the system which only leads to small displacements, 
and secondly the contraction wave which leads to a big shift in the centroid position between time 
points. The user can fit a line through the points representing the contraction wave and thereby set 
the animal-vegetal pole axis. When the contraction is not present, the axis is set based on the 
orientation of the oocyte in the images. 
The curvature that is calculated is specifically the radius of the first principal curvature in a small 
segment of the cortex (200 segments along the contour) and is calculated using finite differences by 
minimising the Chan-Vese energy function (Chan & Vese 2001; Lankton & Tannenbaum 2008). As the 
oocyte can have a non-circular starting shape due to compression by neighbouring oocytes the surface 
curvature relative to the first image is also calculated.  
The resulting curvature per point along cortex values can be plotted in two ways. Firstly the values can 
be plotted as a ring around an image of the oocytes for each time point generating a new time series 
which dynamically shows the changes in cortical curvature. Secondly, the values can be plotted in a 
static form as a kymograph, were the curvature values are plotted for each point along the cortex as 
a line for each time point. The kymographs are the main representation of the curvature used here as 
they allow the observation of time behaviour in a single plot. The curvature values are encoded using 
the jet LUT and to allow easy comparison between plots, all are scale to show values between 100 and 
500 µm. 
To measure the fluorescence intensity along the cortex the segmented mask for each image is used 
as a starting point. This mask is then eroded a number of pixels set by the user to contain part or the 
whole cortex area, and a subtraction of the two masks gives a ring overlying the cortex. This ring is 
segmented into small areas similar to those used for the curvature measurements and the 
fluorescence intensity in each of these areas is measured. The values are only plotted in the 
kymograph form as described above. 
3.9.3 Flow measurements via STICS 
To measure the flow of the cytoplasm during the contraction wave a version of spatiotemporal image 
correlation spectroscopy (STICS) was implemented in the Matlab code. STICS was originally developed 
by (Hebert et al. 2005) and relies on measuring the correlation of image intensities across selected 
68 
 
spatial and temporal windows. This technology allows us to measure both the directionality and 
velocity of the cytoplasmic flow. In the starfish oocytes, we can measure the flow on both brightfield 
images as well as fluorescent images as the yolk platelets in the cytoplasm form a high-contrast (black 
compared to grey values for cytoplasm both in bright-field as well as in fluorescence microscopy) 
substrate whose movement STICS can measure. The STICS measurements were performed by 
calculating the cross-correlation in an interrogation window with a size of 16 px without overlap in 
space and 6 frames with a time resolution of 50 ms in time. To avoid false result at the boundary the 
edges were avoided by picking a suitable offset and filled by extrapolation from the internal data. All 
these analyses were done on a single 2D plane which was chosen to optically bisect the oocyte at the 
equator along the animal-vegetal axis.  
3.10 DATA ANALYSIS AND PLOTTING 
To compare the measured curvature values between different oocytes and especially between 
treatments is key to allow quantification of the observed changes but it is not trivial. The interesting 
aspect is not so much the maximum or minimum curvature value reached during the contraction 
process. Nor is the average curvature value very informative as the contractile cortex is only a small 
part of the whole cortex and averaging obscures the true effect. 
After testing a wide variety of methods to condense this complex multidimensional data set of 
curvature values during contraction into a single reliable and relevant number, I chose to quantify the 
contraction strength using the variance of the radius of curvature values during the contraction wave. 
To do this I summed all cortex area segments having specific curvature values. As the oocyte has a 
certain intrinsic curvature, I quantified the curvature during the contraction wave and during 
metaphase when the curvature is not changing and subtract the background value (Figure 35A). The 
dataset with different strengths have different variance as more areas of the cortex have either a high 
or low radii of curvature (Figure 35B). These measurements were performed in Matlab or in Excel.  
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Figure 35: Quantifying strength of contraction wave. 
A) The oocytes have an intrinsic curvature which is subtracted from the measured curvature values, here for an oocyte treated 
with Blebbistatin which shows very low contraction, i.e. no large difference compared to the background. B) Surface curvature 
measurements for different treatments with different strengths, showing different spreads of values, which are measured in 
the variance.   
The duration of the contraction wave was determined either in the image series or additionally also 
in the kymographs, depending on data quality, and the speed was calculated based on the duration 
and distance along the oocyte cortex. 
All data was plotted in the software R using the ggplot2 package (R Core Team 2016; Wickham 2009). 
In the boxplots used, the top and bottom lines of the box mark the 25th and 75th percentile of the data, 
while the line in the middle marks the median. The whiskers mark the highest and lowest data points 
still within 1.5 interquartile range.   
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4.1 CHANGES IN CORTICAL CONTRACTILITY DURING MEIOSIS 
4.1.1 Changes to the cortex from immature to mature oocyte 
During the process of maturation, the immature oocyte is transformed into a fertilisable egg via 
meiosis. This division process goes along with changes in the cortical contractility, which manifest in 
the contraction waves passing across the cell. The first marker for changes to the cortex is the change 
in surface tension observed during meiosis. Measurements of surface tension have a long tradition in 
the study of eggs and embryos and have previously been performed on the starfish oocytes, using 
both pipet suction (Sawai & Yoneda 1974; Yoneda et al. 1982) and plate compression (Hiramoto 1976; 
Ikeda et al. 1976). Therefore, I first set out to confirm the published results in the particular starfish 
species I used, Patiria miniata.   
The measured surface tension in the immature oocytes is very large (Figure 36A) with values averaging 
around 10 000 pN/µm, which is identical after conversion to the value of 1 dyne/cm measured in 1976 
by Ikeda and colleagues for a related species (Ikeda et al. 1976). After meiosis is completed, the cells 
are an order of magnitude softer (Figure 36A), indicating the drastic change in the cortex. 
To determine the specific time point at which this drastic change in the surface tension takes place, I 
also measured the surface tension over the course of the whole division process (Figure 36B). From 
this, it becomes clear that the change in the surface tension occurs alongside nuclear envelope 
breakdown (NEBD) around 20 min after hormone addition, which signals the beginning of metaphase 
(Figure 36B). The surface tension that the oocyte reaches at metaphase is around 1000 pN/µm. This 
value is very similar to the surface tension measured both in other oocytes in metaphase (e.g. mouse 
(Larson et al. 2010)), as well as in mitotic cells in metaphase (Fischer-Friedrich et al. 2014). Interestingly 
though, while the target value for metaphase is very similar between these different systems, oocytes 
and mitotic cells reach it from two different directions: oocytes reduce their surface tension (Larson 
et al. 2010; Chaigne et al. 2013), while cells in mitosis increase their surface tension to reach the 
metaphase surface tension (Stewart et al. 2011). 
In the starfish oocyte, the surface tension stays relatively constant throughout metaphase and then 
sharply peaks at the transition into anaphase around 70 min after hormone addition. This is the point 
at which the surface contraction wave passes across the cell (Figure 36B). The surface tension levels 
then drop again as the cell enters into metaphase II, before spiking again at anaphase II as the second 
contraction wave crosses the cell. This repetitive behaviour is consistent with our knowledge of 
meiosis, in which two cell cycles immediately follow each other.  
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These changes in the surface tension affect the cell shape and these shape changes can be quantified 
by measuring the radius of the surface curvature. When these curvature values across the whole 
maturation process are plotted in a kymograph certain characteristic become apparent (Figure 36C). 
Both the softening at NEBD as well as the spikes in surface tension at anaphase I and anaphase II go 
along with waves of shape changes moving across the cell, although the extent of these differs.  
The observation that the shape change travels across the cell tells us that the changes to the surface 
tension do not happen everywhere at once but move progressively across the cell, which was not 
detected in the surface tension measurements in Figure 36B as they were performed only at one point 
of the cortex. Simultaneously it becomes clear that the waves are not equal, as the wave of softening 
at NEBD starts at the animal pole (AP) of the cell, where the nucleus is, and moves towards the vegetal 
pole (VP), while the two contraction waves at anaphase move in the opposite direction (Figure 36C). 
Of these two surface contraction waves (SCWs), the first one is much more pronounced and was the 
focus of the investigation described in the following.  
Figure 36: Cortical changes during the oocyte maturation.  
A) Surface tension in the immature and mature oocyte shows a significant difference (p<0.0005). B) Surface tension over the 
time course of meiosis for two example cells, showing the softening at NEBD and the spikes in tension at the two contraction 
waves. C) The radius of surface curvature of the oocyte plotted as kymograph showing the changes in curvature at NEBD, 
SCW I and SCW II. 
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4.1.2 Description of the first surface contraction wave 
If we look in more detail at the first surface contraction wave occurring at anaphase of meiosis I, the 
quantification shows that the contraction wave is, in fact, a band of flattening. This starts at the vegetal 
pole (VP) and moves across the oocyte towards the animal pole (AP) (Figure 37A and C). It arrives at 
the animal pole at the time of polar body formation, as visible in Figure 37A.  
Figure 37: Surface contraction wave.  
A) The radius of curvature plotted as a ring plot along the brightfield images of the oocyte. This shows the corresponding 
shape and the band of flattening moving from VP to AP. B) Cytoplasmic flow during the contraction wave measured by STICS, 
showing biphasic behaviour. C) Detailed view of the cortical flattening during the first SCW as kymograph along the cortex, 
measured as the radius of curvature. All times relative to NEBD. The asterisk marks the polar body.  
This change in the cell shape leads to cytoplasmic flow along with the contraction wave. The flow was 
measured using spatiotemporal image correlation spectroscopy (STICS) and revealed to be biphasic 
(Figure 37B). In the first phase, when the contraction starts and progresses across the vegetal 
hemisphere of the cell, the flow is relatively slow and is directed towards the animal pole. When the 
contraction reaches the equator halfway between animal and vegetal pole the flow stops and 
subsequently reverses as the contraction continues towards the animal pole. It reaches its peak 
velocity pointing away from the animal pole immediately prior to the protrusion of the polar body 
(Figure 37B). This flow behaviour is consistent with the cytoplasm behaving as a passive fluid which is 
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pushed around the cell by the contraction of the cortex. It is important to note that the observed flow 
in the oocyte takes place in the bulk of the cytoplasm and there is no or very little flow in the region 
close to the cortex. The flow we observe in response to the contraction wave is, therefore, distinct 
from the cortical streaming phenomenon observed in C. elegans embryos prior to cytokinesis which 
is mainly observed in the subcortical regions (Munro et al. 2004).  
The detailed analysis of the contraction using brightfield imaging with high time resolution allows me 
to link the shape changes and flow patterns to form a model of the physical process of the contraction 
wave (Figure 38). When we compare this model to the original model of contraction waves and 
cytoplasmic flow in starfish oocytes established by Hamaguchi and Hiramoto in 1971, we find that in 
the basic description of the shape change the models agree (Figure 38). At the same time, with the 
higher time resolution and sophisticated image analysis techniques, I can detect the more subtle early 
shape changes and can correctly assign the cell shape to the observed flow. This was not possible in 
the previous work and this explains why the correlation between shape change and flow pattern that 
I find is somewhat in opposition to the correlation established by Hamaguchi and Hiramoto. 
In summary, a simple observation of the contraction wave along with detailed image analysis revealed 
the contraction wave to be a band of flattening of the cortex that moves across the cell from the 
vegetal to the animal pole. The contraction results in a flow of the cytoplasm whose direction changes 
in accordance with the passing of the wave. 
Figure 38: Model of the shape changes of the contraction wave and the cytoplasmic flow.  
Upper panel shows the original model from (Hamaguchi & Hiramoto 1978) while the lower panel shows the model based on 
my data with the improved assignment of shape and flow stages. Reprinted with permission from Elsevier. 
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4.2 MOLECULAR PATHWAY LEADING TO CONTRACTION 
4.2.1 Role of myosin II in the contraction wave 
4.2.1.1 Myosin II is one of the most abundant molecules in the oocyte 
As the analysis above revealed the surface contraction wave to be a flattening of the cortex, this 
indicates a contractile event. It is therefore of great interest to identify the origin of the contractile 
force. As myosin II is the key motor protein in cells, it is an ideal candidate for driving the contraction 
wave.  
Indeed, myosin II is one of the most abundant proteins in the starfish oocyte. It is found among the 
top 10 proteins in a whole cell proteomics analysis along with key oocyte components such as the 
yolk-related proteins Vitellogenin and fertilisation envelope protein Proteoliaisin (Table 5).  
Table 5: Top 10 proteins in the starfish oocyte as determined by Mass-Spec sorted by counts. 
# Identified Proteins Molecular 
Weight 
average 
counts 
1 Sp-vitellogenin1 153 kDa 281.4167 
2 Sp-vitellogenin1 219 kDa 124.1667 
3 Sp-vitellogenin3 429 kDa 56.91667 
4 Sp-proteoliaisin 149 kDa 45.58333 
5 Sp-myosin-2 438 kDa 32 
6 Receptor-type tyrosine-protein phosphatase R 67 kDa 27 
7 Sp-Macf1-2, microtubule-actin crosslinking factor 1-2 922 kDa 27.08333 
8 Sp-vitellogenin3 138 kDa 25.75 
9 Sp-EMI-EGF  202 kDa 24 
10 Sp-heat shock protein 90 kDa 84 kDa 23 
4.2.1.2 Myosin II localises to the flattened cortex 
To investigate the involvement of myosin II in the contraction wave its localisation was to be 
determined. Commonly in the literature, the localisation of myosin II is investigated using a GFP fusion 
to either one of the myosin light chains (MRLC or MELC). I tested the GFP-tagged version of the starfish 
MRLC, but due to the large cytoplasmic pool, I could not observe any specific localisation of the protein 
during the contraction wave using this fluorescent protein (Figure 39 D). Therefore, I used a GFP-
tagged version of the myosin heavy chain of Patiria miniata1. Starfish oocytes expressing this protein 
allowed me to observe the localisation of myosin II, especially when the myosin heavy chain construct 
was co-expressed with MRLC.  
                                                          
1 The starfish Myosin II heavy chain-EGFP construct was cloned by Kalman Somogyi and Sarah Thome in the 
Lenart lab.  
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In the immature oocyte myosin II is localised to the cortex (Figure 39 A), from where it is lost at NEBD 
in accordance with the observed softening of the oocyte at this time (Figure 36 B). During the 
contraction, myosin II returns to the part of the cortex which is flattened at the time, and moves along 
the cortex as a band until it reaches the animal pole (Figure 39 A). The myosin signal and the cortical 
flattening overlap completely (Figure 39 B). If I quantify the myosin fluorescence intensity in a band of 
cytoplasm underlying the cortex (but not including the cortex), it becomes clear that myosin II is 
recruited from the cytoplasm to the abutting cortex (Figure 39 C). Some of the myosin II molecular 
may also travel along the cortex with the contraction wave. It is important to note that here I observed 
the localisation of myosin II molecules to the cortex going along with the contraction wave, 
independent of their activation via phosphorylation.  
In summary, myosin II is recruited from the cytoplasm to the cortex which is flattened during the 
contraction wave and forms a band moving across the cell. 
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Figure 39: Myosin II in the contraction wave.  
A) Localisation of myosin II heavy chain-EGFP construct in the immature oocyte (first image) and during the contraction wave, 
the arrows show the front of myosin II recruitment to the cortex. B) Quantification of the surface curvature (left panel) and 
the fluorescence intensity along the cortex (right panel) showing the overlap of the two (dashed line). C) Fluorescence intensity 
of myosin II heavy chain in the subcortical cytoplasm, showing depletion of the signal during the contraction wave. D) 
Localisation of the MRLC-EGFP3 construct in the immature oocyte (first image) and during the contraction wave. Dashed line 
indicates flattened cortex area. Scale bars 30 µm, all times relative to NEBD. 
4.2.1.3 Changing myosin II activity affects strength of contraction wave  
The above-observed colocalisation of myosin II molecules with the flattening of the cortex is a good 
indication that myosin II causes the flattening, but to prove a causal relation between the two I 
changed the levels of myosin II activity in the cell. Firstly, to reduce myosin II activity the oocytes were 
treated with the specific non-muscle myosin II inhibitor (-)-Blebbistatin. This inhibitor blocks the 
ATPase activity of the myosin head domain and thereby blocks the force generation of the molecule 
(Straight et al. 2003). 
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Inhibiting myosin II activity in the oocytes leads to a significant reduction of the contraction strength. 
This can be seen in both the stills and kymographs of curvature plots (Figure 40 A and C). Blebbistatin 
treatment on average reduced the contraction strength from a variance of the radius of curvature in 
the control of 417±170 µm2 to 70±35 µm2 (p<0.005) (Figure 40G). To allow for the comparison of the 
contraction strength I used the variance of the radius of curvature along the whole cortex measured 
for all time points of the contraction wave (for details see 3.9.2 Curvature measurement, page 65). 
At the same time Blebbistatin, while very specific in its inhibition, is in this system not a very efficient 
inhibitor and has several drawbacks. Firstly, it is converted to a cytotoxic form upon exposure to blue 
light, limiting the use of fluorescence microscopy, and at the high concentration necessary for 
successful inhibition it forms precipitates in the sea water in which the oocytes are maintained (Figure 
40 F). The high necessary concentration for inhibition is likely due to the large pool of myosin II in the 
oocyte, as described above. In hopes of alleviating these problems, I have tested a recently developed 
derivative of Blebbistatin called para-Nitroblebbistatin (Kepiró et al. 2014)2. I tested the efficiency of 
this drug compared to Blebbistatin in the context of cytokinesis in the embryo as this allowed for an 
easy large-scale comparison. In the embryo myosin II inhibition leads the failure of cytokinesis and 
lack of blastomere formation. It is clear that both para-Nitroblebbistatin and Blebbistatin strongly 
inhibit cytokinesis compared to control treatments, although the effect is stronger for Blebbistatin 
(Figure 40F). At the same time para-Nitroblebbistatin clearly forms much less severe aggregates. The 
lower inhibition of myosin II observed for para-Nitroblebbistatin in cytokinesis was also observed 
during the contraction wave, making it not a viable alternative to Blebbistatin in this context. 
Overall, it is clear that Blebbistatin inhibits the contraction wave, therefore proving that myosin II is 
driving the flattening of the cortex via its motor action.  
 
                                                          
2  I received an early sample of para-Nitroblebbistatin from András Málnási-Csizmadia, Department of 
Biochemistry, Eötvös Loránd University Budapest as a gift for which I am very grateful.  
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Figure 40: Changing myosin II activity.  
A) Oocyte treated with 300 µM Blebbistatin showing no changes in cell shape at the time of contraction wave. B) Oocyte 
overexpressing MRLC showing a stronger contraction wave. Dashed line indicates flattened cortex area. C) Kymograph 
showing the surface curvature change in a Blebbistatin treated oocyte. D) Kymograph showing the surface curvature change 
in a non-treated oocyte. E) Kymograph showing the surface curvature change in an MRLC overexpressing oocyte. F) Efficiency 
of para-Nitroblebbistatin and Blebbistatin in inhibition of cytokinesis in embryos as a measure of myosin II inhibition efficiency. 
G) Quantification of the contraction strength measured as variance of the surface curvature during the contraction resulting 
from the various myosin activity manipulations. Scale bar 30 µm, all times relative to NEBD.    
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To further probe the specific role of myosin II in the contraction process, I overexpressed the myosin 
regulatory light chain (MRLC) in the oocytes (Figure 40B). This overexpression has the effect of strongly 
increasing the contraction strength from a variance in the control of 417±170 µm2 to 3505±404 µm2 
(p<0.001). The shape change of the oocyte becomes much more striking, as visible in the still images 
as well as the curvature kymographs (Figure 40B and E).  
This observation suggests that the oocyte has an overabundance of myosin II heavy chain molecules 
that are not formed into complexes and the overexpression of MRLC allows the formation of more 
fully assembled functional complexes. It also suggests that in the untreated oocyte the strength of the 
contraction could be limited by the number of available myosin molecules.  
All in all, this data shows for the first time that the surface contraction wave is a truly contractile 
process driven by myosin II.  
4.2.2 Myosin II regulation 
4.2.2.1 Myosin II activity is regulated via the phosphorylation site TS17.18  
As myosin II drives the contraction, I next addressed the question of how myosin II is activated during 
the contraction wave. To answer this question, I first explored which phosphorylation sites in the 
myosin regulatory light chain (MRLC) needs to be phosphorylated for proper myosin II function in the 
contraction wave. There are two described phosphorylation sites - the key one at T17 and S18 
(TS17.18) phosphorylated by MLCK, Rok and citron kinase as well as the less common site S1 and S2 
(SS1.2), which has been proposed to be phosphorylated by Cdk1-cyclin B (Figure 41)(Satterwhite et al. 
1992).  
Figure 41: Phosphorylation sites of myosin regulatory light chain (MRLC). 
I generated phosphomutants of these specific sites by replacing the wildtype amino acids with 
glutamic acid or with alanine for phosphomimetic and non-phosphorylatable mutants respectively 
(Figure 42 A). These mutants were overexpressed in the oocytes on the background of the endogenous 
MRLC, which cannot be removed as the oocyte stores proteins in large amounts. This treatment, 
therefore, results only in partial phenotypes, which are nevertheless detectable in the quantification 
of the contraction strength.   
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In all cases of overexpression, the contraction wave is stronger than in the untreated cell as indicated 
by the MRLC overexpression described above (Figure 42 B). The mutants at the TS17.18 site show on 
average a contraction that is stronger compared to the overexpression of the non-mutant version, 
which is visible in the stills as well as the kymographs (Figure 42 D and E compared to C). The 
phosphomimetic TS17.18EE mutant contraction is stronger than that of the non-phosphorylatable 
TS17.18AA, which is the expected pattern (Figure 42 I and J) (4050±622 µm2 and 3024±555 µm2 vs 
2090±998 µm2 for the non-mutant version respectively, p<0.001).  
The mutants at the SS1.2 site show no difference between the phosphomimetic and the non-
phosphorylatable form, even though on average their contraction strength is slightly higher than the 
overexpression of the wildtype MRLC (2537±940 µm2 and 2528±904 µm2 compared to 2090±998 µm2 
respectively), but this difference is relatively small and not statistically significant (Figure 42 F and G).  
From the data present, it seems likely that the TS17.18 site, which is the target of MLCK, Rok and citron 
kinase, is the site by which myosin activity during the contraction wave is controlled. The observation 
that the SS1.2 mutants show no significant difference between each other as well as towards the 
control suggests that this potential phosphorylation site is not important in the context of the 
contraction wave. These results conform to findings in other contractile processes, were TS17.18 is 
also the main regulatory site while the evidence for SS1.2 is relatively weak.  
As the overexpression of a non-phosphorylatable form leads to an increase in contraction strength, it 
is clear that the non-phosphorylatable MRLC has some partial activity. This can be mediated by 
myosins with non-phosphorylatable MRLC assembling into mini-filaments with non-mutated myosins, 
as previously described in the literature (Watanabe et al. 2007). The same can also happen on the 
single-molecule level with non-phosphorylatable MRLC co-assembling into semi-functional myosin 
complexes with non-mutated MRLC present in the cell. 
The role of differential phosphorylation of the sites TS17.18 was not explored here even though it 
would be worth further study as the single and double-phosphorylated forms of MRLC can clearly play 
differential roles in regulating contractility (Watanabe et al. 2007).   
In summary, although the data is slightly obscured by the presence of the endogenous protein, it is 
clear that of the two potential myosin phosphorylation sites, the site which that is key for controlling 
myosin activity during the contraction wave is the site at TS17.18 rather than the SS1.2 site. 
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Figure 42: MRLC phosphomutants.  
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A) Beginning of the MRLC sequence in Patiria miniata, showing the two tested phosphorylation sites with the respective 
changed amino acids for phosphomimetic (EE) and non-phosphorylatable (AA). B) Quantification of the contraction strength 
resulting from the overexpression of the different MRLC mutants compared to overexpression of the non-mutant form and 
wildtype. C-G) Stills of oocyte overexpressing the various MRLC mutant forms as well as non-mutant control during the 
contraction wave. The dashed line indicates the flattened cortex H-L) Kymographs of the surface curvature of oocyte 
overexpressing the various MRLC mutant forms as well as non-mutant control during the contraction wave. Scale bar 30 µm, 
all times relative to NEBD. 
4.2.2.2 Myosin II is phosphorylated by Rok  
Given that above I find evidence suggesting that the most common phosphorylation site of MRLC 
TS17.18 is the site through which myosin activity in the contraction wave is controlled, the next 
question was which kinase is responsible for the phosphorylation at this site. The candidates are 
myosin light chain kinase (MLCK), RhoA-dependent kinase (Rok) and citron kinase, of which the first 
two are much better studied and chemical inhibitors are available against these. Therefore, I focussed 
on elucidating whether MLCK or Rok is responsible for phosphorylating myosin in the context of the 
contraction wave. 
Firstly I tested two inhibitors against MLCK, ML-7 and MLCK inhibitory peptide 18 (Lukas et al. 1999). 
The application of both inhibitors on the oocytes did not lead to any reduction in the strength of the 
contraction (Figure 43 A, B and C). While MLCK is present in the sequenced transcriptome of the 
starfish, the mass spectroscopy dataset of both mature and immature oocytes do not show the 
presence of MLCK. This indicates that likely MLCK is not present in the oocyte. Overall, the lack of 
effect of the inhibitors and the absence from the mass-spec data indicate that MLCK does not function 
in the contraction wave process.  
Rok can activate myosin II via two distinct mechanisms - either by directly phosphorylating MRLC or 
by inhibiting the myosin inhibitor myosin phosphatase. There is a specific small molecule inhibitor for 
Rok called Y27632 (Ishizaki et al. 2000). Application of this inhibitor to the oocytes or injection into the 
cytoplasm lead to the abolishment of the contraction (from a variance of curvature in the control of 
292±141 µm2 to 30±30 µm2, p<0.001) (Figure 43 D, E, F). This proves that in the context of the 
contraction wave myosin regulatory light chain is phosphorylated and thereby activated by the RhoA 
kinase (Rok). Whether this activation is achieved directly or through myosin phosphatase cannot be 
judged from this data. 
The involvement of Rok in activating myosin is consisting with previous knowledge, as Rok is also the 
driving factor of the activation of myosin in cytokinesis which is a similarly contractile process that 
happens in very close temporal correlation with the contraction wave (Kosako et al. 2000).  
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Figure 43: Kinases activating myosin II via phosphorylation. 
A) Stills of oocyte treated with MLCK inhibitor ML-7 and B) Inhibitory peptide 18 during the contraction wave, arrows indicate 
progression of the RhoA signal. C) Quantification of the contraction strength in oocytes treated with MLCK inhibitors showing 
no change in the strength compared to control. D) Quantification of the contraction strength in oocyte treated with Rok 
inhibitor Y27632 compared to control, showing abolishment of contraction. E) Stills of oocyte treated with Rok inhibitor 
Y27632 during the contraction wave. F) Kymograph showing the absence of surface curvature change in oocyte treated with 
Y27632. Scale bar 30 µm, all time relative to NEBD. 
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4.2.3 RhoA controls the contraction wave 
From the above-presented data, it is clear that Rok phosphorylates myosin II in the context of the 
contraction wave. This involvement of Rok suggests that RhoA could serve as the upstream regulator 
of the contraction wave, which was investigated next. While in higher vertebrates RhoA is present in 
cells together with the closely related RhoB and RhoC (Wheeler & Ridley 2004), in the starfish RhoA is 
the only homolog of these three isoforms present in the genome.  
RhoA can exist in an active GTP-bound and an inactive GDP-bound form, which makes a mere study 
of the localisation of RhoA as a protein insufficient. To visualise the localisation of the active form of 
RhoA there are a number of probes, most of which are based on the GTPase-binding domain (GBD) of 
downstream effectors which specifically bind to the RhoA-GTP form. I herein used a probe consisting 
of the GBD of rhotekin (rGBD)3 to visualise the active RhoA form (Figure 44A).  
The rGBD-GFP probe shows that active RhoA localises to the contractile cortex and moves as a band 
across the cell along with the contraction wave (Figure 44 B), similar to what is observed for myosin 
II. Active RhoA forms a sharp high-intensity band which goes along with the contraction wave but 
RhoA remains at the cortex at lower levels for some time after the wave has passed. It is then lost 
from the cortex very abruptly, simultaneously all over the cell (Figure 44 C). 
To prove the functional involvement of RhoA in the contraction wave oocytes were injected with C3 
transferase, an enzyme which ADP-ribosylates RhoA and keeps it terminally in its inactive form in the 
cytoplasm (Mohr et al. 1992; Vogelsgesang et al. 2007). Increasing the dose of the injected inhibitor 
progressively decreased the contraction strength (Figure 44D). Injection of high concentrations of this 
inhibitor fully blocks the recruitment of active RhoA to the cortex and blocks all downstream 
contractile activity (Figure 44 E and F, compared to control G and H) (from an average variance of 
curvature in the control of 695 ±150 µm2 to 10±11 µm2, p<0.001).  
Overall this data clearly shows that RhoA is the upstream control factor regulating the recruitment of 
myosin II to the oocyte cortex during the contraction wave.  
 
                                                          
3 This probe was originally developed by the Bement lab (Benink & Bement 2005) and we received the constructs 
as a kind gift from them.   
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Figure 44: RhoA activity during the contraction wave. 
A) Scheme illustrating the function of the rGBD-GFP probe used to detect RhoA activity. B) Stills of an oocyte expressing the 
probe for RhoA activity during the contraction wave showing signal travelling along the cortex with shape change, marked 
with arrow heads. C) Kymographs showing the surface curvature and cortical fluorescence intensity of RhoA during the 
contraction wave. D) Reducing strength of contraction with increasing amounts of injected RhoA inhibitor C3 transferase. E) 
Stills of an oocyte expressing probe for RhoA activity treated with RhoA inhibitor C3 transferase at the time when the control 
oocyte (G) undergoes contraction, showing a lack of shape change and RhoA activity. F) and H) Kymographs showing the 
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surface curvature and cortical fluorescence intensity of cells in E) and F) respectively. Arrows indicate progression of RhoA 
signal. Scale bar 30 µm, all times relative to NEBD, with time for injection estimated at 5 min.  
4.2.4 Activation of RhoA 
4.2.4.1 Contraction wave is independent of microtubules 
To understand what activates RhoA in this context we can look at the regulation of RhoA activity during 
cytokinesis, as this is a process that shares the above illustrated molecular pathway and occurs in close 
temporal correlation to the contraction wave. Cytokinesis can, therefore, serve to provide candidates 
as starting points for the investigation of the upstream control of RhoA activation. In cytokinesis, RhoA 
activity is spatially patterned by microtubules, via the RhoA activating GEF Ect2. 
To explore whether cytokinesis and the surface contraction wave share this activation pathway, I first 
tested the role of microtubules in the contraction wave. Treating the oocytes with Nocodazole very 
quickly and efficiently depolymerised the microtubules of the spindle (Figure 45D). This complete 
removal of microtubules did not affect the contraction wave in any way. It neither changes the 
orientation nor the strength of the contraction wave (Figure 45 A, B and C). The variance of the radius 
of curvature was 445±233 µm2 for the Nocodazole-treated cells compared to 463±206 µm2 for control. 
This indicates that the contraction wave is independent of microtubules. This is a very interesting 
observation which shows that while the downstream RhoA-Rok-Myosin II pathway is the same in the 
contraction wave and in cytokinesis, their upstream regulation shows differences. From this 
observation, we can essentially frame the contraction wave as the cortical response to cytokinetic 
signals in a large cell independent and unconstraint by the microtubules.  
The independence of the contraction wave from microtubules furthermore asks the question of how 
RhoA is then activated in this system.   
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Figure 45: Function of microtubules during the contraction wave.  
A) Stills of oocyte treated with microtubule depolymerising agent Nocodazole during the contraction wave. Time relative to 
NEBD. B) Kymograph of the surface curvature change of the cell in A). C) Quantification of the contraction strength in oocytes 
treated with Nocodazole relative to control treatment. D) Stills of an oocyte expressing microtubule (+)-end label EB3 showing 
the speed of microtubule depolymerisation after Nocodazole treatment at 0 sec. Scale bar 30 µm.  
4.2.4.2 Ect2 as a possible RhoA activator 
To transfer RhoA into its active GTP-bound state there are a number of activator proteins called GEFs, 
the most important and well-studied of which is Ect2. This protein is key in activating RhoA during 
cytokinesis and so was the first candidate for the activation of RhoA in the contraction wave that I 
tested.  
Ect2 shows a strong nuclear localisation in the immature oocyte but there is no visible localisation to 
the contractile cortex (Figure 46 A and E) 4. At the same time, Ect2 shows a clear localisation to the 
base of the polar body, prepatterning the contractile ring (Figure 46A). This localisation is expected 
from its function in cytokinesis and indicates that the construct localised functionally in this system. 
                                                          
4 I received the Patiria miniata Ect2 construct from the Bement lab.  
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This means that the lack of a signal during the contraction wave may be due either to too low signal 
levels or a lack of localisation to the contractile cortex. 
Figure 46: Ect2 in the contraction wave. 
A) Oocyte expressing Ect2 (in green) and the marker for F-actin Utrophin CH-domain (in red) in the immature stage (left 
panel), as well as during polar body formation (middle panel) and zoom on the polar body (right panel), showing Ect2 in the 
contractile ring at the base of the polar body. B) Quantification of the contraction strength in oocytes expressing Ect2 
compared to untreated cells. C) Stills of an oocyte expressing F-actin marker Utrophin as well as D) the probe for RhoA activity 
(rGBD), both on the background of Ect2 (channel not shown) during the contraction wave showing the rippling behaviour. 
The dashed line marks the flattened cortex while the arrows mark the front of the rGBD signal. Asterisks mark the ripples – 
note the even spacing. E-G) Kymographs of surface curvature and cortical fluorescence intensity of Ect2, F-actin marker 
Utrophin and the probe for RhoA activity (rGBD) respectively. Scale bar 30 µm, all times relative the NEBD. 
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The expression of the GFP-Ect2 construct has no significant effect on the strength of the contraction 
(Figure 46 B). In some cases, stronger contraction waves were observed but no significant difference 
was found (661 ± 437 µm2 for Ect2 compared to 417 ± 186 µm2 for control). 
At the same time, Ect2 overexpression has an interesting effect both on the actin cortex and RhoA 
behaviour. With Ect2 overexpression both RhoA and actin exhibit a strong rippling behaviour, starting 
immediately before the contraction and continuing for some time after the contraction wave has 
passed until RhoA activity is switched off (Figure 46 C, D and F, G). These ripples have a near constant 
wavelength and frequency and were recently described in detail (Bement et al. 2015). They are a sign 
that the cortex is in a division-ready, active state. But there seems to be no functional link to the 
contraction wave apart from the fact that they are both cortical phenomenon occurring at the same 
time. This is consistent with the data from (Bement et al. 2015), who showed no connection to the 
contraction waves. 
From the localisation to the contractile ring and the induction of cortical ripples it is clear that the Ect2 
construct I am using is functional and can induce effects on the level of RhoA signalling when 
overexpressed. The fact that I do not observe a localisation or a significant response to Ect2 
overexpression for the contraction wave can be due to the fact that either Ect2 is not involved in the 
process or that the strength of the contraction wave is limited at a point downstream of Ect2 and 
therefore an overactivation will not show a visible effect. The latter explanation is consistent with the 
MRLC overexpression data shown above, which indicate that myosin levels might limit the contraction 
strength. A further investigation of the involvement of Ect2 is limited by the fact that no specific 
chemical inhibitors for Ect2 are available.   
In summary, I can neither exclude the involvement of Ect2 in the contraction wave nor do I find any 
evidence supporting the idea that Ect2 activates RhoA in the context of the contraction wave.  
4.2.4.3 Alternative GEFs 
As the investigation of Ect2 in the contraction wave remained inconclusive, I investigated alternative 
GEFs which might act instead of Ect2 as RhoA activators. The two candidates I choose based on the 
literature were GEF-H1 and MyoGEF. Both of these have been implicated as alternatives to Ect2 in 
activating RhoA during cytokinesis and are present in the starfish transcriptome. GEF-H1 is inactivated 
via Cdk1-cyclin B phosphorylation and is bounds to microtubules in its inactive form, thereby linking 
cell-cycle, microtubules dynamics and RhoA activation, while a knockdown of GEF-H1 leads to 
cytokinesis defects (Birkenfeld et al. 2007; Krendel et al. 2002). MyoGEF, or myosin-interacting GEF, is 
a much less described GEF but is an exciting candidate in the context of the contraction wave as it 
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interacts with cortical myosin II and activates RhoA. The inhibition of MyoGEF in U2OS cells has been 
reported as causing cytokinesis defects (Wu et al. 2006). 
Expressing the GFP-tagged version of either GEF-H1 or MyoGEF showed no localisation to the 
contractile cortex as well as no effect on the strength of the contraction wave (Figure 47 E) (419 ± 233 
µm2 for MyoGEF, and 337 ± 102 µm2 for GEF-H1 compared to 417 ± 186 µm2 for non-treated cells). At 
the same time, expressing GEF-H1 had an interesting effect in the immature oocyte, causing the cells 
to become misshapen and bumpy, but this effect disappears with the cortex softening at NEBD (Figure 
47 A). Also, the GEF-H1 expressing cells show division defects in the embryos (Figure 47 B), indicating 
that GEF-H1 plays a role in maintaining both immature oocyte shape and in mitotic divisions in the 
embryo. Interestingly polar body formation – the cell division in the oocyte – was not affected by the 
expression of GEF-H1. These clear effects of an overexpression of GEF-H1 in other contexts are at least 
indications that even though a specific localisation cannot be observed with the GFP-tagged protein, 
the construct is functional.  
While GEF-H1 shows these interesting phenotypes, expressing MyoGEF in the oocytes had no effect 
on either contraction wave, immature cell shape or embryonic development which the embryos 
reaching the blastula stage without issues (Figure 47 C and D). From this, no conclusions can be drawn 
as to whether the MyoGEF construct is functional.  
From this brief exploration of the alternative GEFs in the activation of RhoA, I find no strong evidence 
implicating either GEF-H1 or MyoGEF in the contraction wave. At the same time as I only 
overexpressed the GFP-tagged construct and there are no chemical inhibitors available, I was not able 
to firmly exclude their function either.  
It is clear that a GEF must be involved in the activation of RhoA during the contraction wave. It is 
possible that a so far unidentified or uncharacterised GEF fulfils this function in the starfish oocyte. 
Perhaps more likely Ect2 as the highly conserved activator of RhoA might still be active in this system 
without me being able to detect its functionality with the current tools. Further investigations using 
mutant or truncated versions of Ect2 are required to settle the question of its involvement.  
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Figure 47: Alternative GEF candidates for RhoA activation. 
A) Two examples of immature oocytes expressing GEF-H1 showing the ‘bumpy’ surface phenotype. B) Early embryo from an 
oocyte expressing GEF-H1 compared to control embryo showing division defects. C) Two examples of immature oocytes 
expressing MyoGEF showing no abnormalities. D) Early blastula stage of the embryo arising from MyoGEF injected oocyte 
and control embryo. E) Quantification of the contraction strength in oocytes expressing either GEF-H1 or MyoGEF compared 
to wildtype.  
4.2.5 The actin cortex serves as a substrate for contraction 
In the contraction wave myosin II generates the force of contractility but so far I have only focussed 
on the pathway leading to the activation of myosin and have disregarded the substrate on which 
myosin contracts. This shall be rectified in the following section which focusses on the role of the actin 
cortex in the contraction wave. 
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The cortex is a fascinating complex system of actin and a number of interacting proteins. To visualise 
the behaviour of the cortex, oocytes expressing a marker for filamentous actin, Utrophin-CH domain, 
were used. This marker strongly labels the cortex (Figure 48A) but during the contraction wave the 
changes in actin levels at the cortex are relatively subtle (Figure 48A). A closer examination using the 
kymograph of cortical fluorescence intensity allows us to see an increase in the actin signal during the 
contraction (Figure 48B). This increase is however relatively small compared to either myosin II or 
RhoA-GTP, as the cortex shows a strong signal all the way through metaphase before the contraction 
wave. Interestingly, the ripples in the actin signal I already observed in the Ect2 overexpression (Figure 
46 D and F), are also visible when actin is observed on its own, although again they are more subtle 
(Figure 48B).  
Figure 48: Actin localization during the contraction wave 
A) Stills of an oocyte expressing F-actin marker Utrophin CH-domain during the contraction wave. The dashed lines indicate 
the flattened cortex. B) Kymograph of the surface curvature and cortical fluorescence intensity of the cell in A). Scale bar 30 
µm, times relative to NEBD. 
To investigate the feedback between the contractile behaviour, the signalling leading to myosin II 
activation and the actin cortex, I have chosen two methods to manipulate the actin cortex. The first is 
to inject the cells with Phalloidin, a fungal toxin which very efficiently stabilises actin filaments and 
thereby drives the equilibrium of actin assembly towards assembling all actin monomers into actin 
filaments (Wulf et al. 1979).  
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The Phalloidin injection has two effects – one is to stabilise and increase the size of the actin cortex 
while also generating a large number of filaments in the cytoplasm leading to a stiffening of the 
cytoplasm. There is no contraction wave taking place in cells injected with large doses of Phalloidin 
(Figure 49 A, B and F). The variance of the radius of surface curvature in Phalloidin injected oocytes 
was 13 ± 40 µm2 compared to 417 ± 186 µm2 in untreated cells (p<0.0005). Whether this is due to 
myosin II not being able to contract the crosslinked and thickened cortex or whether the force is not 
sufficient to contract against the stiffened cytoplasm cannot be determined from these experiments. 
But at the same time, the RhoA signal still travels along the cortex, although the background signal at 
the cortex is higher in these oocytes (compare Figure 48B and Figure 49B). 
The second and opposite manipulation is the depolymerisation of the actin cortex via the treatment 
with Cytochalasin D (Goddette & Frieden 1986). The effect of this drug treatment can be visualised in 
oocytes expressing Utrophin-GFP, which loose the actin signal from the cortex (Figure 49 E), although 
it is possible that small patches of actin remain at the cortex. The contraction wave does not move 
across the cell anymore if the cortex is removed (Figure 49 C) and no shape change takes place (Figure 
49 C, D and F). The variance of the radius of cortex curvature in Cytochalasin D treated oocytes was 
17 ± 20 µm2 compared to 417 ± 186 µm2 in untreated cells (p<0.0005). This is due to the fact that 
myosin II requires actin as a substrate for its activity. On the other hand, the upstream regulatory RhoA 
signal still travels the whole distance from vegetal pole to animal pole (Figure 49 C and D).  
It is clear when looking at the kymographs that RhoA levels at the cortex previous to the contraction 
wave are different in the cells were actin is manipulated either by Phalloidin or by Cytochalasin D 
compared to non-treated cells (Figure 49C and D, compared to Figure 44C). This is consistent with 
reports of a feedback system between RhoA and actin (Bement et al. 2015). At the same time, the 
distinct RhoA signal of the contraction wave is still visible in the kymographs. This suggests that while 
the reported actin-RhoA feedback system may be in effect, an additional regulatory system controls 
RhoA signalling leading to myosin II recruitment in the contraction wave, likely independent of actin.  
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Figure 49: Actin manipulations during the contraction wave. 
A) Stills of an oocyte expressing RhoA activity probe (rGBD) and injected with Phalloidin during the contraction wave. B) 
Kymograph of the surface curvature and cortical fluorescence intensity of the cells in A) treated with Phalloidin. C) Stills of an 
oocyte expressing RhoA activity probe (rGBD) treated with Cytochalasin D during the contraction wave. D) Kymograph of the 
surface curvature and cortical fluorescence intensity of the cells in C) treated with Cytochalasin D. E) Stills of an oocyte 
expressing F-actin marker Utrophin CH-domain after treatment with Cytochalasin D showing actin depolymerisation. F) 
Quantification of the contraction strength in oocyte injected with Phalloidin or treated with Cytochalasin D compared to 
untreated cells. Scale bar 30 µm, all times relative to NEBD. 
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4.2.6 Role of calcium in the contraction wave 
As calcium is a common regulator of myosin contractility I also wanted to explore whether calcium 
plays a role in the contraction wave process. 
To start investigating this, I injected oocytes with the reporter of calcium concentration 
CalciumGreen™, whose fluorescence scales with the amount of calcium in the cell (Rajdev & Reynolds 
1993). When I quantified the levels of CalciumGreen™ fluorescence across the whole cell over the 
course of the cell cycle, I observe a steady rise during metaphase and a small but consistent spike 
during the contraction wave (Figure 50 A and C). There is also a lesser peak in calcium levels at NEBD. 
At the same time, the rise of calcium observed during the contraction wave (and the whole of meiosis) 
is negligible compared to the spike in calcium levels which go along with fertilisation (Figure 50 B and 
C).  
To test whether the observed change in calcium levels during the contraction wave are functionally 
relevant, I observed oocytes undergoing maturation in calcium-free seawater with added EGTA. The 
contraction wave changes by the removal of Calcium from the cell, leading to a reduction in the 
contraction strength (Figure 50 F). Even though the contraction is lost, the upstream signalling of RhoA 
still progresses around the cell in a normal pattern (Figure 50 D and E).  
It is important to note though, that as the starfish oocytes natural environment is very calcium-rich, 
the perturbations of the calcium levels in the oocyte lead to obvious defects in many cells. The 
common defects I observe are a collapse of the animal pole (Figure 50 G) and a “granulation” of the 
cytoplasm (Figure 50 H). This granulation may signify a change in the viscoelastic properties of the 
cytoplasm which could explain the reduced contraction strength if the cytoplasm becomes stiffer. At 
the same time, the actin cortex could be changed by a reduction in calcium through a gelation effect, 
which may affect myosin’s ability to contract the cortex. Apart from a possible side-effect of the 
treatment, it is also possible that myosin is additionally regulated in the context of the contraction 
wave through the calmodulin-dependent light chain kinase or via a modulation of the actin cortex.  
Overall it is clear that calcium is an important component of the oocytes environment and removal 
impacts the contraction wave, although the mechanism by which this happens remains unclear. 
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Figure 50: Role of calcium in the contraction wave. 
A) Calcium levels during the contraction measured via CalciumGreen showing a spike at contraction wave. B) Calcium levels 
in the oocyte in response to fertilisation measured via CalciumGreen. C) Still of oocyte injected with CalciumGreen during 
contraction wave (upper panel) and during fertilisation (lower panel). D) Oocyte expressing RhoA activity probe (rGBD) 
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maintained in Calcium-free SW with 5 mM EGTA during the contraction wave. E) Kymograph of surface curvature and cortical 
fluorescence intensity of cell D) showing reduced contraction strength. F) Contraction strength with varying doses of EGTA 
added to the Calcium-free SW. G) ‘Animal pole collapse’ phenotype. H) ‘Cytoplasmic granulation’ phenotype. Scale bar 30 
µm, times relative to NEBD.  
4.2.7 Summary of the molecular pathway controlling contraction 
So far I have established the direct molecular control pathway of the contraction wave (Figure 51).  
In this pathway, RhoA is the most upstream control factor. It is activated by a GEF factor whose identity 
I have not be able to determine. RhoA activity than activates RhoA kinase, which in turn activates and 
drives myosin II localization to the cortex. The cortex serves as a substrate for myosin contractility and 
the localisation of myosin II leads to cortex flattening. The progression of this flattening across the cell 
gives rise to the contraction wave.  
This pathway is a highly conserved one that is active in many cellular contexts. One of the key 
processes that is also driven by this pathway is the formation of the contractile ring in cytokinesis 
(Miller 2011). In this context the GEF that activates RhoA is Ect2 and this signal is localised by the 
microtubules of the spindle. This is to be seen in contrast to the contraction wave, where microtubules 
are not involved, indicating that Ect2 is either localised by an alternative mechanism or another GEF 
activates RhoA. 
Figure 51: Molecular pathway regulating myosin II activity in the contraction wave. 
But this molecular pathway is intrinsically static and can only explain the recruitment and activation 
of myosin II at each individual cortical position. How the wave behaviour arises and how the signal is 
spread across the cell will be explored in the next section.  
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4.3 HOW TO FORM A WAVE 
4.3.1 Initiation of the contraction wave 
4.3.1.1 The contraction wave starts opposite of the nucleus 
To determine the mechanism by which a wave is formed, the first aspect to be explored is the setting 
of its starting point. There are two plausible hypothesis to explain the observation that the contraction 
wave always starts at the vegetal pole of the oocyte. Firstly, there could be a predetermined factor 
localised at the vegetal pole which in response to a certain signal sets off the contraction wave. On 
the other hand, the oocyte could respond to the specific cell layout, i.e. to have the wave always start 
opposite of the nucleus. In the wildtype these two possibilities are indistinguishable.  
To allow the differentiation between the two hypotheses, the oocytes can be centrifuged. This is a 
well-established technique which has been applied to the starfish oocytes (Miyazaki et al. 2000). 
Centrifugation allows the repositioning of the nucleus relative to the remainder of the cytoplasm and 
thereby the setting of a new animal-vegetal axis that is distinct from the old animal-vegetal axis (Figure 
52 A). When the oocytes are matured after centrifugation, it can be observed which of the two animal-
vegetal axes the wave follows.  
From the observation of a number of cells I can conclude that the contraction wave always follows the 
new animal-vegetal axis, that is, the wave is always oriented towards the nucleus, independent of 
where the nucleus previously was. This becomes obvious upon observation of a sample oocyte (Figure 
52 C), where the centrosomes (in green) mark the position of the nucleus previous to centrifugation 
(Figure 52 C white arrow) while the nucleus is positioned at the top of the oocyte after centrifugation. 
The contraction wave then moves towards the top. This can also be seen in the kymograph, where the 
flattening no longer starts at the old (pre-centrifugation) vegetal pole but rather at the new (post-
centrifugation) vegetal pole (Figure 52 D). 
The effect of the centrifugation can be quantified for a larger number of cells by measuring the angle 
α between the axis of contraction and the old and new animal-vegetal axis respectively (Figure 52 B). 
The angle between the contraction wave and the new animal-vegetal axis is always near 0, i.e. both 
go in parallel, while there is no pattern in the angle between the axis of contraction and the old animal-
vegetal axis (Figure 52 B).  
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Figure 52: Changing AP-VP axis via centrifugation. 
A) Scheme showing the set-up used for centrifugation, adapted from (Borrego Pinto 2015), which a random orientation of 
oocytes before centrifugation and all nuclei facing upwards after centrifugation. B) Quantification of the angle between the 
axis of contraction and the old and new animal-vegetal axis respectively. C) Oocyte expressing F-actin marker Utrophin CH-
domain and injected with fluorescently labelled tubulin and H1B protein. The first image shows immature oocyte after 
centrifugation with the arrow indicating the centrosomes marking the original animal pole (AP) and later images showing 
the contraction wave moving towards the new nuclear position. The dashed line marks the flattened cortex during the 
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contraction wave. D) Kymograph of the surface curvature of the cell in C), with marks indicating both the pre-centrifugation 
(pre-c.) and post-centrifugation (post-c.) poles. Scale bar 30 µm, all time relative to NEBD.   
These results indicate that the axis of the oocyte is not predetermined early in the development of 
the oocyte but is responsive to change. At the same time, the change induced by centrifugation is a 
very drastic perturbation, which will not occur in nature as there the nucleus is held in position by the 
microtubules at the animal pole against gravitational forces (Miyazaki et al. 2000). I can conclude from 
this data that the factor controlling the starting point of the contraction wave is the position of the 
nucleus and is therefore likely by a nuclear factor.    
4.3.1.2 A gradient of cell cycle activity is present in the oocyte 
In the search for a potential nuclear factor which controls the orientation of the contraction wave, a 
good candidate is the central metaphase regulator Cdk1-cyclin B. This is due to the fact that it is 
imported into the nucleus immediately before metaphase entry (Terasaki et al. 2003). Furthermore, 
Cdk1-cyclin B levels change drastically at the exit of metaphase, and given the tight temporal 
correlation between the contraction wave and metaphase exit, this suggests that Cdk1-cyclin B could 
play a role in controlling the contraction wave. 
As a first step to investigate whether Cdk1/Cyclin B plays a role in controlling the contraction wave, I 
generated a GFP-tagged form of the Patiria miniata Cyclin B. Cyclin B shows very interesting and 
temporally varied localisations throughout the cell cycle (Figure 53 A).  
In the immature oocyte cyclin B forms aggregates in the cytoplasm (Figure 53 A arrows), which had 
previously been reported (Terasaki et al. 2003), while the nucleus is devoid of cyclin B. As maturation 
starts, within the first 5 min after hormone addition the aggregates disappear, and 10 min later cyclin 
B begins to be imported into the nucleus. The import leads to a strong concentration of cyclin B in the 
nucleus immediately preceding NEBD, which then leads to a spread of concentrated cyclin B at the 
whole animal pole. Due to the localisation of the nucleus at the cortex, the import establishes a 
gradient of cyclin B across the whole of the oocyte. This means that the highest levels of cyclin B are 
located at the animal pole while the levels at the vegetal pole are lower (Figure 53 B). 
Over the time course of metaphase the levels of cyclin B drop progressively, as cyclin B is degraded by 
targeting of the protein to the proteasome by the APC/C (Oita et al. 2004). The degradation is equal 
all over the cell, meaning that the gradient is maintained throughout metaphase. This becomes clear 
when the cyclin B levels are quantified along the animal-vegetal axis (Figure 53 B). During the 
contraction wave, cyclin B levels are already very low, but higher levels at the animal pole still remain, 
and levels continue to fall as the wave progresses (Figure 53 A). 
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Figure 53: Cyclin B. 
A) Oocyte expressing cyclin B-EGFP at various time points before NEBD (upper panel) and contraction wave (lower panel). 
Arrows mark cytoplasmic cyclin B aggregates. The dashed line indicates the flattened cortexB) Quantification of fluorescence 
intensity of cyclin B normalised to background injected Dextran 10kD along the animal-vegetal axis at various time points. C) 
Virtual time series of cold MeOH-fixed oocytes, stained using cyclin B antibody (red), anti-tubulin (green) and DNA marker 
Draq5 (blue). Scale bar 30 µm, all times relative to NEBD.  
These results indicate that Cdk1-cyclin B could serve as a guide for the contraction wave as it forms a 
gradient based on the nuclear position, giving the cell a molecular marker for its animal-vegetal axis. 
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To observe the gradient via an alternative technique, I tested various antibodies against Cdk1 activity 
and cyclin B localisation. Antibodies against starfish cyclin B were generated by the Kishimoto-
Tachibana and Chiba labs and I received aliquots from both5. Testing multiple fixation and staining 
protocols for both the anti-cyclin B and the anti-Cdk1 Y15 antibodies led to very low and unspecific 
stainings (not shown). For the cyclin B antibody from the Chiba lab, I could observe changes in the 
intensity of staining over the time course, but the signal was too low to allow the visualisation of the 
gradient (Figure 53 C). The time course of the fixed oocytes was generated on the basis of spindle and 
chromosome morphology which were additionally stained.  
There are multiple possible reasons for why the immunostaining of cyclin B did not allow easy 
visualisation of the cyclin B gradient. Firstly the Cdk1 activity antibody is not specific against the 
starfish protein and likely did not recognise it sufficiently. Secondly, while the starfish cyclin B antibody 
clearly recognised the protein, it is difficult to observe a specific staining as cyclin B is spread 
throughout the cytoplasm and not localised to a specific structure. This makes it difficult to normalise 
the signal against the background staining. Furthermore, small cytoplasmic proteins are much easier 
lost during the fixation and permeabilisation step, which can contribute to the low signal. I can also 
not be sure of the quality of the antibody I received, and a preliminary testing of the antibody on 
western blot showed very low signal levels. To solve this problem, either a new antibody against the 
starfish cyclin B protein would have to be produced or a further optimisation of the fixation/staining 
protocols would be necessary. As I have other lines of evidence to prove the idea of a gradient of 
Cdk1-cyclin B activity across the cell, I did not pursue these options.  
4.3.1.3 The Cdk1 gradient controls the direction of the contraction wave  
Based on the observations above indicating a gradient of cyclin B across the cell which would go along 
with a gradient of Cdk1 activity, I hypothesise that this gradient inhibits the activation of myosin II 
downstream of RhoA in metaphase. As the Cdk1-cyclin B activity is progressively reduced over the 
course of metaphase the threshold at which the inhibition is no longer sufficient will be hit first at the 
lowest point of the gradient, i.e. at the vegetal pole.  
To test this hypothesis, I locally treated the oocytes at the animal pole with Cdk1 inhibitors at a time 
before the contraction wave would normally occur. There are a number of these inhibitors 
commercially available with varying inhibition efficiency. I used both the less efficient Roscovitine 
(Meijer et al. 1997), as well as the more efficient Flavopiridol (Kaur et al. 1992) and RO-3306 (Vassilev 
et al. 2006). I hypothesise that the local treatment with the Cdk1 inhibitor at the animal pole results 
                                                          
5 I am very grateful for the generous gifts of these antibodies from Prof. Chiba at Ochanomizu University, Japan 
and Profs. Kishimoto and Tachibana at the Tokyo Institute of Technology.  
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in the flipping of the gradient. This is due to the fact that the lowest point of Cdk1 activity is induced 
at the animal pole due to the treatment while some level of Cdk1 activity remains at the vegetal pole 
as the treatment was performed during metaphase. This flipping of the gradient results in a reversal 
of the direction of the contraction wave (Figure 54). In the treated oocytes I can observe both a 
reversal of the physical shape change as the contraction wave moves in the opposite direction (Figure 
54 B, D and F) as well as in the underlying signal at the level of RhoA (Figure 54 A, C and E).  
The same result can be reached with all three inhibitors (compare Figure 54 A, C and E). After 
treatment, the contraction wave starts at whatever point was treated with the inhibitor and 
progresses to the opposite end of the cell. I also applied the inhibitors in various geometries inducing 
contraction wave starts laterally in the cells as well as a full reversal in which the contraction wave 
runs from the animal pole to the vegetal pole (Figure 54 C compared to A and E).  
The ability to start the wave at the point of local Cdk1 inhibitor treatment supports the idea that the 
lowest point of the Cdk1 gradient normally marks the starting point of the contraction wave. As the 
same result is reached with a number of different inhibitors, it is unlikely that the observed effect is 
due to side-effects of the individual inhibitors. 
The local inhibitor treatment furthermore induces the wave at different times compared to when it 
normally occurs in the maturation process (compare timing in treatment Figure 54 A and control 
Figure 54 G). Treatment of cells with Cdk1 inhibitors is known to force metaphase exit in cells (Vassilev 
et al. 2006), and the fact that the contraction wave can be induced prematurely strongly indicates that 
the contraction wave itself is an effect of metaphase exit, connected to the Cdk1 activity levels. This 
becomes further clear when oocytes expressing cyclin B are treated with the inhibitor. In this case, 
the contraction wave starts while the cyclin B levels are still much higher than they would be in the 
wildtype case where the contraction wave is allowed to start naturally (Figure 54 C). This is due to the 
fact that the mechanism by which Cdk1 inhibitors act is based on blocking the kinase activity of Cdk1 
while cyclin B is in the normal case degraded by targeting to the proteasome. Therefore, Cdk1 
inhibitors can override the normal cell cycle regulation and force the starting of the contraction wave. 
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Figure 54: Local Cdk1 inhibitor treatment. 
A&B) Stills and kymographs of an oocyte expressing the RhoA activity probe (rGBD) treated locally at the animal pole (*) with 
Cdk1 inhibitor Roscovitine, showing the reversal of contraction wave and RhoA signal. C&D) Stills and kymograph of an oocyte 
expressing cyclin B-EGFP treated with Flavopiridol laterally (*) during induced contraction. E&F) Kymographs and stills of an 
oocyte expressing the RhoA activity probe (rGBD) treated locally (*) at the animal pole with Cdk1 inhibitor RO-3306, showing 
the reversal of contraction wave and RhoA signal. G&H) Stills and kymographs of an oocyte expressing the RhoA activity 
probe (rGBD) treated locally (*) with DMSO as control, showing no change in the pattern of contraction. Scale bar 30 µm, all 
times relative to NEBD. 
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From this I can conclude that the contraction wave starts at whatever point in the cell has the lowest 
level of Cdk1 activity, which is normally at the vegetal pole. This indicates that during metaphase Cdk1 
activity suppresses RhoA, while once it drops below a certain threshold during the transition to 
anaphase the contraction wave can start. 
4.3.1.4 The Cdk1 gradient controls the starting point of the contraction wave 
To further test the hypothesis of an inhibitory gradient of Cdk1-cyclin B, I injected active Cdk1-cyclin 
B protein into the oocyte. The active protein complex can be purified from starfish oocytes as 
established by (Okumura 1996)6. As the purified protein is unlabelled, it was co-injected with a 
fluorescently labelled 500 kDa Dextran to mark the site of injection. Oocytes expressing the marker 
for active RhoA were injected as close to the vegetal pole as possible without injuring the cell, to 
visualise the progression of both the contraction wave itself as well as the upstream signalling in 
response to the manipulation of the Cdk1 activity gradient (Figure 55 A).  
Oocyte injected with active Cdk1 protein showed abnormal contraction behaviour, with the 
contraction wave starting laterally in the cell, somewhere between vegetal and animal pole (Figure 55 
B and D). The wave then progresses around the oocyte from the starting point. The behaviour varies 
slightly even with relatively similar injection sites as in the two examples shown here (Figure 55 C and 
E), likely due to slight differences in injection position and volumes.  
At the same time injecting additional Cdk1/Cyclin B slightly delays the start of the contraction wave 
(timing of Figure 55 B and D), which is understandable as the degradation machinery of the APC/C has 
to degrade more substrate to reach the same threshold which increases the duration of metaphase. 
This behaviour of the contraction wave confirms that the low point of the gradient is the starting point 
of the contraction wave.  
 
                                                          
6 I received purified Cdk1/Cyclin B protein as a kind gift from Dr Okumura, Tokyo Institute of Technology. 
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Figure 55: Injection of Cdk1-cyclin B protein complex. 
A) Scheme of the oocyte with the hypothetical Cdk1 gradient (in blue) showing the injection position. B and D) Stills of two 
sample oocytes expressing the RhoA activity marker (rGBD in green), injected with Cdk1 protein and labelled Dextran (in red) 
during the contraction wave. Arrow marks the start site of the contraction wave. C and E) Kymographs of surface curvature 
and cortical fluorescence intensity of the cells in B) and D). Scale bar 30 µm, all times relative to NEBD. 
4.3.2 Propagation of the wave 
4.3.2.1 The Cdk1 gradient controls the progression of the contraction wave  
From the above experiments, it is clear that the point of lowest Cdk1 activity regulates the starting 
point of the contraction wave. There are two potential pathways by which the wave can then spread 
from this starting point. The proposed gradient suggest an intuitive explanation where contractility is 
induced at each site along the cortex in response the Cdk1 activity locally dropping below the 
threshold and inducing the activation of myosin II. Alternatively, it can be imagined that once the 
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contraction wave has started at the point of lowest Cdk1 activity it progresses across the cell via an 
independent contractile module. 
To test how the progression of the contraction wave across the cell is controlled I changed the shape 
of the oocyte by placing them in small microfabricated wells. This allowed me to change the length of 
the animal-vegetal axis and thereby affect the gradient and observe the resulting contraction wave. 
The first variants of the shape change which are interesting in answering this question are the ones in 
which the cells are compressed either along the AP-VP axis or perpendicular to it. In the examples 
shown in Figure 56, the animal pole is marked by the microtubules marker EB3 (in red), showing the 
different aspect ratios achieved by the shape change. In Figure 56A, the AP-VP axis is elongated by a 
factor of 1.4 compared to the control cell in Figure 56B in which the normal round shape is maintained 
while in the cell in Figure 56C the AP-VP distance is compressed to roughly half.  
Firstly from the round cell which is compressed but not changed in its shape, it is clear that the cells 
behave normally in these experimental conditions, with active RhoA being recruited normally to the 
cortex (rGBD in green) and a normal polar body forming. The duration of the contraction wave is also 
normal with 8 min.  
Of course, both other cells have a similar ellipse shape with a roughly comparable half-circumference 
(i.e. distance from AP to VP along the cortex on one side) with 266 µm and 255 µm respectively while 
the distance across the cytoplasm is drastically different with 213 µm versus 84 µm. Crucially the time 
that the contraction takes to cross the cell scales with the distance across the cytoplasm, taking much 
longer in the cell with the elongated AP-VP axis (Figure 56A vs C, Table 6).   
Table 6: Results of the shape change experiments 
 Elongated AP-VP axis 
(A) 
Normal AP-VP axis 
(B) 
Shortened AP-VP axis 
(C) 
Cytoplasmic distance AP-
VP 
216 µm 152 µm 85 µm 
Cortical distance AP-VP 
(half-circumference) 
266 µm 236 µm 255 µm 
Duration of contraction 
wave 
24 min 8 min 6 min 
Speed of wave along the 
cortex 
11 µm/min 29 µm/min 42 µm/min 
 
 
113 
 
Figure 56: Effect of shape change on the contraction wave.  
A) Stills of an oocyte with an elongated AP-VP axis. B) Stills of oocyte whose shape is not changed. C) Stills of an oocyte with 
a shortened AP-VP axis. D) Stills of an oocyte in a triangle shape with the two paths of the contraction wave marked by orange 
and blue arrows and white dashed line marking the AP-VP axis. E) Kymograph of the cortical fluorescence intensity of the cell 
in D), showing the blue and orange half and the varying speeds at which the wave progresses. All cells are expressing 
microtubule marker EB3 (red) and RhoA activity probe (rGBD in green), with the direct AP-VP distance as well as the half-
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circumference marked on the respective first frames and the white dashed line indicating the contracting cortex. Scale bar 30 
µm, time starts at the beginning of contraction wave as NEBD was induced outside of the shapes.  
This indicates that the speed of the contraction wave depends on the cytoplasmic distance, arguing 
that the wave progression is controlled in the cytoplasm, likely by the Cdk1 gradient. 
The gradient hypothesis is further strengthened when we look at different shapes that the cells can 
be turned into, such as the triangle in Figure 56D. In this case, we have two unequal sides of the cell 
in relation to the animal-vegetal axis and we can observe the contraction wave moving across them 
disparately. In the normal oocyte, the wave progresses equally on both halves of the cell and at a 
constant speed. In this case though, the two sides (marked in blue and orange) exhibit very different 
behaviours.  
Of most interest is the half of the cell which contains two sides of the triangle which are positioned at 
very different angles to the AP-VP axis (orange side). If we assume the Cdk1 gradient driving the 
contraction wave goes along the AP-VP axis, the different angles at which the sides of the triangle are 
oriented towards the gradient should result in a different speed at which the wave moves along these 
sides. This is exactly what I observe in the kymograph of RhoA activity moving along the cortex (Figure 
56E) where the orange half of the triangle clearly exhibits three separate phases of wave progression 
along the cortex. In the first phase the cortex is close to perpendicular to the AP-VP axis and the wave 
progresses relatively fast across it as the threshold value will be reached in very similar time frames 
for each position of this cortex. Then in the second phase the wave passes the corner and moves very 
fast, which may be in part due to geometric effects at the high cortex curvature. In the third phase the 
cortex is positioned at a roughly 45° angle to the AP-VP axis and the wave moves slower than in the 
previous phases, indicating that the thresholds are hit at higher time intervals between neighbouring 
points of the cortex as these are exposed to more of the gradient than points on the other side of the 
triangle.  
4.3.2.2 Feedback between contraction strength and wave speed 
While the gradient guides the progression of the contraction wave, it is not the sole controller. I find 
evidence for additional regulation of the wave speed when I manipulated myosin activity, which 
changes not only the contraction strength but also affects the speed of the contraction. When plotting 
the respective strength and speed values for these treatments it becomes apparent that there is an 
exponential correlation between these two variables (Figure 57 A). This correlation is only true for the 
direct manipulations of myosin – that is Blebbistatin treatment and MRLC overexpression. At the same 
time inhibition of the regulatory pathway above myosin, i.e. inhibition of Rok, does not affect the 
speed of the signalling wave while the contraction is inhibited (Figure 58A and B). This means that only 
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when changing myosin II activity itself a stronger wave progresses slower while a weaker wave 
progresses faster. This indicates a feedback from myosin II activity to the upstream control pathway. 
As this is a quite surprising observation I choose to explore this further using oocytes overexpressing 
MRLC with a slower wave. To determine at which point of the regulatory pathway this feedback 
enters, I probed the various steps in the cells overexpressing MRLC.  
It is clear that the curvature change that is the manifestation of the contraction wave is caused by 
myosin II localisations and we can, therefore, assume that the recruitment of myosin itself progresses 
slower around the cell when MRLC is overexpressed.  
When looking at the RhoA signal in the case of MRLC overexpression, it is clear that this signal also 
travels slower and there is no separation between the active RhoA signal and the flattening of the cell 
cortex (Figure 57 C and D). Therefore, the feedback from MRLC overexpression which leads to the 
slowing down affects the speed at which RhoA is recruited along the cortex. When I measured the 
rate at which cyclin B is degraded in the oocytes in which MRLC is overexpressed, I could find no 
difference to the wildtype degradation rates in untreated cells (Figure 57 B). This conforms to 
expectations, as a feedback from myosin II levels to the cell cycle machinery would be very surprising 
and lacking any precedent. 
That the feedback arises from myosin activity in this context is further underscored by the fact that 
the speed change is also observed in oocytes treated with Blebbistatin. Blebbistatin blocks the myosin 
power stroke while it does not affect the binding of myosin II to the cortex. The fact that the speed is 
affected by Blebbistatin, therefore, means that the actual myosin activity is what feeds back to the 
speed of wave progression not merely its localisation. Manipulations of the actin levels in the oocyte 
also change the speed at which the RhoA signal progresses across the cell (Figure 58), especially in 
Phalloidin injected cells which exhibited a slowing down of the wave. Although this slowing is non-
significant compared to wildtype and it is less pronounced than for the slowing down achieved by 
manipulation of myosin II. 
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Figure 57: Correlation of wave speed and contraction strength. 
A) The strength of contraction plotted against the speed of the contraction wave for various manipulations of myosin activity. 
B) Cyclin B degradation in the whole oocyte compared between non-treated cells and cells overexpression MRLC. C) 
Kymograph of the surface curvature and the cortical fluorescence intensity of the cell in D). D) Stills of an oocyte expressing 
RhoA activity probe (rGBD) and overexpressing MRLC (channel not shown) during the contraction wave. E) Scheme showing 
potential regulatory network in metaphase (left side) and in anaphase (right side) compared to that in the case of myosin 
overexpression. Scale bar 30 µm, all times relative to NEBD.  
I, therefore, conclude that the feedback from myosin activity targets the activation of RhoA. This can 
be explained as follows (Figure 57E): 
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RhoA exists in two states – an active and an inactive one – and it is held in the inactive form by Cdk1 
activity while once RhoA is activated there is both a positive autocatalytic feedback to RhoA itself, as 
has been reported in the literature (Bement et al. 2015) as well as a negative feedback from the 
downstream pathway. When I overexpress MRLC the negative feedback to RhoA is strengthened, 
therefore leading to an overall greater inhibition of RhoA. To achieve the same amount of RhoA 
activation under these conditions, Cdk1 inhibition needs to be lifted more compared to the non-
treated case. These different levels of Cdk1 required for the RhoA activation in the case of MRLC 
overexpression compared to untreated cells shifts the threshold at which the Cdk1 gradient starts the 
contraction at each point along the cortex and therefore slows down the progression of the wave. 
Figure 58: Speed of contraction wave with manipulations of RhoA, Rok and actin. 
A) The speed of the contraction wave with increasing doses of injected RhoA inhibitor C3 transferase. B) The speed of 
contraction wave in cells treated with the Rok inhibitor Y27632 compared to control. C) The speed of contraction wave 
compared to control for actin manipulations, i.e. injection with Phalloidin and treatment with Cytochalasin D.  
4.3.2.3 Feedback to regulate band width 
The above serves to explain the starting of the wave as well as the progression of the wave across the 
cell, but it does not touch on the process by which the contraction is limited to a band. This band 
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nature of the contraction wave is seen on all levels, from the flattening to the myosin II and active 
RhoA signals.  
However, when I perturb the RhoA effector Rok, which results in a block of the contraction but does 
not affect the recruitment of RhoA to the cortex (Figure 43E), the band is no longer formed. This means 
that blocking the pathway downstream of RhoA impacts the off-switch behaviour of RhoA after the 
contraction wave has passed. When the Rok inhibitor is applied to the cells active RhoA is no longer 
recruited only in a band but stays at constant high levels at the cortex during the whole time of 
contraction until it is switched off completely (Figure 59 A and B). With increasing concentrations of 
the Rok inhibitor, as can be achieved via injection, the pattern of the off-switching behaviour changes 
even further, with RhoA no longer disappearing from the cortex all over the cell simultaneously but 
rather in a drawn-out process (Figure 59C) until at higher concentrations there is no off-switching to 
be observed (Figure 59D). These observations of an aberrant off-switch behaviour of RhoA following 
Rok manipulation suggest a feedback regulating RhoA activity from further downstream in the 
signalling pathway.  
As what is regulated here is clearly a GAP factor which deactivates RhoA, this feedback is consistent 
with the feedback affecting the wave speed described above. From the Rok inhibition data, it is not 
clear at which step downstream of RhoA the feedback arises, i.e. whether it originates from Rok itself 
or from myosin.  
It is, however, clear that while the progression of the contraction wave is controlled by the Cdk1 
gradient, feedback within the pathway from myosin II activity regulates the progression in concert 
with Cdk1 while feedback from Rok regulates the deactivation of RhoA and thereby controls the width 
of the band of activity (Figure 60).  
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Figure 59: Regulation of RhoA inactivation. 
A) Stills of an oocyte expressing RhoA activity marker (rGBD) treated with Rok inhibitor Y27632 during the contraction wave. 
The arrows show the progression of the RhoA signal front. B) Kymographs of surface curvature and cortical fluorescence 
intensity of the cell in A). C and D) Kymograph of cortical fluorescence intensity of the RhoA activity probe (rGBD) in oocytes 
injected with increasing amounts of Rok inhibitor Y27632. Scale bar 30 µm, all times relative to NEBD.   
Figure 60: Complete molecular pathway regulation the contraction wave. 
In this system the core signalling pathway RhoA-Rok-Myosin II is regulated by Cdk1 and feedback from Myosin II and Rok, 
controlling the progression of the wave and the inactivation of RhoA respectively. 
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4.4 POTENTIAL FUNCTION OF THE CONTRACTION WAVE 
4.4.1 Polar Body Formation as a function of contraction wave 
It was originally proposed by Hamaguchi and Hiramoto in 1978 during the first description of the 
contraction wave in the starfish oocyte that there is a causative relationship between the contraction 
wave and polar body formation (Hamaguchi & Hiramoto 1978). This idea has a large intuitive appeal 
as the two processes are closely correlated and it is easy to imagine that the contraction wave 
generates the forces required to push out the polar body from the oocyte. But the idea of the polar 
body as a global pressure release was historically contradicted by the work of Rappaport who argued 
that the polar body extrusion was a local phenomenon, independent of the contraction wave and 
pressure (Rappaport & Rappaport 1985). The divergence between these two ideas has remained 
unresolved to this day. 
Given the variety of methods I have here established to manipulate the contraction wave, I can test 
these two proposed mechanisms. When I observe the formation of the polar body in oocytes where 
the contraction wave is manipulated, I find that the polar body still protrudes out of the cell normally 
(compare Figure 61 A and C to B). This is true for both the inhibited contraction with Blebbistatin 
(Figure 61A) as well as an increased contraction by the overexpression of MRLC (Figure 61 C). It has to 
be noted though that I can here only look at the protrusion of the polar body and not at the full polar 
body formation as the latter requires cytokinesis, which is inhibited by all inhibitors of the contraction 
wave. Therefore in the case of Blebbistatin (and all other inhibitors of the regulatory pathway), 
cytokinesis cannot be completed and the polar body is reabsorbed into the oocyte a few minutes after 
protrusion.  
However the protrusion process of the polar body is identical in the Blebbistatin treated oocyte 
compared to control when measuring the height of the protrusion (Figure 61 D), while obviously the 
width of the protrusion changes in the control case when the contractile ring starts ingressing, which 
does not happen in the case of the Blebbistatin treated oocyte. This similarity in the protrusion speed 
and height, as well as the identical area, indicates that the contraction wave and any potential 
resultant pressure is not required for the protrusion of the polar body (Figure 61E).  
The pressure hypothesis is further inconsistent with my measurements of the cytoplasmic flow and 
arises in the Hamaguchi and Hiramoto model from a wrong assignment of the specific shape change 
to the resulting flow (see Figure 38). When I observe the cytoplasmic flow at the moment when polar 
body protrusion starts it has peak values pointing away from the animal pole and comes to a still at 
later time points of the protrusion formation. This is inconsistent with the flow pushing out the polar 
body. 
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Furthermore when I reverse the contraction wave via the local application of a Cdk1 inhibitor at a late 
stage close to when the contraction wave would occur normally, the oocyte forms a normal polar body 
even when the direction of the contraction wave is reversed and any potential pressure should be 
directed away from the site of polar body formation (Figure 61F).  
Summarising all this evidence it is clear that polar body formation does not depend on the contraction 
wave but is a local process that is independent of the remainder of the oocyte.  
Figure 61: Polar body formation. 
A) Oocyte treated with Blebbistatin showing protruding polar body (arrow). B) Wildtype oocyte with protruding polar body 
(arrow). C) Oocyte overexpressing MRLC with protruding polar body (arrow). D) Width and height of polar body protrusion 
over time in DMSO treated control cells and Blebbistatin treated oocyte. E) Area of the polar body in optical sections for 
various treatments. F) Oocyte locally treated with a Cdk1 inhibitor (*) and subsequent contraction wave starting at the 
marked position, showing normally protruding polar body (arrow). Scale bar 30 µm.  
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5.1 CONTRACTION WAVES AS A CORTICAL PHENOMENON DURING CYTOKINESIS 
The cellular cortex is key for many cellular functions, including cell division and migration, and 
therefore regulation of cortical contractility is an important aspect controlling cellular behaviour. The 
cortex integrates a wide variety of signals, especially during cell division, as this is a process involving 
a large degree of cortical remodelling and is driven by the cortex.  
One effect of the cortical remodelling during cytokinesis observed in very large dividing cells are 
surface contraction waves (SCWs). These waves of contraction occur immediately prior to cell division, 
indicating a link to cell cycle regulation (Hara 1971). Therefore, surface contraction waves offer an 
exciting system to study the cell cycle regulation of cortical contractility. But while contraction waves 
are a striking phenomenon, they are not very well characterised in the literature. Few papers go above 
a description of the phenomenon (Hamaguchi & Hiramoto 1978), and those that do focus specifically 
on the cell cycle process with little regard to the regulation of the contractile process (Rankin & 
Kirschner 1997; Chang & Ferrell 2013; Hara et al. 1980). No molecular details of the contraction 
process were known, necessitating a lot of groundwork to establish the pathway regulating cortical 
contractility in the contraction waves, before questions of the overarching regulation by the cell cycle 
could be answered.   
Specifically, I studied the contraction wave which occurs in the starfish oocyte during meiosis as the 
cell transitions from metaphase to anaphase. In summary, I find that this contraction wave arises from 
a band of flattening that moves across the oocyte, caused by the accumulation of myosin II in a band 
along the cortex. The accumulation of myosin II is regulated by the RhoA-Rok-Myosin II pathway and 
the movement of the contraction across the cell depends on a gradient of Cdk1 activity. Cdk1-cyclin B 
is the central cell cycle controlling complex and forms a gradient across the oocyte, the lowest point 
of which sets the start point of the contraction wave while the progression of the wavefront is 
regulated by the gradient itself. At the same time, feedback within the RhoA-Rok-Myosin II signalling 
cascade interacts with the gradient in controlling the speed of the wave progression and the width of 
the band of activity.  
In the following I will discuss further implications of these findings in the context of other research 
and illustrate some of the open questions that remain.   
5.2 THE SPATIAL DIMENSION OF THE CELL CYCLE 
The key finding presented herein is that the cell cycle gradient regulates the progression of the 
contraction wave. 
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Classically the cell cycle is seen as a one-dimensional process through which the cell moves. This is a 
reasonable view, as most dividing cells are small enough that mixing of components is near enough 
instantaneous allowing us to disregard the spatial dimension. Furthermore, most divisions are 
symmetric with the division signal originating in the middle of the cell, leading to identical behaviour 
in both sides of the cell. But there are examples of cells that do not fit these stereotypes of dividing 
cells and these specialised systems allow us to study an additional dimension of the cell cycle. 
The starfish oocyte in meiosis is such a system due to two critical attributes. The first is its size. With 
a diameter of 180 µm the oocyte is large enough that diffusion cannot equilibrate things in a 
reasonable time frame compared to the time the cell cycle takes. Secondly, the meiotic division is a 
highly asymmetric division and this asymmetry is prepatterned by the nucleus which is positioned off-
centre. These two characteristics are key adaptations to the oocyte function, with the size being 
required for nutrient storage while the polarisation of the nuclear position is necessary to allow for 
easy asymmetric cell division. 
My work shows that the cell cycle gradient controls the contraction wave and this gradient arises from 
these two adaptations. The surface contraction wave is, therefore, an easily visible physical 
manifestation of the spatial dimension of the cell cycle. Essentially in the starfish oocyte the individual 
phases of the cell cycle do not happen simultaneously across the whole cell but rather start first at 
one end of the cell and move progressively across it (Figure 62). 
Figure 62: Cell cycle in space and time in starfish oocyte compared to a somatic cell in mitosis 
A) In a somatic cell, the cell cycle transitions happen in the whole cell simultaneously. B) The cell cycle gradient in the starfish 
oocyte is spread in space and time. Interphase in blue, metaphase in green, anaphase in red. Size of the cells not to scale. 
5.3 THE CELL CYCLE DEPENDENCE OF THE CONTRACTION WAVES IN STARFISH AND XENOPUS  
The previously best-described example of contraction waves are the ones in the Xenopus embryo. In 
this system, it was recently shown that the spatial dimension of the cell cycle drives the SCWs. Work 
by Chang and Ferrell showed that in the very large Xenopus egg the cell cycle signal is spread by a 
mechanism other than diffusion (Chang & Ferrell 2013). They showed that the signal leading the entry 
of the cell into metaphase - the rise in Cdk1 levels - travels across the cell as a trigger wave and that 
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this underlies the SCWa. It is interesting to speculate what the parallels are between the contraction 
wave in the starfish oocyte and in the Xenopus embryo and if they share the same trigger wave 
mechanism controlling them.  
If we compare the SCWs in these two systems, two key differences emerge (Figure 63). The first is that 
while both systems exhibit two contraction waves, one at metaphase entry and one at metaphase 
exit, the temporal spacing between the two waves is very different. In the Xenopus, the contraction 
waves occur within around 10 minutes from each other, while in the starfish oocyte around 40 minutes 
pass between them. Secondly, the directionality between the two waves is reversed. In the Xenopus 
system, both waves move in the same direction while in the starfish they travel in opposite directions. 
These difference indicate a likely functional difference and make the transfer of knowledge from one 
system to the other difficult, especially as in Xenopus mainly the wave at metaphase entry has been 
studied while I focussed on the wave at metaphase exit.   
My data show that in addition to forming a gradient, the degradation of cyclin B happens equally all 
across the cell maintaining the gradient with dropping levels. This suggests that it is likely not a trigger 
wave which controls the progression of the contraction wave but rather the gradient in the starfish 
system. Furthermore, it is likely that the regulatory network at metaphase exit is not able to give rise 
to the bistability needed to achieve a trigger wave. This is due to the fact that the metaphase exit 
network contains only a single feedback loop, while the metaphase entry network contains both a 
positive and a negative feedback loop (Figure 15). Whether the wave of relaxation at metaphase entry 
in this system is controlled by a trigger wave, or whether a gradient also acts there, remains to be 
explored in the future.  
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Figure 63: Comparison of contraction waves in Xenopus and starfish. 
SCWs in Xenopus artificially activated egg as seen by the change in surface pigmentation. There are three pairs of SCWs in 
this kymograph, each going along with one cell cycle. In comparison in the starfish oocyte, the SCWs in meiosis are visualised 
by the surface curvature measurements. This comparison shows the difference in timing and direction between the two SCWs 
in Xenopus and starfish. Xenopus data reprinted by permission from Macmillan Publishers Ltd: Nature (Chang & Ferrell 2013), 
copyright 2013. 
In summary, my data suggest the mechanism by which the cell cycle induces the contraction wave in 
the starfish is different from the one in Xenopus. But while the specific mechanism may differ, viewing 
the commonalities from both the starfish and the Xenopus system opens up a new view of the cell 
cycle, where its spatial dimension is a factor controlling cortical behaviour. This spatial dimension can 
only be studied in large cells or semi-in vitro systems like the Xenopus egg extract, making a case for 
the use of these models in addition to classical cell culture systems. This is especially important as the 
spatial dimension of the cell cycle opens up the view for new interactions between the cell cycle and 
its downstream targets, which can be investigated in the contraction waves, but may also occur 
elsewhere.  
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5.4 LINKING CDK1 ACTIVITY TO CONTRACTILITY 
5.4.1 The contraction wave is independent of microtubules 
The contraction wave offers an exciting system in which to study pure cortical responses to cell cycle 
signalling. In regular cell divisions, the cortical response is largely regulated by the microtubule spindle, 
which takes up a large part of the cellular volume. In a meiotic oocyte, however, the spindle is very 
small in comparison to the cell itself. This means that the vast majority of the cortex is exposed to the 
changing cell cycle signals directly without the intermediate regulation by the microtubules and the 
contraction wave can be interpreted as a direct consequence of this. 
Consistent with this framing, complete removal of the microtubules did not change the contraction 
wave in any way. This finding of microtubule independence of the contraction wave is very interesting 
in terms of the parallels to cytokinesis. The two processes share the same downstream regulatory 
pathway of RhoA-Rok-Myosin II, which induces the contraction wave and cytokinetic ring formation 
respectively. But while this pathway is identical in the two processes, in cytokinesis it is regulated 
spatially by the microtubules and temporally in response to the cell cycle. But my data clearly shows 
that in the contraction wave the RhoA-Rok-Myosin II pathway is regulated in both time and space by 
the cell cycle alone. This makes the contraction wave a response of the cortex to the metaphase to 
anaphase transition without constraint by the microtubules, as is the case in somatic cells.  
This is an interesting observation in light of evidence that is emerging for a general role of microtubules 
in regulating cortical contractility. In different cellular contexts, it appears that microtubules may 
consistently act to suppress local cortical contractility. The examples come mainly from cells during 
the adhesion process which have their microtubules removed (Pletjushkina et al. 2001; Paluch et al. 
2005), leading to cortical oscillations while contractility is suppressed by the stabilisation of 
microtubules (Danowski 1989). There is furthermore clinical data in cardiomyocytes supporting this 
idea (Ishibashi & Tsutsui 1996).  
This little-studied aspect of the regulation of cortical contractility certainly deserves further 
investigation as the molecular details by which microtubules could suppress cortical contractility are 
unknown. It is fascinating to speculate about the importance of this regulation in maintaining stable 
cellular shape and cortical cohesion by preventing hypercontractility and bleb formation. The 
contraction wave, as a contractile process unrestrained by microtubules, may serve as a system to 
understand what happens in the cortex in the absence of microtubule regulation.  
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5.4.2 GEFs regulating the contraction wave 
While I was able to directly show both the role of the cell cycle regulation as well as the downstream 
pathway regulating contractility, the molecular connection between these two aspects proved hard 
to find. It is clear that the downregulation of Cdk1 activity at the end of metaphase leads to the 
activation of RhoA, which subsequently activates myosin II, and that these two factors must be linked 
via a GEF.  
The GEFs in action in cytokinesis – Ect2 and GEF-H1 – are very well characterised in both their 
molecular function as well as in their response to the cell cycle, but both rely critically in their 
regulation on microtubules. As my data indicates a lack of microtubule-based regulation, it is perhaps 
not surprising that I cannot find evidence for the involvement of either Ect2 or GEF-H1 in the 
contraction wave. It has to be noted thought that the tools I have for exploring the involvement of 
various GEFs are much more limited than the tools used in other aspects of this research. This is to a 
large degree due to the fact that there are no commercially available small molecule inhibitors of Ect2 
as well as no efficient dominant negative mutants described in the literature. As the starfish oocyte is 
not amenable to genetic manipulation, this commonly used method for the study of various GEFs was 
not open to me. Due to these limitations, I cannot completely rule out the involvement of the classical 
cytokinetic GEFs in linking the cell cycle to the contraction wave. But given that I find effects based on 
the overexpression of either of these GEFs on other cellular contexts, it is quite possible that simply 
neither of them are involved in regulating the contraction wave.  
In this case, there must be a different GEF at work in the context of the contraction wave linking cell 
cycle progression to RhoA activation. There is certainly no paucity of candidates, as the Dbl family of 
GEFs, the largest of the GEF families, to which both Ect2 and GEF-H1 belong, alone as 69 members in 
humans, active in many different cellular contexts (Rossman et al. 2005). Many of these proteins have 
not been characterised in any detail, illustrating how little we know about GTPases above the core 
few proteins and making it likely that the GEF controlling the contraction wave may be found in future. 
It is possible that the thus identified GEF will also play a role in the regulation of cortical contractility 
during the cell cycle outside of the specific case of the contraction wave.  
5.5 MOLECULAR PATHWAY CONTROLLING THE CONTRACTION WAVE 
5.5.1 The highly conserved RhoA-Rok-Myosin II signalling axis 
While the GEF linking the cell cycle to cortical contractility remains a question for the future, I was 
able to identify the molecular pathway directly controlling the contraction wave. This is the first time 
the molecular basis of the contraction wave has been identified in any species.  
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The pathway itself is a highly conserved one, where RhoA activates its effector Rok, which in turns 
activates myosin II. This pathway is not only the one that drives cytokinesis (Miller 2011), but it also 
important in cell migration and adhesion (Vicente-Manzanares et al. 2009), maintaining the cellular 
contacts of stem cells (Harb et al. 2008) and formation of the immune synapse (Rougerie & Delon 
2012), to name just a few examples. It is therefore very well characterised, both in terms of the 
individual proteins as well as their interaction (Amano et al. 1996; Jordan & Canman 2012).  
The novelty my data adds is to consistently prove the activity of the whole RhoA-Rok-Myosin II 
pathway in the contraction wave, for which the molecular players had previously been unknown. With 
this, I add another example of a contractile process regulated by the RhoA-Rok-Myosin II signalling 
axis, which shares interesting parallels to cytokinesis in terms of its cell cycle dependence but with a 
divergent upstream spatial regulation as discussed above.  
5.5.2 Feedback in the RhoA-Rok-Myosin II pathway 
Due to its dynamic nature, the contraction wave offers a system where I could uncover additional 
characteristics of the RhoA-Rok-Myosin II pathway. Specifically, as the contraction wave always forms 
a sharp band where the signal pathway is active which moves across the cell and I have a number of 
specific inhibitors of the individual components, I can study regulatory feedback in this system. The 
feedback within the RhoA-Rok-Myosin II pathway is not well studied, particularly in cytokinesis. Some 
data on mechanical feedback exists in cell migration and polarisation (Bhadriraju et al. 2007; Petrie & 
Yamada 2012), but how general these feedback mechanisms are, remains an open question. My 
evidence supports the idea of extensive feedback within the pathway. 
The evidence I have for feedback within the pathway comes from two datasets. Firstly, I observe 
changes in the speed with which the wave progresses across the cell when I manipulate myosin II itself 
but not when the upstream pathway components are inhibited (Figure 57). Secondly, when Rok is 
inhibited, I observe abnormal off-switching behaviour for RhoA, which then no longer forms a band 
but rather remains active at the whole cortex after the wave has passed (Figure 59). These two 
feedbacks are independent, with the RhoA off-switching being normal in the case of the changed wave 
speed while the speed is normal when the abnormal off-switching behaviour is induced by Rok 
inhibition. But both feedbacks clearly impact the activity state of RhoA, although most likely via 
different pathways (Figure 64). The data suggests that myosin II negatively regulates the activation of 
RhoA in concert with Cdk1, likely targeting the GEF.  
The feedback regulating the off-switching behaviour of RhoA clearly targets a GAP which is responsible 
for the transition from active RhoA-GTP to inactive RhoA-GDP. I have not identified the specific GAP 
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in question as there are a large number of GAPs, most of which are poorly characterised (Bernards 
2003).  
Figure 64: Complete molecular pathway regulating the contraction wave.  
Overall it is clear that in the contraction wave the RhoA-Rok-Myosin II pathway exhibits two feedback 
loops (Figure 64). The first one controlling the speed of the wave progression originates from myosin 
II activity and therein interacts with the Cdk1 regulation in some manner, potentially by feeding back 
into the same GEF which is regulated by Cdk1 inhibition. The second feedback loop arises from Rok 
and activates a GAP, which is responsible for defining the width of the band of RhoA activity. There 
may very well be additional feedback systems at least partially in this pathway, such as the feedback 
between actin polymerisation and RhoA activation (Bement et al. 2015).     
5.6 THE OOCYTE CORTEX AND ITS DYNAMICS 
While I focussed my investigation of the contraction wave on understanding the regulation of 
myosin II activity, the cortex, which serves as the substrate for the contraction, is worth some 
considerations. 
Cortex dynamics are a very important aspect of the regulation of cortical behaviour. It is assumed that 
the actin cortex, in general, has a turn-over time of around 1 min, although there are distinct 
subpopulations of actin with faster turnover (Salbreux et al. 2012). Other proteins in the cortex, such 
as myosin II and the actin crosslinker actinin have been shown to turn over significantly quicker 
(Fritzsche et al. 2013). All these measurements come from somatic cells in cell culture, and although 
133 
 
these values are widely used and generally accepted, if we can apply them to the starfish oocyte cortex 
remains an open question. 
In general, we know very little about the organisation of the cortex in these cells and rely on 
assumptions from other systems. One fact which has been described in old papers, and which I re-
established for the specific oocytes I was working with, is that their surface tension is very high. For 
HeLa cells in interphase the tension is measured at around 0.2 mN/m, rising to 1.6 mN/m in metaphase 
(Fischer-Friedrich et al. 2014). The starfish oocyte, on the other hand, has in its immature state, which 
is prophase arrest, a surface tension of 10 mN/m, dropping to around 1 mN/m at metaphase entry. 
These values for the resting/non-division phase cortexes are surprisingly different and the mechanism 
by which the oocyte generate such higher pressure has so far not been investigated.  
It is clear that the oocytes have very large amounts of myosin II, most of which is located in the cortex 
of the immature oocyte. This very likely strongly contributes to this high tension. How this higher 
tension affects cortex turnover rates and if the myosin is perhaps more stably bound in the cortex of 
the immature starfish oocyte remains an open question. A convenient method to explore these 
questions would be FRAP to measure the lifetime of different proteins in the cortex or laser ablations 
as recently proposed by (Saha et al. 2016).  
It is also interesting to speculate why the starfish oocytes go to the effort of generating such very stiff 
cortexes. One would instinctively assume that this is due to the external fertilisation and ex utero 
development that the oocytes of the starfish undergo in the open sea and the resulting requirement 
for physical toughness. But normally the oocytes are only released into the water in the middle of 
metaphase when they have softened considerably. The resulting tension of around 1 mN/m seems 
sufficient to allow survival even in the harsh conditions of the open ocean. So why do the oocytes have 
such a high tension in the prophase-arrested state when they are in the ovary and reasonably 
protected? It is possible that the high tension allows for the tight packing of the oocytes observed in 
the ovaries without damaging cellular integrity. Ultimately this remains an open question that will be 
interesting to explore in the future, especially if comparative measurements can be made on other 
marine and non-marine animals undergoing external fertilisation, to determine if the tension is an 
adaptation specific to starfish, the marine environment, external fertilisation, or oocyte generally.  
5.7 SIMILARITY TO OTHER CONTRACTION WAVES 
5.7.1 Other contraction waves in the starfish oocyte 
While all experiments herein were performed with a focus on the main contraction wave associated 
with meiosis I, there are two other waves happening during the course of oocyte maturation. The first 
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wave is the one that occurs at NEBD and moves from the animal pole to the vegetal pole. And although 
this wave looks very similar to the contraction wave, it is in fact not a contractile wave at all. It is rather 
a wave of relaxation when the surface tension drops at the entry into metaphase, which is marked by 
NEBD. Along with this wave, I observe the loss of myosin from the cortex, causally explaining the 
underlying softening (Figure 65). This relaxation wave at NEBD is therefore very likely identical to the 
SCWa in the Xenopus eggs , which is also a wave of relaxation at metaphase entry and precedes the 
actually contractile SCWb (Sawai 1982; Rankin & Kirschner 1997).  
 
Figure 65: SCW at NEBD in the starfish oocyte.  
Kymograph of curvature (upper panel) and cortical myosin II intensity (lower) for complete meiosis I. This shows the relaxation 
wave at NEBD which goes along with the loss of myosin II from the cortex and later the contraction wave going along with 
myosin II recruitment to the cortex.   
How similar the mechanisms between the relaxation wave at NEBD and the contraction wave at 
anaphase are, remains to be answered in the future. The basic involvement of myosin II is clearly a 
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common factor and both waves are responses to changes in the activity levels of Cdk1, with relaxation 
occurring in response to a rise in Cdk1 activity while contraction occurs in response to a drop. These 
similarities suggest quite a high level of mechanistic conservation but to really compare the two wave 
consistently a detailed analysis of the relaxation wave is required.  
The second contraction wave that occurs during maturation in the starfish oocyte is associated with 
meiosis II. It occurs at exactly the same cell cycle stage as the first and main contraction wave, namely 
at the metaphase to anaphase transition alongside polar body formation. It is to be expected that 
these two processes are in every way molecularly equivalent. The only difference between them is 
the difference of their magnitude, with the second contraction wave being much more subtle than 
the first, inducing much less curvature change (Figure 36). 
This difference in the magnitude of the second contraction wave can be explained by the cell cycle 
gradient controlling the contraction wave. In the run-up to meiosis II, cyclin B is re-synthesised to 
lower levels than during meiosis I and the whole cell cycle is much quicker (Okano-Uchida et al. 1998). 
It takes only around 30 min, compared to the 60 min of meiosis I. Therefore we can speculate that the 
resulting gradient will have lower peak levels and be potentially shallower, leading to a less 
pronounced contraction wave. But a detailed quantification of the gradient during meiosis II would be 
necessary to definitely answer this question, which is not possible using the fluorescently tagged 
constructs used herein as they are not resynthesized fast and specifically enough. 
5.7.2 SCWs in other systems 
With the work presented herein, the starfish oocyte becomes the systems with the best understood 
SCW, as we now have a more detailed molecular understanding than even the classical Xenopus model 
system. On the other hand, this means that apart from these two systems we have preciously little 
data on SCWs, which makes a cross-species comparison very difficult. Although some level of evidence 
for surface contraction waves is present in a wide variety of species, most of the descriptions are very 
old and lack details and especially molecular data.  
It appears quite clear that a good case can be made for the comparable nature of the SCWs in starfish 
and in the Xenopus egg, especially with regards to the dependence of the contraction wave on cell 
cycle regulation and the progression of the cell cycle across a large cell as discussed above. It 
furthermore seems likely that the molecular details of the contractile pathway are comparable, as the 
RhoA-Rok-Myosin II pathway is so conserved across species and can be hypothesised to drive SCWs in 
many systems. Whether the upstream regulation is quite the same remains an open question until 
more molecular details are available in the other system. 
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In addition to the lack of available data on SCWs in other species, an evolutionary comparison is made 
difficult by the diversity of oocyte behaviour. These behaviours including arrests and fertilisation at 
different cell cycle stages, in response to which the contraction waves in many of these systems occur 
(Prodon et al. 2008; Shimizu 1984). But it is perhaps possible that for all cases, where the SCWs are 
true contractions, the basic molecular pathway will be similar and therefore this study can serve as a 
starting point for the exploration of upstream regulatory elements in the contraction waves in other 
systems. 
5.8 THE CONTRACTION WAVE AS A FUNCTION VS THE FUNCTION OF THE CONTRACTION WAVE 
5.8.1 The contraction wave is a result of oocyte adaptation 
As the contraction wave is such a striking phenomenon the early papers describing SCWs are full of 
speculations regarding their function. These functions have not been explored experimentally in any 
of the common systems.  
The findings I present herein indicate that the search for a function of the contraction wave might, in 
fact, be a wild goose chase. The contraction wave is driven by a cell cycle gradient established due to 
the off-centre position of the nucleus. Following this logic, the contraction wave is merely a result or 
side-effect of the adaptations of the oocyte to its function. And while this may seem counterintuitive 
due to the striking nature of the process, it is important to consider that as long as there are no 
negative side effects or the evolutionary cost is not too high, there might be no reason for the cells to 
develop a mechanism to suppress this side-effect. This presupposes that it would even be possible to 
suppress the contractile phenomenon during the contraction wave without negatively impacting the 
contraction of the cytokinetic ring which occurs using the same molecular pathway at the same time. 
The contraction wave can be fully explained as a result of oocyte adaptation, but of course, this does 
not rule out the possibility that the contraction wave has additional, potentially later acquired, 
functions.  
5.8.2 Polar body protrusion is independent of the contraction wave 
In the starfish system, the main proposed function is the generation of pressure to drive the protrusion 
of the polar body. This was originally proposed by Hamaguchi and Hiramoto when they first described 
the contraction wave in this system (Hamaguchi & Hiramoto 1978). This idea has been opposed by 
data from Rappaport who argued that polar body formation is independent of any global pressure 
built-up and is a locally induced phenomenon (Rappaport & Rappaport 1985). 
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The link to polar body formation is intuitively appealing due to its close temporal and spatial 
correlation. But the data I have gathered while investigating the contraction wave convincingly argues 
that polar body formation is independent of the contraction wave. Neither inhibiting nor 
strengthening the contraction wave made a difference to the size of the polar body protrusion. At the 
same time, it has to be noted that the full polar body formation cannot be observed when the 
contraction wave is inhibited as the molecules of the contraction wave and the contractile ring are 
identical, so the inhibitors block both. I, therefore, focussed on the formation of the protrusion of the 
polar body.   
To underscore the independence of the polar body formation and contraction wave we also have to 
take a closer look at the pattern of cytoplasmic flow immediately prior to polar body formation. At the 
time point of polar body formation, the contraction wave is in the upper half close to the animal pole 
and the cytoplasmic flow is pointing away from the animal pole. This strongly argues against the idea 
that there even is pressure pointing in the right direction to drive polar body protrusion. It is also in 
opposition to the flow pattern assigned in the original study, explaining their opposing conclusion 
(Figure 66).  
 
Figure 66: Curvature change and cytoplasmic flow in the oocyte. 
Upper panel shows the shapes and flow as originally proposed by Hamaguchi and Hiramoto, compared to my findings (lower 
panel). The early description showed some of the key shape changes, but the early ones were missed and the assignment of 
flow pattern to shape change has been updated by my detailed analysis.  Upper panel reprinted  from (Hamaguchi & Hiramoto 
1978) with permission from Elsevier. 
Due to the fact that inhibitor treatments that block the contraction wave also block the cytokinetic 
ring, with this data, I cannot rule out that the contraction wave plays a role in bringing the contractile 
machinery to the site of cytokinesis. This would be similar to the cortical flow which brings myosin II 
to the contractile furrow in dividing cells (Wang et al. 1994; Mandato et al. 2000). But we can rule out 
this potential function of the contraction wave in the experiments where I change the direction of the 
contraction wave. In this case, a full polar body forms even if the wave runs at an angle to it or against 
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it. Additionally in the cases of the reversed contraction wave I can detect strong recruitment of the 
upstream signalling factor RhoA at the animal pole even when the wave has passed across it. This 
signifies that the spindle is able to recruit the signals required for polar body formation independently 
of the contraction wave. 
In conclusion, I can rule out the involvement of the contraction wave in the formation of the polar 
body. But polar body formation remains none the less an interesting question and the mechanism that 
regulates polar body formation are open for investigation. On the molecular side, there is good data 
from Xenopus oocytes indicating that polar body formation is driven by the small GTPase Cdc42 
inducing Arp2/3 driven actin polymerisation (Zhang et al. 2008). In the starfish oocyte I also observe a 
strong accumulation of actin in the polar body, supporting this model on the base level (Figure 67). It 
could easily be further explored using Arp2/3 and Cdc42 inhibitors and reporters.  
Figure 67: First polar body.  
Oocyte expressing the actin marker Utrophin CH-domain EGFP with the newly formed polar body, showing the accumulation 
of actin at the polar body cortex. Time relative to NEBD.  
On the more upstream level, it is fascinating to speculate which factors drive the formation of the 
polar body. It is clear that the spindle alone is sufficient to cause polar body formation, as a 
translocation of the spindle along the cortex causes the polar body to form at the new site (Rappaport 
& Rappaport 1985). It would be interesting to know if the individual components of the spindle alone 
are sufficient to drive polar body formation, especially in light of data from mouse oocyte where DNA-
coated beads along can induce the cortical differentiations that predetermine the polar body cortex 
(Figure 68) (Deng et al. 2007). It would be interesting to see if the same is true in starfish and if the 
pathway that links chromatin signals to Cdc42 activation can be illuminated.     
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Figure 68: Cortical differentiation in response to chromatin signal. 
Both DNA beads (arrow) and MII spindle (arrowhead) cause cortical differentiation by accumulating actin (M) and myosin II 
(N) at the cortex in mouse oocytes in meiosis II. Reprinted from (Deng et al. 2007) with permission from Elsevier. 
5.8.3 Potential function of the contraction wave in development 
As the development of the oocyte sets the stage for embryonic development, many have suggested 
that the contraction waves may be required for localising some developmental determinants. The 
suggestions range from the localisation of broad cER-mRNA domains in ascidians (Figure 69) (Prodon 
et al. 2005) to the localisation of specific mRNAs in jellyfish (Houliston et al. 1993; Amiel & Houliston 
2009). In general, these factors are thought to be involved with setting the embryonic animal-vegetal 
axis and determining micromere and resulting germ cell formation. 
It is, however, unclear if there is a direct link between these localisations and the contraction wave or 
whether processes controlled by the same molecules are behind the localisation of these factors. 
Given that it is difficult to infer whether the contraction waves are evolutionarily similar between 
distally related species a speculation regarding a conserved function is even more difficult, especially 
in light of the paucity of evidence.  
 
Figure 69: Polarisation of developmental determinants. 
Localisation of Mitochondria in an embryo of the ascidian Halocynthia roretzi after treatment with various cytoskeletal 
inhibitors. C and D) Removal of both actin and myosin II shows a lack of normal AP-VP polarisation of mitochondria 
distribution, compared to control and microtubule removal (A and B). Reprinted from (Prodon et al. 2008) with permission 
from Elsevier. 
Sadly, none of the methods I have developed here to inhibit the contraction wave allow the formation 
of a fully mature oocyte. This is either due to polar body cytokinesis being inhibited (by the inhibitors 
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of the RhoA-Rok-Myosin II pathway) or the cell cycle being blocked (by Cdk1 inhibitors) for subsequent 
divisions. Therefore, I cannot generate fully mature and fertilisable oocyte which have never 
experienced a contraction wave, with which I could test the hypothesis of a developmental role of the 
contraction wave.  
This will be an important challenge for the future, as a developmental role of the contraction wave is 
an exciting possibility with potentially wide-reaching developmental consequences.  
It is well imaginable that the surface contraction waves developed originally only in response to the 
oocyte adaptations, but that they were later co-opted for the localisation of developmental 
determinants. The contraction waves are ideal candidates for this as they run along the animal-vegetal 
axis and thereby may help to communicate the cellular layout in these large cells. The cytoplasmic 
streaming taking place during the contraction wave would certainly give a plausible mechanism for 
how specific localisation could be achieved, especially in combination with specific binding sites, for 
example at the vegetal pole.  
The identification of polarity markers, whose positioning happens during oocyte maturation and 
which can be visualised during maturation, will be an important first step in testing this intriguing 
hypothesis. 
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Surface contraction waves are a prominent example of spatially and temporally tightly regulated 
cortical contractility. They are commonly observed in large dividing cells, such as oocytes and early 
embryos, in a wide variety of species (Hara 1971; Hamaguchi & Hiramoto 1978). Previous studies have 
indicated that the contraction waves are linked to cell cycle transitions (Rankin & Kirschner 1997; 
Chang & Ferrell 2013), but the molecular basis of the contraction, its regulation by the cell cycle and 
the mechanisms that pattern this process in space and time had not previously been explored. 
I studied surface contraction waves using starfish oocytes. They are a well-suited model system, 
exhibiting prominent contraction waves during meiosis, which can be imaged at high spatial and 
temporal resolution and are accessible to a variety of chemical and physical manipulations. 
I first carefully and quantitatively characterised the cell shape changes associated with the contraction 
wave. This revealed that they arise from a band of flattening of the cortex which forms first at the 
vegetal pole and then moves across the cell towards the animal pole. Co-localized with the flattened 
cortex, I observed an accumulation of non-muscle myosin II molecules, and consistently, inhibition of 
myosin II weakens the contraction wave, while upregulation of myosin II strengthens it. As revealed 
by specific small molecule inhibitors, recruitment of myosin II to the cortex during the contraction 
wave is controlled by the RhoA kinase (Rok) which in turn is controlled by the localisation of active 
RhoA to the cortex. I further showed that RhoA activation was independent of microtubules, but 
depended on cdk1-cyclinB activity.  Taken together, these data allow me to conclude that the pathway 
of RhoA-Rok-Myosin II drives the contraction wave. This offers the first molecular mechanism of 
surface contraction waves in any species. Indeed, the core signalling module composed of RhoA-Rok-
Myosin II is a highly conserved pathway that controls cortical contractility in diverse physiological 
contexts including cytokinesis (Miller & Bement 2009) and embryo morphogenesis (Vasquez et al. 
2014). The question that follows from this observation is how this pathway gives rise to the spatially 
and temporally complex pattern of contraction waves. 
Indeed, a striking feature of the contraction wave is that it moves across the cell from one pole to the 
other. By investigating this dynamic behaviour in correlation with cell cycle regulators, I could show 
that the key cell cycle kinase, cdk1-cyclin B forms a gradient across the animal-vegetal axis of the 
oocyte and that this gradient defines the orientation of the contraction wave. The gradient is 
established early in meiosis due to the accumulation of cdk1-cyclinB in the nucleus, which is located 
at the animal pole. As the cell cycle proceeds, the cyclin B subunit of cdk1-cyclinB is progressively 
degraded, inactivating the kinase subunit, cdk1. Importantly, I could show that degradation of cyclin 
B is spatially homogenous and therefore the animal-vegetal gradient of cdk1-cyclinB is maintained 
throughout meiosis. As a consequence, the bottom threshold of cdk1 activity will be reached first 
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opposite of the nucleus that is at the vegetal pole. In a series of experiments using local application of 
inhibitors of cdk1 as well as locally introducing additional cdk1-cyclinB protein, I could demonstrate 
that the contraction wave initiates at the location where cdk1 activity first hits the bottom threshold. 
Furthermore, by changing the shape of the oocytes using mirofabricated chambers, I could show that 
the gradient of cdk1-cyclin B across the oocyte regulates the progression of the wave.  
From these data, I conclude that the activity gradient of cdk1-cyclin B provides the initial spatial cue 
setting the starting point and direction of the contraction wave. Additionally, I could show that 
feedbacks internal to the downstream signalling network further shape the contraction wave 
determining its speed and the width of the band of activity. In particular, I could show that myosin II 
activity feeds back to control the speed of the wave, and that a negative feedback from Rok controls 
RhoA deactivation and thereby defines the width of the wave. 
In summary, based on the above experiments, I can propose the first comprehensive model for the 
molecular mechanism controlling surface contraction waves in space and time. My work reveals that 
while in small somatic cells the cell cycle machinery merely functions in temporal control and the 
microtubule spindle provides the spatial cues, in the large oocytes the cell cycle kinases form a spatial 
gradient that patterns contractile processes during cytokinesis. The spatial gradient arises from two 
specific features of the oocyte: the large size of the cell and the asymmetric nuclear position. In this 
sense, the contraction wave can be seen as a result of a cellular adaptation to the specific architecture 
of oocytes.  
While cdk1-cyclin B activity is clearly the master regulator, my work also revealed important feedback 
mechanisms internal to the conserved RhoA-Rok-Myosin II signalling module wherein Rok and 
myosin II activity feeds back into the regulation of the contraction wave. These feedbacks have 
previously not been characterised, and I could detect and quantify them here for the first time due to 
the large size the cell as well as the dynamic behaviour of the signalling cascade. As the pathway is 
highly conserved, this feedback is likely to be present and may have important functions in other 
systems.  
Overall, my work identified the molecular regulatory pathway controlling the surface contraction 
waves in the starfish oocytes revealing how a spatial gradient of cell cycle factors in combination with 
feedbacks internal to the highly conserved RhoA-Rok-Myosin II pathway can pattern this spatially and 
temporally highly complex cellular behaviour.   
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